WO2022102628A1 - Composition for oral cavity - Google Patents
Composition for oral cavity Download PDFInfo
- Publication number
- WO2022102628A1 WO2022102628A1 PCT/JP2021/041226 JP2021041226W WO2022102628A1 WO 2022102628 A1 WO2022102628 A1 WO 2022102628A1 JP 2021041226 W JP2021041226 W JP 2021041226W WO 2022102628 A1 WO2022102628 A1 WO 2022102628A1
- Authority
- WO
- WIPO (PCT)
- Prior art keywords
- oral composition
- mass
- content
- feeling
- less
- Prior art date
Links
- 239000000203 mixture Substances 0.000 title claims abstract description 128
- 210000000214 mouth Anatomy 0.000 title abstract description 17
- 239000000843 powder Substances 0.000 claims abstract description 28
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000004094 surface-active agent Substances 0.000 claims abstract description 12
- 239000002826 coolant Substances 0.000 claims abstract 2
- -1 mentonglycerol ketal Chemical compound 0.000 claims description 61
- 150000003839 salts Chemical class 0.000 claims description 22
- 150000005846 sugar alcohols Polymers 0.000 claims description 15
- 239000000551 dentifrice Substances 0.000 claims description 14
- 238000002844 melting Methods 0.000 claims description 13
- 230000008018 melting Effects 0.000 claims description 13
- MPDGHEJMBKOTSU-YKLVYJNSSA-N 18beta-glycyrrhetic acid Chemical compound C([C@H]1C2=CC(=O)[C@H]34)[C@@](C)(C(O)=O)CC[C@]1(C)CC[C@@]2(C)[C@]4(C)CC[C@@H]1[C@]3(C)CC[C@H](O)C1(C)C MPDGHEJMBKOTSU-YKLVYJNSSA-N 0.000 claims description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 claims description 12
- 239000002904 solvent Substances 0.000 claims description 11
- 239000003795 chemical substances by application Substances 0.000 claims description 9
- LPLVUJXQOOQHMX-QWBHMCJMSA-N glycyrrhizinic acid Chemical compound O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@@H]1C([C@H]2[C@]([C@@H]3[C@@]([C@@]4(CC[C@@]5(C)CC[C@@](C)(C[C@H]5C4=CC3=O)C(O)=O)C)(C)CC2)(C)CC1)(C)C)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O LPLVUJXQOOQHMX-QWBHMCJMSA-N 0.000 claims description 7
- VTAJIXDZFCRWBR-UHFFFAOYSA-N Licoricesaponin B2 Natural products C1C(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2)C(O)=O)C)(C)CC2)(C)C2C(C)(C)CC1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O VTAJIXDZFCRWBR-UHFFFAOYSA-N 0.000 claims description 6
- LPLVUJXQOOQHMX-UHFFFAOYSA-N glycyrrhetinic acid glycoside Natural products C1CC(C2C(C3(CCC4(C)CCC(C)(CC4C3=CC2=O)C(O)=O)C)(C)CC2)(C)C2C(C)(C)C1OC1OC(C(O)=O)C(O)C(O)C1OC1OC(C(O)=O)C(O)C(O)C1O LPLVUJXQOOQHMX-UHFFFAOYSA-N 0.000 claims description 6
- 239000001685 glycyrrhizic acid Substances 0.000 claims description 6
- 229960004949 glycyrrhizic acid Drugs 0.000 claims description 6
- UYRUBYNTXSDKQT-UHFFFAOYSA-N glycyrrhizic acid Natural products CC1(C)C(CCC2(C)C1CCC3(C)C2C(=O)C=C4C5CC(C)(CCC5(C)CCC34C)C(=O)O)OC6OC(C(O)C(O)C6OC7OC(O)C(O)C(O)C7C(=O)O)C(=O)O UYRUBYNTXSDKQT-UHFFFAOYSA-N 0.000 claims description 6
- 235000019410 glycyrrhizin Nutrition 0.000 claims description 6
- VUNOFAIHSALQQH-UHFFFAOYSA-N Ethyl menthane carboxamide Chemical group CCNC(=O)C1CC(C)CCC1C(C)C VUNOFAIHSALQQH-UHFFFAOYSA-N 0.000 claims description 5
- MPDGHEJMBKOTSU-UHFFFAOYSA-N Glycyrrhetinsaeure Natural products C12C(=O)C=C3C4CC(C)(C(O)=O)CCC4(C)CCC3(C)C1(C)CCC1C2(C)CCC(O)C1(C)C MPDGHEJMBKOTSU-UHFFFAOYSA-N 0.000 claims description 5
- 238000001816 cooling Methods 0.000 claims description 5
- 229960003720 enoxolone Drugs 0.000 claims description 5
- 239000011248 coating agent Substances 0.000 claims description 4
- 230000035597 cooling sensation Effects 0.000 claims description 4
- FPJRGEOLQICYQZ-UHFFFAOYSA-N n-[4-(cyanomethyl)phenyl]-5-methyl-2-propan-2-ylcyclohexane-1-carboxamide Chemical compound CC(C)C1CCC(C)CC1C(=O)NC1=CC=C(CC#N)C=C1 FPJRGEOLQICYQZ-UHFFFAOYSA-N 0.000 claims description 3
- ZYTMANIQRDEHIO-UHFFFAOYSA-N p-menth-8-en-3-ol Chemical compound CC1CCC(C(C)=C)C(O)C1 ZYTMANIQRDEHIO-UHFFFAOYSA-N 0.000 claims description 3
- UJNOLBSYLSYIBM-WISYIIOYSA-N [(1r,2s,5r)-5-methyl-2-propan-2-ylcyclohexyl] (2r)-2-hydroxypropanoate Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@H]1OC(=O)[C@@H](C)O UJNOLBSYLSYIBM-WISYIIOYSA-N 0.000 claims 1
- 230000014759 maintenance of location Effects 0.000 abstract description 12
- 238000005299 abrasion Methods 0.000 abstract 1
- 230000002349 favourable effect Effects 0.000 abstract 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 31
- 235000002639 sodium chloride Nutrition 0.000 description 29
- 235000014113 dietary fatty acids Nutrition 0.000 description 26
- 239000000194 fatty acid Substances 0.000 description 26
- 229930195729 fatty acid Natural products 0.000 description 26
- 238000011156 evaluation Methods 0.000 description 22
- 230000003020 moisturizing effect Effects 0.000 description 22
- YLRFCQOZQXIBAB-RBZZARIASA-N fluoxymesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@]2(F)[C@@H]1[C@@H]1CC[C@](C)(O)[C@@]1(C)C[C@@H]2O YLRFCQOZQXIBAB-RBZZARIASA-N 0.000 description 18
- 239000002202 Polyethylene glycol Substances 0.000 description 17
- 229920001223 polyethylene glycol Polymers 0.000 description 17
- 235000011187 glycerol Nutrition 0.000 description 16
- KWIUHFFTVRNATP-UHFFFAOYSA-N glycine betaine Chemical compound C[N+](C)(C)CC([O-])=O KWIUHFFTVRNATP-UHFFFAOYSA-N 0.000 description 14
- 150000004665 fatty acids Chemical class 0.000 description 12
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical class O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 11
- 239000002994 raw material Substances 0.000 description 11
- 230000035807 sensation Effects 0.000 description 10
- 235000019615 sensations Nutrition 0.000 description 10
- 239000007788 liquid Substances 0.000 description 9
- 239000003921 oil Substances 0.000 description 9
- 239000000049 pigment Substances 0.000 description 9
- 238000005498 polishing Methods 0.000 description 9
- 229920003171 Poly (ethylene oxide) Polymers 0.000 description 8
- 239000003945 anionic surfactant Substances 0.000 description 8
- 125000004432 carbon atom Chemical group C* 0.000 description 8
- 239000004615 ingredient Substances 0.000 description 8
- 235000019198 oils Nutrition 0.000 description 8
- 229960003237 betaine Drugs 0.000 description 7
- 239000011230 binding agent Substances 0.000 description 7
- 239000003205 fragrance Substances 0.000 description 7
- 239000002245 particle Substances 0.000 description 7
- PUPZLCDOIYMWBV-UHFFFAOYSA-N (+/-)-1,3-Butanediol Chemical compound CC(O)CCO PUPZLCDOIYMWBV-UHFFFAOYSA-N 0.000 description 6
- GWEVSGVZZGPLCZ-UHFFFAOYSA-N Titan oxide Chemical compound O=[Ti]=O GWEVSGVZZGPLCZ-UHFFFAOYSA-N 0.000 description 6
- 239000002253 acid Substances 0.000 description 6
- 230000000052 comparative effect Effects 0.000 description 6
- 235000003599 food sweetener Nutrition 0.000 description 6
- 239000007787 solid Substances 0.000 description 6
- PRAKJMSDJKAYCZ-UHFFFAOYSA-N squalane Chemical compound CC(C)CCCC(C)CCCC(C)CCCCC(C)CCCC(C)CCCC(C)C PRAKJMSDJKAYCZ-UHFFFAOYSA-N 0.000 description 6
- 239000003765 sweetening agent Substances 0.000 description 6
- 235000001014 amino acid Nutrition 0.000 description 5
- 239000002280 amphoteric surfactant Substances 0.000 description 5
- 239000004359 castor oil Substances 0.000 description 5
- 235000019438 castor oil Nutrition 0.000 description 5
- 239000002552 dosage form Substances 0.000 description 5
- ZEMPKEQAKRGZGQ-XOQCFJPHSA-N glycerol triricinoleate Natural products CCCCCC[C@@H](O)CC=CCCCCCCCC(=O)OC[C@@H](COC(=O)CCCCCCCC=CC[C@@H](O)CCCCCC)OC(=O)CCCCCCCC=CC[C@H](O)CCCCCC ZEMPKEQAKRGZGQ-XOQCFJPHSA-N 0.000 description 5
- 238000004519 manufacturing process Methods 0.000 description 5
- 238000005259 measurement Methods 0.000 description 5
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- VTYYLEPIZMXCLO-UHFFFAOYSA-L Calcium carbonate Chemical compound [Ca+2].[O-]C([O-])=O VTYYLEPIZMXCLO-UHFFFAOYSA-L 0.000 description 4
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 4
- 239000003082 abrasive agent Substances 0.000 description 4
- 238000010521 absorption reaction Methods 0.000 description 4
- 125000000217 alkyl group Chemical group 0.000 description 4
- 150000008051 alkyl sulfates Chemical class 0.000 description 4
- 235000019658 bitter taste Nutrition 0.000 description 4
- 239000003086 colorant Substances 0.000 description 4
- 238000007796 conventional method Methods 0.000 description 4
- 239000000499 gel Substances 0.000 description 4
- OSWPMRLSEDHDFF-UHFFFAOYSA-N methyl salicylate Chemical compound COC(=O)C1=CC=CC=C1O OSWPMRLSEDHDFF-UHFFFAOYSA-N 0.000 description 4
- 239000002736 nonionic surfactant Substances 0.000 description 4
- 239000003002 pH adjusting agent Substances 0.000 description 4
- 239000003755 preservative agent Substances 0.000 description 4
- 239000000377 silicon dioxide Substances 0.000 description 4
- 159000000000 sodium salts Chemical class 0.000 description 4
- BDHFUVZGWQCTTF-UHFFFAOYSA-M sulfonate Chemical compound [O-]S(=O)=O BDHFUVZGWQCTTF-UHFFFAOYSA-M 0.000 description 4
- 239000000080 wetting agent Substances 0.000 description 4
- 239000004711 α-olefin Substances 0.000 description 4
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- LYCAIKOWRPUZTN-UHFFFAOYSA-N Ethylene glycol Chemical compound OCCO LYCAIKOWRPUZTN-UHFFFAOYSA-N 0.000 description 3
- IAYPIBMASNFSPL-UHFFFAOYSA-N Ethylene oxide Chemical compound C1CO1 IAYPIBMASNFSPL-UHFFFAOYSA-N 0.000 description 3
- WEEGYLXZBRQIMU-UHFFFAOYSA-N Eucalyptol Chemical compound C1CC2CCC1(C)OC2(C)C WEEGYLXZBRQIMU-UHFFFAOYSA-N 0.000 description 3
- BIVBRWYINDPWKA-VLQRKCJKSA-L Glycyrrhizinate dipotassium Chemical compound [K+].[K+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O BIVBRWYINDPWKA-VLQRKCJKSA-L 0.000 description 3
- 239000004354 Hydroxyethyl cellulose Substances 0.000 description 3
- 229920000663 Hydroxyethyl cellulose Polymers 0.000 description 3
- 239000004698 Polyethylene Substances 0.000 description 3
- 229920001214 Polysorbate 60 Polymers 0.000 description 3
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 3
- DNIAPMSPPWPWGF-UHFFFAOYSA-N Propylene glycol Chemical compound CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 3
- HEMHJVSKTPXQMS-UHFFFAOYSA-M Sodium hydroxide Chemical compound [OH-].[Na+] HEMHJVSKTPXQMS-UHFFFAOYSA-M 0.000 description 3
- 150000005215 alkyl ethers Chemical class 0.000 description 3
- 150000003863 ammonium salts Chemical class 0.000 description 3
- 230000001680 brushing effect Effects 0.000 description 3
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 3
- 238000005238 degreasing Methods 0.000 description 3
- HNPSIPDUKPIQMN-UHFFFAOYSA-N dioxosilane;oxo(oxoalumanyloxy)alumane Chemical compound O=[Si]=O.O=[Al]O[Al]=O HNPSIPDUKPIQMN-UHFFFAOYSA-N 0.000 description 3
- 229940101029 dipotassium glycyrrhizinate Drugs 0.000 description 3
- 239000003814 drug Substances 0.000 description 3
- 229940079593 drug Drugs 0.000 description 3
- 229920000591 gum Polymers 0.000 description 3
- 235000019447 hydroxyethyl cellulose Nutrition 0.000 description 3
- MTNDZQHUAFNZQY-UHFFFAOYSA-N imidazoline Chemical compound C1CN=CN1 MTNDZQHUAFNZQY-UHFFFAOYSA-N 0.000 description 3
- 238000000034 method Methods 0.000 description 3
- JXTPJDDICSTXJX-UHFFFAOYSA-N n-Triacontane Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCC JXTPJDDICSTXJX-UHFFFAOYSA-N 0.000 description 3
- GLDOVTGHNKAZLK-UHFFFAOYSA-N octadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCCCO GLDOVTGHNKAZLK-UHFFFAOYSA-N 0.000 description 3
- 239000002304 perfume Substances 0.000 description 3
- 229920000573 polyethylene Polymers 0.000 description 3
- XAEFZNCEHLXOMS-UHFFFAOYSA-M potassium benzoate Chemical compound [K+].[O-]C(=O)C1=CC=CC=C1 XAEFZNCEHLXOMS-UHFFFAOYSA-M 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 238000009987 spinning Methods 0.000 description 3
- 229940032094 squalane Drugs 0.000 description 3
- 239000002562 thickening agent Substances 0.000 description 3
- 239000000341 volatile oil Substances 0.000 description 3
- 239000001993 wax Substances 0.000 description 3
- LDVVTQMJQSCDMK-UHFFFAOYSA-N 1,3-dihydroxypropan-2-yl formate Chemical compound OCC(CO)OC=O LDVVTQMJQSCDMK-UHFFFAOYSA-N 0.000 description 2
- HFDVRLIODXPAHB-UHFFFAOYSA-N 1-tetradecene Chemical compound CCCCCCCCCCCCC=C HFDVRLIODXPAHB-UHFFFAOYSA-N 0.000 description 2
- XDOFQFKRPWOURC-UHFFFAOYSA-N 16-methylheptadecanoic acid Chemical compound CC(C)CCCCCCCCCCCCCCC(O)=O XDOFQFKRPWOURC-UHFFFAOYSA-N 0.000 description 2
- XPALGXXLALUMLE-UHFFFAOYSA-N 2-(dimethylamino)tetradecanoic acid Chemical compound CCCCCCCCCCCCC(N(C)C)C(O)=O XPALGXXLALUMLE-UHFFFAOYSA-N 0.000 description 2
- 108010011485 Aspartame Proteins 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- VEXZGXHMUGYJMC-UHFFFAOYSA-M Chloride anion Chemical compound [Cl-] VEXZGXHMUGYJMC-UHFFFAOYSA-M 0.000 description 2
- 244000060011 Cocos nucifera Species 0.000 description 2
- 235000013162 Cocos nucifera Nutrition 0.000 description 2
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 2
- 239000004386 Erythritol Substances 0.000 description 2
- UNXHWFMMPAWVPI-UHFFFAOYSA-N Erythritol Natural products OCC(O)C(O)CO UNXHWFMMPAWVPI-UHFFFAOYSA-N 0.000 description 2
- 206010016334 Feeling hot Diseases 0.000 description 2
- VZCYOOQTPOCHFL-OWOJBTEDSA-N Fumaric acid Chemical compound OC(=O)\C=C\C(O)=O VZCYOOQTPOCHFL-OWOJBTEDSA-N 0.000 description 2
- 239000004471 Glycine Substances 0.000 description 2
- 229920002153 Hydroxypropyl cellulose Polymers 0.000 description 2
- 235000017858 Laurus nobilis Nutrition 0.000 description 2
- 235000004347 Perilla Nutrition 0.000 description 2
- 244000124853 Perilla frutescens Species 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- AUNGANRZJHBGPY-SCRDCRAPSA-N Riboflavin Chemical compound OC[C@@H](O)[C@@H](O)[C@@H](O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-SCRDCRAPSA-N 0.000 description 2
- FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 2
- 229920002125 Sokalan® Polymers 0.000 description 2
- 244000125380 Terminalia tomentosa Species 0.000 description 2
- 235000005212 Terminalia tomentosa Nutrition 0.000 description 2
- RTAQQCXQSZGOHL-UHFFFAOYSA-N Titanium Chemical compound [Ti] RTAQQCXQSZGOHL-UHFFFAOYSA-N 0.000 description 2
- TVXBFESIOXBWNM-UHFFFAOYSA-N Xylitol Natural products OCCC(O)C(O)C(O)CCO TVXBFESIOXBWNM-UHFFFAOYSA-N 0.000 description 2
- 229910021536 Zeolite Inorganic materials 0.000 description 2
- 125000004442 acylamino group Chemical group 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- WNROFYMDJYEPJX-UHFFFAOYSA-K aluminium hydroxide Chemical compound [OH-].[OH-].[OH-].[Al+3] WNROFYMDJYEPJX-UHFFFAOYSA-K 0.000 description 2
- 230000002421 anti-septic effect Effects 0.000 description 2
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 2
- CUFNKYGDVFVPHO-UHFFFAOYSA-N azulene Chemical compound C1=CC=CC2=CC=CC2=C1 CUFNKYGDVFVPHO-UHFFFAOYSA-N 0.000 description 2
- 239000002585 base Substances 0.000 description 2
- HUMNYLRZRPPJDN-UHFFFAOYSA-N benzaldehyde Chemical compound O=CC1=CC=CC=C1 HUMNYLRZRPPJDN-UHFFFAOYSA-N 0.000 description 2
- 239000001055 blue pigment Substances 0.000 description 2
- 229910000019 calcium carbonate Inorganic materials 0.000 description 2
- 159000000007 calcium salts Chemical class 0.000 description 2
- OSGAYBCDTDRGGQ-UHFFFAOYSA-L calcium sulfate Chemical compound [Ca+2].[O-]S([O-])(=O)=O OSGAYBCDTDRGGQ-UHFFFAOYSA-L 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 235000010418 carrageenan Nutrition 0.000 description 2
- 239000000679 carrageenan Substances 0.000 description 2
- 229920001525 carrageenan Polymers 0.000 description 2
- 229940113118 carrageenan Drugs 0.000 description 2
- QMVPMAAFGQKVCJ-UHFFFAOYSA-N citronellol Chemical compound OCCC(C)CCC=C(C)C QMVPMAAFGQKVCJ-UHFFFAOYSA-N 0.000 description 2
- JOZKFWLRHCDGJA-UHFFFAOYSA-N citronellol acetate Chemical compound CC(=O)OCCC(C)CCC=C(C)C JOZKFWLRHCDGJA-UHFFFAOYSA-N 0.000 description 2
- 239000003240 coconut oil Substances 0.000 description 2
- 235000019864 coconut oil Nutrition 0.000 description 2
- 238000013329 compounding Methods 0.000 description 2
- 229910052802 copper Inorganic materials 0.000 description 2
- 239000010949 copper Substances 0.000 description 2
- MWKFXSUHUHTGQN-UHFFFAOYSA-N decan-1-ol Chemical compound CCCCCCCCCCO MWKFXSUHUHTGQN-UHFFFAOYSA-N 0.000 description 2
- 238000009826 distribution Methods 0.000 description 2
- POULHZVOKOAJMA-UHFFFAOYSA-N dodecanoic acid Chemical compound CCCCCCCCCCCC(O)=O POULHZVOKOAJMA-UHFFFAOYSA-N 0.000 description 2
- 238000001035 drying Methods 0.000 description 2
- UNXHWFMMPAWVPI-ZXZARUISSA-N erythritol Chemical compound OC[C@H](O)[C@H](O)CO UNXHWFMMPAWVPI-ZXZARUISSA-N 0.000 description 2
- 235000019414 erythritol Nutrition 0.000 description 2
- 229940009714 erythritol Drugs 0.000 description 2
- RRAFCDWBNXTKKO-UHFFFAOYSA-N eugenol Chemical compound COC1=CC(CC=C)=CC=C1O RRAFCDWBNXTKKO-UHFFFAOYSA-N 0.000 description 2
- 238000005187 foaming Methods 0.000 description 2
- 239000011521 glass Substances 0.000 description 2
- 150000004676 glycans Chemical class 0.000 description 2
- BXWNKGSJHAJOGX-UHFFFAOYSA-N hexadecan-1-ol Chemical compound CCCCCCCCCCCCCCCCO BXWNKGSJHAJOGX-UHFFFAOYSA-N 0.000 description 2
- JARKCYVAAOWBJS-UHFFFAOYSA-N hexanal Chemical compound CCCCCC=O JARKCYVAAOWBJS-UHFFFAOYSA-N 0.000 description 2
- 235000010977 hydroxypropyl cellulose Nutrition 0.000 description 2
- 239000001863 hydroxypropyl cellulose Substances 0.000 description 2
- MLFHJEHSLIIPHL-UHFFFAOYSA-N isoamyl acetate Chemical compound CC(C)CCOC(C)=O MLFHJEHSLIIPHL-UHFFFAOYSA-N 0.000 description 2
- ZYTMANIQRDEHIO-KXUCPTDWSA-N isopulegol Chemical compound C[C@@H]1CC[C@@H](C(C)=C)[C@H](O)C1 ZYTMANIQRDEHIO-KXUCPTDWSA-N 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 239000000832 lactitol Substances 0.000 description 2
- 235000010448 lactitol Nutrition 0.000 description 2
- 229960003451 lactitol Drugs 0.000 description 2
- 229940057995 liquid paraffin Drugs 0.000 description 2
- 159000000003 magnesium salts Chemical class 0.000 description 2
- VQHSOMBJVWLPSR-WUJBLJFYSA-N maltitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-WUJBLJFYSA-N 0.000 description 2
- 235000010449 maltitol Nutrition 0.000 description 2
- 239000000845 maltitol Substances 0.000 description 2
- 229940035436 maltitol Drugs 0.000 description 2
- 239000000463 material Substances 0.000 description 2
- HEBKCHPVOIAQTA-UHFFFAOYSA-N meso ribitol Natural products OCC(O)C(O)C(O)CO HEBKCHPVOIAQTA-UHFFFAOYSA-N 0.000 description 2
- VAMXMNNIEUEQDV-UHFFFAOYSA-N methyl anthranilate Chemical compound COC(=O)C1=CC=CC=C1N VAMXMNNIEUEQDV-UHFFFAOYSA-N 0.000 description 2
- 239000002324 mouth wash Substances 0.000 description 2
- TWNQGVIAIRXVLR-UHFFFAOYSA-N oxo(oxoalumanyloxy)alumane Chemical compound O=[Al]O[Al]=O TWNQGVIAIRXVLR-UHFFFAOYSA-N 0.000 description 2
- XNGIFLGASWRNHJ-UHFFFAOYSA-N phthalic acid Chemical compound OC(=O)C1=CC=CC=C1C(O)=O XNGIFLGASWRNHJ-UHFFFAOYSA-N 0.000 description 2
- 229940068918 polyethylene glycol 400 Drugs 0.000 description 2
- 229920002503 polyoxyethylene-polyoxypropylene Polymers 0.000 description 2
- 229920001282 polysaccharide Polymers 0.000 description 2
- 239000005017 polysaccharide Substances 0.000 description 2
- 239000001267 polyvinylpyrrolidone Substances 0.000 description 2
- 235000013855 polyvinylpyrrolidone Nutrition 0.000 description 2
- 229920000036 polyvinylpyrrolidone Polymers 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- 230000003449 preventive effect Effects 0.000 description 2
- RMAQACBXLXPBSY-UHFFFAOYSA-N silicic acid Chemical compound O[Si](O)(O)O RMAQACBXLXPBSY-UHFFFAOYSA-N 0.000 description 2
- 235000012239 silicon dioxide Nutrition 0.000 description 2
- PUZPDOWCWNUUKD-UHFFFAOYSA-M sodium fluoride Chemical compound [F-].[Na+] PUZPDOWCWNUUKD-UHFFFAOYSA-M 0.000 description 2
- 229910052719 titanium Inorganic materials 0.000 description 2
- 239000010936 titanium Substances 0.000 description 2
- 239000004408 titanium dioxide Substances 0.000 description 2
- OGIDPMRJRNCKJF-UHFFFAOYSA-N titanium oxide Inorganic materials [Ti]=O OGIDPMRJRNCKJF-UHFFFAOYSA-N 0.000 description 2
- 230000002087 whitening effect Effects 0.000 description 2
- 239000009637 wintergreen oil Substances 0.000 description 2
- 229920001285 xanthan gum Polymers 0.000 description 2
- 235000010493 xanthan gum Nutrition 0.000 description 2
- 239000000230 xanthan gum Substances 0.000 description 2
- 229940082509 xanthan gum Drugs 0.000 description 2
- 239000000811 xylitol Substances 0.000 description 2
- 235000010447 xylitol Nutrition 0.000 description 2
- 229960002675 xylitol Drugs 0.000 description 2
- HEBKCHPVOIAQTA-SCDXWVJYSA-N xylitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)CO HEBKCHPVOIAQTA-SCDXWVJYSA-N 0.000 description 2
- 239000010457 zeolite Substances 0.000 description 2
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 2
- NOOLISFMXDJSKH-UTLUCORTSA-N (+)-Neomenthol Chemical compound CC(C)[C@@H]1CC[C@@H](C)C[C@@H]1O NOOLISFMXDJSKH-UTLUCORTSA-N 0.000 description 1
- DTGKSKDOIYIVQL-WEDXCCLWSA-N (+)-borneol Chemical compound C1C[C@@]2(C)[C@@H](O)C[C@@H]1C2(C)C DTGKSKDOIYIVQL-WEDXCCLWSA-N 0.000 description 1
- JWZZKOKVBUJMES-UHFFFAOYSA-N (+-)-Isoprenaline Chemical compound CC(C)NCC(O)C1=CC=C(O)C(O)=C1 JWZZKOKVBUJMES-UHFFFAOYSA-N 0.000 description 1
- REPVLJRCJUVQFA-UHFFFAOYSA-N (-)-isopinocampheol Natural products C1C(O)C(C)C2C(C)(C)C1C2 REPVLJRCJUVQFA-UHFFFAOYSA-N 0.000 description 1
- NFLGAXVYCFJBMK-BDAKNGLRSA-N (-)-menthone Chemical compound CC(C)[C@@H]1CC[C@@H](C)CC1=O NFLGAXVYCFJBMK-BDAKNGLRSA-N 0.000 description 1
- 239000001871 (1R,2R,5S)-5-methyl-2-prop-1-en-2-ylcyclohexan-1-ol Substances 0.000 description 1
- FTLYMKDSHNWQKD-UHFFFAOYSA-N (2,4,5-trichlorophenyl)boronic acid Chemical compound OB(O)C1=CC(Cl)=C(Cl)C=C1Cl FTLYMKDSHNWQKD-UHFFFAOYSA-N 0.000 description 1
- MBDOYVRWFFCFHM-SNAWJCMRSA-N (2E)-hexenal Chemical compound CCC\C=C\C=O MBDOYVRWFFCFHM-SNAWJCMRSA-N 0.000 description 1
- KZRXPHCVIMWWDS-AWEZNQCLSA-N (4S)-4-amino-5-dodecanoyloxy-5-oxopentanoic acid Chemical compound CCCCCCCCCCCC(=O)OC(=O)[C@@H](N)CCC(O)=O KZRXPHCVIMWWDS-AWEZNQCLSA-N 0.000 description 1
- QYIXCDOBOSTCEI-QCYZZNICSA-N (5alpha)-cholestan-3beta-ol Chemical compound C([C@@H]1CC2)[C@@H](O)CC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CC[C@H]([C@H](C)CCCC(C)C)[C@@]2(C)CC1 QYIXCDOBOSTCEI-QCYZZNICSA-N 0.000 description 1
- GRWFGVWFFZKLTI-YGPZHTELSA-N (5r)-4,6,6-trimethylbicyclo[3.1.1]hept-3-ene Chemical compound C1C2CC=C(C)[C@]1([H])C2(C)C GRWFGVWFFZKLTI-YGPZHTELSA-N 0.000 description 1
- ALSTYHKOOCGGFT-KTKRTIGZSA-N (9Z)-octadecen-1-ol Chemical compound CCCCCCCC\C=C/CCCCCCCCO ALSTYHKOOCGGFT-KTKRTIGZSA-N 0.000 description 1
- WRIDQFICGBMAFQ-UHFFFAOYSA-N (E)-8-Octadecenoic acid Natural products CCCCCCCCCC=CCCCCCCC(O)=O WRIDQFICGBMAFQ-UHFFFAOYSA-N 0.000 description 1
- QMVPMAAFGQKVCJ-SNVBAGLBSA-N (R)-(+)-citronellol Natural products OCC[C@H](C)CCC=C(C)C QMVPMAAFGQKVCJ-SNVBAGLBSA-N 0.000 description 1
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- WUOACPNHFRMFPN-SECBINFHSA-N (S)-(-)-alpha-terpineol Chemical compound CC1=CC[C@@H](C(C)(C)O)CC1 WUOACPNHFRMFPN-SECBINFHSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- 229940058015 1,3-butylene glycol Drugs 0.000 description 1
- HNAGHMKIPMKKBB-UHFFFAOYSA-N 1-benzylpyrrolidine-3-carboxamide Chemical compound C1C(C(=O)N)CCN1CC1=CC=CC=C1 HNAGHMKIPMKKBB-UHFFFAOYSA-N 0.000 description 1
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- HVNMCCPQUIEPCT-UHFFFAOYSA-N 2-(dimethylazaniumyl)pentanoate Chemical compound CCCC(N(C)C)C(O)=O HVNMCCPQUIEPCT-UHFFFAOYSA-N 0.000 description 1
- LBIZZGIYNNLXQN-UHFFFAOYSA-N 2-dodecoxy-2-oxoethanesulfonic acid Chemical class CCCCCCCCCCCCOC(=O)CS(O)(=O)=O LBIZZGIYNNLXQN-UHFFFAOYSA-N 0.000 description 1
- LQJBNNIYVWPHFW-UHFFFAOYSA-N 20:1omega9c fatty acid Natural products CCCCCCCCCCC=CCCCCCCCC(O)=O LQJBNNIYVWPHFW-UHFFFAOYSA-N 0.000 description 1
- ILKFYYOGOCVZRU-UHFFFAOYSA-N 3-(dodecanoylamino)propanoic acid Chemical class CCCCCCCCCCCC(=O)NCCC(O)=O ILKFYYOGOCVZRU-UHFFFAOYSA-N 0.000 description 1
- HKJKXDULJBGDED-UHFFFAOYSA-N 3-(tetradecylamino)propanoic acid Chemical class CCCCCCCCCCCCCCNCCC(O)=O HKJKXDULJBGDED-UHFFFAOYSA-N 0.000 description 1
- UNWFFCPRJXMCNV-UHFFFAOYSA-N 3-[dodecanoyl(methyl)amino]propanoic acid Chemical class CCCCCCCCCCCC(=O)N(C)CCC(O)=O UNWFFCPRJXMCNV-UHFFFAOYSA-N 0.000 description 1
- XGRSAFKZAGGXJV-UHFFFAOYSA-N 3-azaniumyl-3-cyclohexylpropanoate Chemical compound OC(=O)CC(N)C1CCCCC1 XGRSAFKZAGGXJV-UHFFFAOYSA-N 0.000 description 1
- IJALWSVNUBBQRA-UHFFFAOYSA-N 4-Isopropyl-3-methylphenol Chemical compound CC(C)C1=CC=C(O)C=C1C IJALWSVNUBBQRA-UHFFFAOYSA-N 0.000 description 1
- HIQIXEFWDLTDED-UHFFFAOYSA-N 4-hydroxy-1-piperidin-4-ylpyrrolidin-2-one Chemical compound O=C1CC(O)CN1C1CCNCC1 HIQIXEFWDLTDED-UHFFFAOYSA-N 0.000 description 1
- AXCXHFKZHDEKTP-NSCUHMNNSA-N 4-methoxycinnamaldehyde Chemical compound COC1=CC=C(\C=C\C=O)C=C1 AXCXHFKZHDEKTP-NSCUHMNNSA-N 0.000 description 1
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 1
- QSBYPNXLFMSGKH-UHFFFAOYSA-N 9-Heptadecensaeure Natural products CCCCCCCC=CCCCCCCCC(O)=O QSBYPNXLFMSGKH-UHFFFAOYSA-N 0.000 description 1
- RSWGJHLUYNHPMX-UHFFFAOYSA-N Abietic-Saeure Natural products C12CCC(C(C)C)=CC2=CCC2C1(C)CCCC2(C)C(O)=O RSWGJHLUYNHPMX-UHFFFAOYSA-N 0.000 description 1
- 239000004382 Amylase Substances 0.000 description 1
- 102000013142 Amylases Human genes 0.000 description 1
- 108010065511 Amylases Proteins 0.000 description 1
- 240000002900 Arthrospira platensis Species 0.000 description 1
- 235000016425 Arthrospira platensis Nutrition 0.000 description 1
- 241000416162 Astragalus gummifer Species 0.000 description 1
- 235000011301 Brassica oleracea var capitata Nutrition 0.000 description 1
- 244000178937 Brassica oleracea var. capitata Species 0.000 description 1
- OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
- NPBVQXIMTZKSBA-UHFFFAOYSA-N Chavibetol Natural products COC1=CC=C(CC=C)C=C1O NPBVQXIMTZKSBA-UHFFFAOYSA-N 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- WTEVQBCEXWBHNA-UHFFFAOYSA-N Citral Natural products CC(C)=CCCC(C)=CC=O WTEVQBCEXWBHNA-UHFFFAOYSA-N 0.000 description 1
- JOZKFWLRHCDGJA-LLVKDONJSA-N Citronellyl acetate Natural products CC(=O)OCC[C@H](C)CCC=C(C)C JOZKFWLRHCDGJA-LLVKDONJSA-N 0.000 description 1
- 239000005749 Copper compound Substances 0.000 description 1
- SEBIKDIMAPSUBY-ARYZWOCPSA-N Crocin Chemical compound C([C@H]1O[C@H]([C@@H]([C@@H](O)[C@@H]1O)O)OC(=O)C(C)=CC=CC(C)=C\C=C\C=C(/C)\C=C\C=C(C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO[C@H]2[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O2)O)O1)O)O[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O SEBIKDIMAPSUBY-ARYZWOCPSA-N 0.000 description 1
- FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
- AUNGANRZJHBGPY-UHFFFAOYSA-N D-Lyxoflavin Natural products OCC(O)C(O)C(O)CN1C=2C=C(C)C(C)=CC=2N=C2C1=NC(=O)NC2=O AUNGANRZJHBGPY-UHFFFAOYSA-N 0.000 description 1
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 1
- FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
- XHXUANMFYXWVNG-UHFFFAOYSA-N D-menthyl acetate Natural products CC(C)C1CCC(C)CC1OC(C)=O XHXUANMFYXWVNG-UHFFFAOYSA-N 0.000 description 1
- NOOLISFMXDJSKH-UHFFFAOYSA-N DL-menthol Natural products CC(C)C1CCC(C)CC1O NOOLISFMXDJSKH-UHFFFAOYSA-N 0.000 description 1
- 244000000626 Daucus carota Species 0.000 description 1
- 235000002767 Daucus carota Nutrition 0.000 description 1
- 240000002943 Elettaria cardamomum Species 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 239000005977 Ethylene Substances 0.000 description 1
- 239000005770 Eugenol Substances 0.000 description 1
- 239000001329 FEMA 3811 Substances 0.000 description 1
- 240000001972 Gardenia jasminoides Species 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- 241000208690 Hamamelis Species 0.000 description 1
- 235000005206 Hibiscus Nutrition 0.000 description 1
- 235000007185 Hibiscus lunariifolius Nutrition 0.000 description 1
- 244000284380 Hibiscus rosa sinensis Species 0.000 description 1
- 206010020751 Hypersensitivity Diseases 0.000 description 1
- SKCKOFZKJLZSFA-UHFFFAOYSA-N L-Gulomethylit Natural products CC(O)C(O)C(O)C(O)CO SKCKOFZKJLZSFA-UHFFFAOYSA-N 0.000 description 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 description 1
- QNAYBMKLOCPYGJ-REOHCLBHSA-N L-alanine Chemical compound C[C@H](N)C(O)=O QNAYBMKLOCPYGJ-REOHCLBHSA-N 0.000 description 1
- 239000005639 Lauric acid Substances 0.000 description 1
- 235000019501 Lemon oil Nutrition 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 235000006679 Mentha X verticillata Nutrition 0.000 description 1
- 235000002899 Mentha suaveolens Nutrition 0.000 description 1
- 235000001636 Mentha x rotundifolia Nutrition 0.000 description 1
- ILRKKHJEINIICQ-OOFFSTKBSA-N Monoammonium glycyrrhizinate Chemical compound N.O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C(O)=O)C(O)=O)[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@H]1O ILRKKHJEINIICQ-OOFFSTKBSA-N 0.000 description 1
- 108010014251 Muramidase Proteins 0.000 description 1
- 102000016943 Muramidase Human genes 0.000 description 1
- 108010062010 N-Acetylmuramoyl-L-alanine Amidase Proteins 0.000 description 1
- BACYUWVYYTXETD-UHFFFAOYSA-N N-Lauroylsarcosine Chemical class CCCCCCCCCCCC(=O)N(C)CC(O)=O BACYUWVYYTXETD-UHFFFAOYSA-N 0.000 description 1
- SUZRRICLUFMAQD-UHFFFAOYSA-N N-Methyltaurine Chemical class CNCCS(O)(=O)=O SUZRRICLUFMAQD-UHFFFAOYSA-N 0.000 description 1
- 239000004677 Nylon Substances 0.000 description 1
- 239000005642 Oleic acid Substances 0.000 description 1
- ZQPPMHVWECSIRJ-UHFFFAOYSA-N Oleic acid Natural products CCCCCCCCC=CCCCCCCCC(O)=O ZQPPMHVWECSIRJ-UHFFFAOYSA-N 0.000 description 1
- 235000019502 Orange oil Nutrition 0.000 description 1
- 240000007594 Oryza sativa Species 0.000 description 1
- 235000007164 Oryza sativa Nutrition 0.000 description 1
- 229910019142 PO4 Inorganic materials 0.000 description 1
- 241000282320 Panthera leo Species 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- XCOJIVIDDFTHGB-UEUZTHOGSA-N Perillartine Chemical compound CC(=C)[C@H]1CCC(\C=N\O)=CC1 XCOJIVIDDFTHGB-UEUZTHOGSA-N 0.000 description 1
- LQKRYVGRPXFFAV-UHFFFAOYSA-N Phenylmethylglycidic ester Chemical compound CCOC(=O)C1OC1(C)C1=CC=CC=C1 LQKRYVGRPXFFAV-UHFFFAOYSA-N 0.000 description 1
- 239000004743 Polypropylene Substances 0.000 description 1
- 239000004372 Polyvinyl alcohol Substances 0.000 description 1
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 description 1
- HDSBZMRLPLPFLQ-UHFFFAOYSA-N Propylene glycol alginate Chemical compound OC1C(O)C(OC)OC(C(O)=O)C1OC1C(O)C(O)C(C)C(C(=O)OCC(C)O)O1 HDSBZMRLPLPFLQ-UHFFFAOYSA-N 0.000 description 1
- 239000004365 Protease Substances 0.000 description 1
- UVMRYBDEERADNV-UHFFFAOYSA-N Pseudoeugenol Natural products COC1=CC(C(C)=C)=CC=C1O UVMRYBDEERADNV-UHFFFAOYSA-N 0.000 description 1
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical class C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 1
- 102100037486 Reverse transcriptase/ribonuclease H Human genes 0.000 description 1
- KHPCPRHQVVSZAH-HUOMCSJISA-N Rosin Natural products O(C/C=C/c1ccccc1)[C@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 KHPCPRHQVVSZAH-HUOMCSJISA-N 0.000 description 1
- PMZURENOXWZQFD-UHFFFAOYSA-L Sodium Sulfate Chemical compound [Na+].[Na+].[O-]S([O-])(=O)=O PMZURENOXWZQFD-UHFFFAOYSA-L 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- 244000299461 Theobroma cacao Species 0.000 description 1
- 235000005764 Theobroma cacao ssp. cacao Nutrition 0.000 description 1
- 235000005767 Theobroma cacao ssp. sphaerocarpum Nutrition 0.000 description 1
- 240000002657 Thymus vulgaris Species 0.000 description 1
- 235000007303 Thymus vulgaris Nutrition 0.000 description 1
- ATJFFYVFTNAWJD-UHFFFAOYSA-N Tin Chemical class [Sn] ATJFFYVFTNAWJD-UHFFFAOYSA-N 0.000 description 1
- 229910021626 Tin(II) chloride Inorganic materials 0.000 description 1
- XEFQLINVKFYRCS-UHFFFAOYSA-N Triclosan Chemical compound OC1=CC(Cl)=CC=C1OC1=CC=C(Cl)C=C1Cl XEFQLINVKFYRCS-UHFFFAOYSA-N 0.000 description 1
- ZMANZCXQSJIPKH-UHFFFAOYSA-N Triethylamine Chemical class CCN(CC)CC ZMANZCXQSJIPKH-UHFFFAOYSA-N 0.000 description 1
- 229930003268 Vitamin C Natural products 0.000 description 1
- HCHKCACWOHOZIP-UHFFFAOYSA-N Zinc Chemical compound [Zn] HCHKCACWOHOZIP-UHFFFAOYSA-N 0.000 description 1
- WHMDKBIGKVEYHS-IYEMJOQQSA-L Zinc gluconate Chemical compound [Zn+2].OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C([O-])=O WHMDKBIGKVEYHS-IYEMJOQQSA-L 0.000 description 1
- 244000273928 Zingiber officinale Species 0.000 description 1
- 235000006886 Zingiber officinale Nutrition 0.000 description 1
- XHXUANMFYXWVNG-WCQGTBRESA-N [(1s,2r,5s)-5-methyl-2-propan-2-ylcyclohexyl] acetate Chemical compound CC(C)[C@H]1CC[C@H](C)C[C@@H]1OC(C)=O XHXUANMFYXWVNG-WCQGTBRESA-N 0.000 description 1
- KPQJOKRSYYJJEL-VLQRKCJKSA-K [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O Chemical compound [Na+].[Na+].CC1(C)[C@H](CC[C@@]2(C)[C@H]1CC[C@]1(C)[C@@H]2C(=O)C=C2[C@@H]3C[C@](C)(CC[C@]3(C)CC[C@@]12C)C([O-])=O)O[C@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O[C@@H]1O[C@@H]([C@@H](O)[C@H](O)[C@H]1O)C([O-])=O)C([O-])=O KPQJOKRSYYJJEL-VLQRKCJKSA-K 0.000 description 1
- ZIALXKMBHWELGF-UHFFFAOYSA-N [Na].[Cu] Chemical compound [Na].[Cu] ZIALXKMBHWELGF-UHFFFAOYSA-N 0.000 description 1
- DPXJVFZANSGRMM-UHFFFAOYSA-N acetic acid;2,3,4,5,6-pentahydroxyhexanal;sodium Chemical compound [Na].CC(O)=O.OCC(O)C(O)C(O)C(O)C=O DPXJVFZANSGRMM-UHFFFAOYSA-N 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 125000002252 acyl group Chemical group 0.000 description 1
- 235000004279 alanine Nutrition 0.000 description 1
- 150000001299 aldehydes Chemical class 0.000 description 1
- 229910052783 alkali metal Inorganic materials 0.000 description 1
- 125000005210 alkyl ammonium group Chemical group 0.000 description 1
- 208000026935 allergic disease Diseases 0.000 description 1
- OVKDFILSBMEKLT-UHFFFAOYSA-N alpha-Terpineol Natural products CC(=C)C1(O)CCC(C)=CC1 OVKDFILSBMEKLT-UHFFFAOYSA-N 0.000 description 1
- QYIXCDOBOSTCEI-UHFFFAOYSA-N alpha-cholestanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 QYIXCDOBOSTCEI-UHFFFAOYSA-N 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229940088601 alpha-terpineol Drugs 0.000 description 1
- AZDRQVAHHNSJOQ-UHFFFAOYSA-N alumane Chemical class [AlH3] AZDRQVAHHNSJOQ-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 229910000323 aluminium silicate Inorganic materials 0.000 description 1
- 150000001413 amino acids Chemical class 0.000 description 1
- 229960002684 aminocaproic acid Drugs 0.000 description 1
- 235000019418 amylase Nutrition 0.000 description 1
- 239000003242 anti bacterial agent Substances 0.000 description 1
- 230000000844 anti-bacterial effect Effects 0.000 description 1
- 229940121363 anti-inflammatory agent Drugs 0.000 description 1
- 239000002260 anti-inflammatory agent Substances 0.000 description 1
- 150000001483 arginine derivatives Chemical class 0.000 description 1
- 235000010323 ascorbic acid Nutrition 0.000 description 1
- 229960005070 ascorbic acid Drugs 0.000 description 1
- 239000011668 ascorbic acid Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 239000003212 astringent agent Substances 0.000 description 1
- 239000003899 bactericide agent Substances 0.000 description 1
- 239000000440 bentonite Substances 0.000 description 1
- 229910000278 bentonite Inorganic materials 0.000 description 1
- SVPXDRXYRYOSEX-UHFFFAOYSA-N bentoquatam Chemical compound O.O=[Si]=O.O=[Al]O[Al]=O SVPXDRXYRYOSEX-UHFFFAOYSA-N 0.000 description 1
- 229960000686 benzalkonium chloride Drugs 0.000 description 1
- UREZNYTWGJKWBI-UHFFFAOYSA-M benzethonium chloride Chemical compound [Cl-].C1=CC(C(C)(C)CC(C)(C)C)=CC=C1OCCOCC[N+](C)(C)CC1=CC=CC=C1 UREZNYTWGJKWBI-UHFFFAOYSA-M 0.000 description 1
- 229960001950 benzethonium chloride Drugs 0.000 description 1
- CADWTSSKOVRVJC-UHFFFAOYSA-N benzyl(dimethyl)azanium;chloride Chemical compound [Cl-].C[NH+](C)CC1=CC=CC=C1 CADWTSSKOVRVJC-UHFFFAOYSA-N 0.000 description 1
- JGQFVRIQXUFPAH-UHFFFAOYSA-N beta-citronellol Natural products OCCC(C)CCCC(C)=C JGQFVRIQXUFPAH-UHFFFAOYSA-N 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- CKDOCTFBFTVPSN-UHFFFAOYSA-N borneol Natural products C1CC2(C)C(C)CC1C2(C)C CKDOCTFBFTVPSN-UHFFFAOYSA-N 0.000 description 1
- 229940116229 borneol Drugs 0.000 description 1
- 235000012745 brilliant blue FCF Nutrition 0.000 description 1
- 235000019437 butane-1,3-diol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- OBNCKNCVKJNDBV-UHFFFAOYSA-N butanoic acid ethyl ester Natural products CCCC(=O)OCC OBNCKNCVKJNDBV-UHFFFAOYSA-N 0.000 description 1
- 125000000484 butyl group Chemical group [H]C([*])([H])C([H])([H])C([H])([H])C([H])([H])[H] 0.000 description 1
- 235000001046 cacaotero Nutrition 0.000 description 1
- 239000011575 calcium Substances 0.000 description 1
- 229910052791 calcium Inorganic materials 0.000 description 1
- AXCZMVOFGPJBDE-UHFFFAOYSA-L calcium dihydroxide Chemical compound [OH-].[OH-].[Ca+2] AXCZMVOFGPJBDE-UHFFFAOYSA-L 0.000 description 1
- JUNWLZAGQLJVLR-UHFFFAOYSA-J calcium diphosphate Chemical compound [Ca+2].[Ca+2].[O-]P([O-])(=O)OP([O-])([O-])=O JUNWLZAGQLJVLR-UHFFFAOYSA-J 0.000 description 1
- FUFJGUQYACFECW-UHFFFAOYSA-L calcium hydrogenphosphate Chemical compound [Ca+2].OP([O-])([O-])=O FUFJGUQYACFECW-UHFFFAOYSA-L 0.000 description 1
- 239000000920 calcium hydroxide Substances 0.000 description 1
- 229910001861 calcium hydroxide Inorganic materials 0.000 description 1
- ROPDWRCJTIRLTR-UHFFFAOYSA-L calcium metaphosphate Chemical compound [Ca+2].[O-]P(=O)=O.[O-]P(=O)=O ROPDWRCJTIRLTR-UHFFFAOYSA-L 0.000 description 1
- 239000001506 calcium phosphate Substances 0.000 description 1
- 229910000389 calcium phosphate Inorganic materials 0.000 description 1
- 235000011010 calcium phosphates Nutrition 0.000 description 1
- 229940043256 calcium pyrophosphate Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 239000002775 capsule Substances 0.000 description 1
- 150000003857 carboxamides Chemical class 0.000 description 1
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 1
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 1
- 235000005300 cardamomo Nutrition 0.000 description 1
- 239000004203 carnauba wax Substances 0.000 description 1
- 235000013869 carnauba wax Nutrition 0.000 description 1
- 239000003093 cationic surfactant Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229940082500 cetostearyl alcohol Drugs 0.000 description 1
- 229960000541 cetyl alcohol Drugs 0.000 description 1
- 229960001927 cetylpyridinium chloride Drugs 0.000 description 1
- YMKDRGPMQRFJGP-UHFFFAOYSA-M cetylpyridinium chloride Chemical compound [Cl-].CCCCCCCCCCCCCCCC[N+]1=CC=CC=C1 YMKDRGPMQRFJGP-UHFFFAOYSA-M 0.000 description 1
- 229930002875 chlorophyll Natural products 0.000 description 1
- 235000019804 chlorophyll Nutrition 0.000 description 1
- ATNHDLDRLWWWCB-AENOIHSZSA-M chlorophyll a Chemical compound C1([C@@H](C(=O)OC)C(=O)C2=C3C)=C2N2C3=CC(C(CC)=C3C)=[N+]4C3=CC3=C(C=C)C(C)=C5N3[Mg-2]42[N+]2=C1[C@@H](CCC(=O)OC\C=C(/C)CCC[C@H](C)CCC[C@H](C)CCCC(C)C)[C@H](C)C2=C5 ATNHDLDRLWWWCB-AENOIHSZSA-M 0.000 description 1
- 229930007050 cineol Natural products 0.000 description 1
- 229960005233 cineole Drugs 0.000 description 1
- 229940043350 citral Drugs 0.000 description 1
- 235000000484 citronellol Nutrition 0.000 description 1
- 239000002734 clay mineral Substances 0.000 description 1
- 238000004140 cleaning Methods 0.000 description 1
- 239000010634 clove oil Substances 0.000 description 1
- MRUAUOIMASANKQ-UHFFFAOYSA-N cocamidopropyl betaine Chemical compound CCCCCCCCCCCC(=O)NCCC[N+](C)(C)CC([O-])=O MRUAUOIMASANKQ-UHFFFAOYSA-N 0.000 description 1
- 229940073507 cocamidopropyl betaine Drugs 0.000 description 1
- 229920001577 copolymer Polymers 0.000 description 1
- 150000001879 copper Chemical class 0.000 description 1
- 150000001880 copper compounds Chemical class 0.000 description 1
- 239000002537 cosmetic Substances 0.000 description 1
- 239000006071 cream Substances 0.000 description 1
- 239000003431 cross linking reagent Substances 0.000 description 1
- 230000002950 deficient Effects 0.000 description 1
- 210000004268 dentin Anatomy 0.000 description 1
- 235000019821 dicalcium diphosphate Nutrition 0.000 description 1
- 235000019700 dicalcium phosphate Nutrition 0.000 description 1
- UAOMVDZJSHZZME-UHFFFAOYSA-N diisopropylamine Chemical class CC(C)NC(C)C UAOMVDZJSHZZME-UHFFFAOYSA-N 0.000 description 1
- GQOKIYDTHHZSCJ-UHFFFAOYSA-M dimethyl-bis(prop-2-enyl)azanium;chloride Chemical compound [Cl-].C=CC[N+](C)(C)CC=C GQOKIYDTHHZSCJ-UHFFFAOYSA-M 0.000 description 1
- SZXQTJUDPRGNJN-UHFFFAOYSA-N dipropylene glycol Chemical compound OCCCOCCCO SZXQTJUDPRGNJN-UHFFFAOYSA-N 0.000 description 1
- BNIILDVGGAEEIG-UHFFFAOYSA-L disodium hydrogen phosphate Chemical compound [Na+].[Na+].OP([O-])([O-])=O BNIILDVGGAEEIG-UHFFFAOYSA-L 0.000 description 1
- OOYIOIOOWUGAHD-UHFFFAOYSA-L disodium;2',4',5',7'-tetrabromo-4,5,6,7-tetrachloro-3-oxospiro[2-benzofuran-1,9'-xanthene]-3',6'-diolate Chemical compound [Na+].[Na+].O1C(=O)C(C(=C(Cl)C(Cl)=C2Cl)Cl)=C2C21C1=CC(Br)=C([O-])C(Br)=C1OC1=C(Br)C([O-])=C(Br)C=C21 OOYIOIOOWUGAHD-UHFFFAOYSA-L 0.000 description 1
- DTGKSKDOIYIVQL-UHFFFAOYSA-N dl-isoborneol Natural products C1CC2(C)C(O)CC1C2(C)C DTGKSKDOIYIVQL-UHFFFAOYSA-N 0.000 description 1
- LQZZUXJYWNFBMV-UHFFFAOYSA-N dodecan-1-ol Chemical compound CCCCCCCCCCCCO LQZZUXJYWNFBMV-UHFFFAOYSA-N 0.000 description 1
- 125000003438 dodecyl group Chemical group [H]C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])C([H])([H])* 0.000 description 1
- MOTZDAYCYVMXPC-UHFFFAOYSA-N dodecyl hydrogen sulfate Chemical compound CCCCCCCCCCCCOS(O)(=O)=O MOTZDAYCYVMXPC-UHFFFAOYSA-N 0.000 description 1
- 229940043264 dodecyl sulfate Drugs 0.000 description 1
- 239000000975 dye Substances 0.000 description 1
- 235000013399 edible fruits Nutrition 0.000 description 1
- 230000000694 effects Effects 0.000 description 1
- 239000000839 emulsion Substances 0.000 description 1
- 230000002708 enhancing effect Effects 0.000 description 1
- 229940088598 enzyme Drugs 0.000 description 1
- 150000002148 esters Chemical class 0.000 description 1
- RTZKZFJDLAIYFH-UHFFFAOYSA-N ether Substances CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 1
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 1
- 239000010642 eucalyptus oil Substances 0.000 description 1
- 229940044949 eucalyptus oil Drugs 0.000 description 1
- 229960002217 eugenol Drugs 0.000 description 1
- 108010000165 exo-1,3-alpha-glucanase Proteins 0.000 description 1
- 239000000284 extract Substances 0.000 description 1
- 239000010408 film Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- 229910052587 fluorapatite Inorganic materials 0.000 description 1
- 150000002222 fluorine compounds Chemical class 0.000 description 1
- 239000006260 foam Substances 0.000 description 1
- 239000001530 fumaric acid Substances 0.000 description 1
- 239000009627 gardenia yellow Substances 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- WTEVQBCEXWBHNA-JXMROGBWSA-N geranial Chemical compound CC(C)=CCC\C(C)=C\C=O WTEVQBCEXWBHNA-JXMROGBWSA-N 0.000 description 1
- 235000008397 ginger Nutrition 0.000 description 1
- 229940070818 glycyrrhizate Drugs 0.000 description 1
- 229940093915 gynecological organic acid Drugs 0.000 description 1
- 150000004679 hydroxides Chemical class 0.000 description 1
- 229910052588 hydroxylapatite Inorganic materials 0.000 description 1
- 229920003088 hydroxypropyl methyl cellulose Polymers 0.000 description 1
- 230000009610 hypersensitivity Effects 0.000 description 1
- 230000001771 impaired effect Effects 0.000 description 1
- 239000003112 inhibitor Substances 0.000 description 1
- 239000001023 inorganic pigment Substances 0.000 description 1
- 229940117955 isoamyl acetate Drugs 0.000 description 1
- QXJSBBXBKPUZAA-UHFFFAOYSA-N isooleic acid Natural products CCCCCCCC=CCCCCCCCCC(O)=O QXJSBBXBKPUZAA-UHFFFAOYSA-N 0.000 description 1
- NFIDBGJMFKNGGQ-UHFFFAOYSA-N isopropylmethylphenol Natural products CC(C)CC1=CC=CC=C1O NFIDBGJMFKNGGQ-UHFFFAOYSA-N 0.000 description 1
- 229940095045 isopulegol Drugs 0.000 description 1
- CYPPCCJJKNISFK-UHFFFAOYSA-J kaolinite Chemical compound [OH-].[OH-].[OH-].[OH-].[Al+3].[Al+3].[O-][Si](=O)O[Si]([O-])=O CYPPCCJJKNISFK-UHFFFAOYSA-J 0.000 description 1
- 229910052622 kaolinite Inorganic materials 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- VQHSOMBJVWLPSR-JVCRWLNRSA-N lactitol Chemical compound OC[C@H](O)[C@@H](O)[C@@H]([C@H](O)CO)O[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O VQHSOMBJVWLPSR-JVCRWLNRSA-N 0.000 description 1
- 238000007561 laser diffraction method Methods 0.000 description 1
- 229940071085 lauroyl glutamate Drugs 0.000 description 1
- 239000000171 lavandula angustifolia l. flower oil Substances 0.000 description 1
- 239000010501 lemon oil Substances 0.000 description 1
- XMGQYMWWDOXHJM-UHFFFAOYSA-N limonene Chemical compound CC(=C)C1CCC(C)=CC1 XMGQYMWWDOXHJM-UHFFFAOYSA-N 0.000 description 1
- CDOSHBSSFJOMGT-UHFFFAOYSA-N linalool Chemical compound CC(C)=CCCC(C)(O)C=C CDOSHBSSFJOMGT-UHFFFAOYSA-N 0.000 description 1
- SXQCTESRRZBPHJ-UHFFFAOYSA-M lissamine rhodamine Chemical compound [Na+].C=12C=CC(=[N+](CC)CC)C=C2OC2=CC(N(CC)CC)=CC=C2C=1C1=CC=C(S([O-])(=O)=O)C=C1S([O-])(=O)=O SXQCTESRRZBPHJ-UHFFFAOYSA-M 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000004325 lysozyme Substances 0.000 description 1
- 235000010335 lysozyme Nutrition 0.000 description 1
- 229960000274 lysozyme Drugs 0.000 description 1
- ZLNQQNXFFQJAID-UHFFFAOYSA-L magnesium carbonate Chemical compound [Mg+2].[O-]C([O-])=O ZLNQQNXFFQJAID-UHFFFAOYSA-L 0.000 description 1
- 239000001095 magnesium carbonate Substances 0.000 description 1
- 229910000021 magnesium carbonate Inorganic materials 0.000 description 1
- GVALZJMUIHGIMD-UHFFFAOYSA-H magnesium phosphate Chemical compound [Mg+2].[Mg+2].[Mg+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O GVALZJMUIHGIMD-UHFFFAOYSA-H 0.000 description 1
- 229910000400 magnesium phosphate tribasic Inorganic materials 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 238000000691 measurement method Methods 0.000 description 1
- 239000000155 melt Substances 0.000 description 1
- 239000001525 mentha piperita l. herb oil Substances 0.000 description 1
- 229940041616 menthol Drugs 0.000 description 1
- 229910052751 metal Inorganic materials 0.000 description 1
- 239000002184 metal Substances 0.000 description 1
- 229940102398 methyl anthranilate Drugs 0.000 description 1
- 229920000609 methyl cellulose Polymers 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 229960001047 methyl salicylate Drugs 0.000 description 1
- XJRBAMWJDBPFIM-UHFFFAOYSA-N methyl vinyl ether Chemical compound COC=C XJRBAMWJDBPFIM-UHFFFAOYSA-N 0.000 description 1
- 239000001923 methylcellulose Substances 0.000 description 1
- 239000010445 mica Substances 0.000 description 1
- 229910052618 mica group Inorganic materials 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 229910000403 monosodium phosphate Inorganic materials 0.000 description 1
- 235000019799 monosodium phosphate Nutrition 0.000 description 1
- 210000002200 mouth mucosa Anatomy 0.000 description 1
- 239000001627 myristica fragrans houtt. fruit oil Substances 0.000 description 1
- 229940070800 myristoyl glutamate Drugs 0.000 description 1
- GOQYKNQRPGWPLP-UHFFFAOYSA-N n-heptadecyl alcohol Natural products CCCCCCCCCCCCCCCCCO GOQYKNQRPGWPLP-UHFFFAOYSA-N 0.000 description 1
- ITVGXXMINPYUHD-CUVHLRMHSA-N neohesperidin dihydrochalcone Chemical compound C1=C(O)C(OC)=CC=C1CCC(=O)C(C(=C1)O)=C(O)C=C1O[C@H]1[C@H](O[C@H]2[C@@H]([C@H](O)[C@@H](O)[C@H](C)O2)O)[C@@H](O)[C@H](O)[C@@H](CO)O1 ITVGXXMINPYUHD-CUVHLRMHSA-N 0.000 description 1
- 229940089953 neohesperidin dihydrochalcone Drugs 0.000 description 1
- 235000010434 neohesperidine DC Nutrition 0.000 description 1
- 229920001778 nylon Polymers 0.000 description 1
- WNIFXKPDILJURQ-JKPOUOEOSA-N octadecyl (2s,4as,6ar,6as,6br,8ar,10s,12as,14br)-10-hydroxy-2,4a,6a,6b,9,9,12a-heptamethyl-13-oxo-3,4,5,6,6a,7,8,8a,10,11,12,14b-dodecahydro-1h-picene-2-carboxylate Chemical compound C1C[C@H](O)C(C)(C)[C@@H]2CC[C@@]3(C)[C@]4(C)CC[C@@]5(C)CC[C@@](C(=O)OCCCCCCCCCCCCCCCCCC)(C)C[C@H]5C4=CC(=O)[C@@H]3[C@]21C WNIFXKPDILJURQ-JKPOUOEOSA-N 0.000 description 1
- ZQPPMHVWECSIRJ-KTKRTIGZSA-N oleic acid Chemical compound CCCCCCCC\C=C/CCCCCCCC(O)=O ZQPPMHVWECSIRJ-KTKRTIGZSA-N 0.000 description 1
- 229940055577 oleyl alcohol Drugs 0.000 description 1
- XMLQWXUVTXCDDL-UHFFFAOYSA-N oleyl alcohol Natural products CCCCCCC=CCCCCCCCCCCO XMLQWXUVTXCDDL-UHFFFAOYSA-N 0.000 description 1
- 239000004006 olive oil Substances 0.000 description 1
- 235000008390 olive oil Nutrition 0.000 description 1
- 229940100690 oral cream Drugs 0.000 description 1
- 239000010502 orange oil Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 239000002540 palm oil Substances 0.000 description 1
- 229940070802 palmitoyl glutamate Drugs 0.000 description 1
- QNGNSVIICDLXHT-UHFFFAOYSA-N para-ethylbenzaldehyde Natural products CCC1=CC=C(C=O)C=C1 QNGNSVIICDLXHT-UHFFFAOYSA-N 0.000 description 1
- 239000006072 paste Substances 0.000 description 1
- XYJRXVWERLGGKC-UHFFFAOYSA-D pentacalcium;hydroxide;triphosphate Chemical compound [OH-].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O XYJRXVWERLGGKC-UHFFFAOYSA-D 0.000 description 1
- 235000019477 peppermint oil Nutrition 0.000 description 1
- 239000010452 phosphate Substances 0.000 description 1
- NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 1
- 230000000704 physical effect Effects 0.000 description 1
- 239000000419 plant extract Substances 0.000 description 1
- 229920003023 plastic Polymers 0.000 description 1
- 239000004033 plastic Substances 0.000 description 1
- 229920003229 poly(methyl methacrylate) Polymers 0.000 description 1
- 229920001495 poly(sodium acrylate) polymer Polymers 0.000 description 1
- 229940113115 polyethylene glycol 200 Drugs 0.000 description 1
- 229940057847 polyethylene glycol 600 Drugs 0.000 description 1
- 239000005020 polyethylene terephthalate Substances 0.000 description 1
- 229920000139 polyethylene terephthalate Polymers 0.000 description 1
- 229920000642 polymer Polymers 0.000 description 1
- 239000004926 polymethyl methacrylate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 229920001155 polypropylene Polymers 0.000 description 1
- 229920001451 polypropylene glycol Polymers 0.000 description 1
- 229920002451 polyvinyl alcohol Polymers 0.000 description 1
- 235000010409 propane-1,2-diol alginate Nutrition 0.000 description 1
- 239000000770 propane-1,2-diol alginate Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- WPPDXAHGCGPUPK-UHFFFAOYSA-N red 2 Chemical compound C1=CC=CC=C1C(C1=CC=CC=C11)=C(C=2C=3C4=CC=C5C6=CC=C7C8=C(C=9C=CC=CC=9)C9=CC=CC=C9C(C=9C=CC=CC=9)=C8C8=CC=C(C6=C87)C(C=35)=CC=2)C4=C1C1=CC=CC=C1 WPPDXAHGCGPUPK-UHFFFAOYSA-N 0.000 description 1
- 239000001054 red pigment Substances 0.000 description 1
- 239000002151 riboflavin Substances 0.000 description 1
- 235000019192 riboflavin Nutrition 0.000 description 1
- 229960002477 riboflavin Drugs 0.000 description 1
- 235000009566 rice Nutrition 0.000 description 1
- 239000010668 rosemary oil Substances 0.000 description 1
- 229940058206 rosemary oil Drugs 0.000 description 1
- CVHZOJJKTDOEJC-UHFFFAOYSA-N saccharin Chemical compound C1=CC=C2C(=O)NS(=O)(=O)C2=C1 CVHZOJJKTDOEJC-UHFFFAOYSA-N 0.000 description 1
- 235000019204 saccharin Nutrition 0.000 description 1
- 229940081974 saccharin Drugs 0.000 description 1
- 239000000901 saccharin and its Na,K and Ca salt Substances 0.000 description 1
- 229940085605 saccharin sodium Drugs 0.000 description 1
- 239000010670 sage oil Substances 0.000 description 1
- 229920006395 saturated elastomer Polymers 0.000 description 1
- 238000000790 scattering method Methods 0.000 description 1
- 239000008299 semisolid dosage form Substances 0.000 description 1
- 238000000926 separation method Methods 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 235000010413 sodium alginate Nutrition 0.000 description 1
- 239000000661 sodium alginate Substances 0.000 description 1
- 229940005550 sodium alginate Drugs 0.000 description 1
- WXMKPNITSTVMEF-UHFFFAOYSA-M sodium benzoate Chemical compound [Na+].[O-]C(=O)C1=CC=CC=C1 WXMKPNITSTVMEF-UHFFFAOYSA-M 0.000 description 1
- 239000004299 sodium benzoate Substances 0.000 description 1
- 235000010234 sodium benzoate Nutrition 0.000 description 1
- 235000019812 sodium carboxymethyl cellulose Nutrition 0.000 description 1
- 229920001027 sodium carboxymethylcellulose Polymers 0.000 description 1
- 239000011780 sodium chloride Substances 0.000 description 1
- AJPJDKMHJJGVTQ-UHFFFAOYSA-M sodium dihydrogen phosphate Chemical compound [Na+].OP(O)([O-])=O AJPJDKMHJJGVTQ-UHFFFAOYSA-M 0.000 description 1
- 239000011775 sodium fluoride Substances 0.000 description 1
- 235000013024 sodium fluoride Nutrition 0.000 description 1
- BFDWBSRJQZPEEB-UHFFFAOYSA-L sodium fluorophosphate Chemical compound [Na+].[Na+].[O-]P([O-])(F)=O BFDWBSRJQZPEEB-UHFFFAOYSA-L 0.000 description 1
- 229940075560 sodium lauryl sulfoacetate Drugs 0.000 description 1
- 229960004711 sodium monofluorophosphate Drugs 0.000 description 1
- NNMHYFLPFNGQFZ-UHFFFAOYSA-M sodium polyacrylate Chemical compound [Na+].[O-]C(=O)C=C NNMHYFLPFNGQFZ-UHFFFAOYSA-M 0.000 description 1
- UAJTZZNRJCKXJN-UHFFFAOYSA-M sodium;2-dodecoxy-2-oxoethanesulfonate Chemical compound [Na+].CCCCCCCCCCCCOC(=O)CS([O-])(=O)=O UAJTZZNRJCKXJN-UHFFFAOYSA-M 0.000 description 1
- 239000007901 soft capsule Substances 0.000 description 1
- 239000007909 solid dosage form Substances 0.000 description 1
- 239000000243 solution Substances 0.000 description 1
- 239000000600 sorbitol Substances 0.000 description 1
- 229960002920 sorbitol Drugs 0.000 description 1
- 235000010356 sorbitol Nutrition 0.000 description 1
- 229940082787 spirulina Drugs 0.000 description 1
- 239000007921 spray Substances 0.000 description 1
- 229910001220 stainless steel Inorganic materials 0.000 description 1
- 239000010935 stainless steel Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- WNIFXKPDILJURQ-UHFFFAOYSA-N stearyl glycyrrhizinate Natural products C1CC(O)C(C)(C)C2CCC3(C)C4(C)CCC5(C)CCC(C(=O)OCCCCCCCCCCCCCCCCCC)(C)CC5C4=CC(=O)C3C21C WNIFXKPDILJURQ-UHFFFAOYSA-N 0.000 description 1
- 229910001631 strontium chloride Inorganic materials 0.000 description 1
- AHBGXTDRMVNFER-UHFFFAOYSA-L strontium dichloride Chemical compound [Cl-].[Cl-].[Sr+2] AHBGXTDRMVNFER-UHFFFAOYSA-L 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000003871 sulfonates Chemical class 0.000 description 1
- 125000000542 sulfonic acid group Chemical group 0.000 description 1
- 230000001629 suppression Effects 0.000 description 1
- 239000000725 suspension Substances 0.000 description 1
- 229920003002 synthetic resin Polymers 0.000 description 1
- 239000000057 synthetic resin Substances 0.000 description 1
- 239000006188 syrup Substances 0.000 description 1
- 235000020357 syrup Nutrition 0.000 description 1
- 238000012360 testing method Methods 0.000 description 1
- TUNFSRHWOTWDNC-HKGQFRNVSA-N tetradecanoic acid Chemical compound CCCCCCCCCCCCC[14C](O)=O TUNFSRHWOTWDNC-HKGQFRNVSA-N 0.000 description 1
- 229940095068 tetradecene Drugs 0.000 description 1
- OULAJFUGPPVRBK-UHFFFAOYSA-N tetratriacontyl alcohol Natural products CCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCCO OULAJFUGPPVRBK-UHFFFAOYSA-N 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 239000010678 thyme oil Substances 0.000 description 1
- 239000001585 thymus vulgaris Substances 0.000 description 1
- YUOWTJMRMWQJDA-UHFFFAOYSA-J tin(iv) fluoride Chemical compound [F-].[F-].[F-].[F-].[Sn+4] YUOWTJMRMWQJDA-UHFFFAOYSA-J 0.000 description 1
- 150000003609 titanium compounds Chemical class 0.000 description 1
- GYDJEQRTZSCIOI-LJGSYFOKSA-N tranexamic acid Chemical compound NC[C@H]1CC[C@H](C(O)=O)CC1 GYDJEQRTZSCIOI-LJGSYFOKSA-N 0.000 description 1
- 229960000401 tranexamic acid Drugs 0.000 description 1
- VZCYOOQTPOCHFL-UHFFFAOYSA-N trans-butenedioic acid Natural products OC(=O)C=CC(O)=O VZCYOOQTPOCHFL-UHFFFAOYSA-N 0.000 description 1
- KHPCPRHQVVSZAH-UHFFFAOYSA-N trans-cinnamyl beta-D-glucopyranoside Natural products OC1C(O)C(O)C(CO)OC1OCC=CC1=CC=CC=C1 KHPCPRHQVVSZAH-UHFFFAOYSA-N 0.000 description 1
- QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
- 229960003500 triclosan Drugs 0.000 description 1
- GSEJCLTVZPLZKY-UHFFFAOYSA-O triethanolammonium Chemical class OCC[NH+](CCO)CCO GSEJCLTVZPLZKY-UHFFFAOYSA-O 0.000 description 1
- VXYADVIJALMOEQ-UHFFFAOYSA-K tris(lactato)aluminium Chemical compound CC(O)C(=O)O[Al](OC(=O)C(C)O)OC(=O)C(C)O VXYADVIJALMOEQ-UHFFFAOYSA-K 0.000 description 1
- CCXAYLQLOLXXKE-DWJAGBRCSA-K trisodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4s,5s,6s)-2-[[(3s,4ar,6ar,6bs,8as,11s,12ar,14ar,14bs)-11-carboxylato-4,4,6a,6b,8a,11,14b-heptamethyl-14-oxo-2,3,4a,5,6,7,8,9,10,12,12a,14a-dodecahydro-1h-picen-3-yl]oxy]-6-carboxylato-4,5-dihydroxyoxan-3-yl]oxy-3,4,5-t Chemical compound [Na+].[Na+].[Na+].O([C@@H]1[C@@H](O)[C@H](O)[C@H](O[C@@H]1O[C@H]1CC[C@]2(C)[C@H]3C(=O)C=C4[C@@H]5C[C@](C)(CC[C@@]5(CC[C@@]4(C)[C@]3(C)CC[C@H]2C1(C)C)C)C([O-])=O)C([O-])=O)[C@@H]1O[C@H](C([O-])=O)[C@@H](O)[C@H](O)[C@H]1O CCXAYLQLOLXXKE-DWJAGBRCSA-K 0.000 description 1
- UJMBCXLDXJUMFB-UHFFFAOYSA-K trisodium;5-oxo-1-(4-sulfonatophenyl)-4-[(4-sulfonatophenyl)diazenyl]-4h-pyrazole-3-carboxylate Chemical compound [Na+].[Na+].[Na+].[O-]C(=O)C1=NN(C=2C=CC(=CC=2)S([O-])(=O)=O)C(=O)C1N=NC1=CC=C(S([O-])(=O)=O)C=C1 UJMBCXLDXJUMFB-UHFFFAOYSA-K 0.000 description 1
- WGIWBXUNRXCYRA-UHFFFAOYSA-H trizinc;2-hydroxypropane-1,2,3-tricarboxylate Chemical compound [Zn+2].[Zn+2].[Zn+2].[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O.[O-]C(=O)CC(O)(CC([O-])=O)C([O-])=O WGIWBXUNRXCYRA-UHFFFAOYSA-H 0.000 description 1
- MWOOGOJBHIARFG-UHFFFAOYSA-N vanillin Chemical compound COC1=CC(C=O)=CC=C1O MWOOGOJBHIARFG-UHFFFAOYSA-N 0.000 description 1
- FGQOOHJZONJGDT-UHFFFAOYSA-N vanillin Natural products COC1=CC(O)=CC(C=O)=C1 FGQOOHJZONJGDT-UHFFFAOYSA-N 0.000 description 1
- 235000012141 vanillin Nutrition 0.000 description 1
- 239000002966 varnish Substances 0.000 description 1
- 229940099259 vaseline Drugs 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 235000019154 vitamin C Nutrition 0.000 description 1
- 239000011718 vitamin C Substances 0.000 description 1
- 238000009736 wetting Methods 0.000 description 1
- 239000011701 zinc Substances 0.000 description 1
- 229910052725 zinc Inorganic materials 0.000 description 1
- 239000011746 zinc citrate Substances 0.000 description 1
- 235000006076 zinc citrate Nutrition 0.000 description 1
- 229940068475 zinc citrate Drugs 0.000 description 1
- 239000011670 zinc gluconate Substances 0.000 description 1
- 235000011478 zinc gluconate Nutrition 0.000 description 1
- 229960000306 zinc gluconate Drugs 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/19—Cosmetics or similar toiletry preparations characterised by the composition containing inorganic ingredients
- A61K8/25—Silicon; Compounds thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/34—Alcohols
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/33—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing oxygen
- A61K8/37—Esters of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/40—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing nitrogen
- A61K8/42—Amides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K8/00—Cosmetics or similar toiletry preparations
- A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
- A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
- A61K8/49—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds containing heterocyclic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
- A61Q11/00—Preparations for care of the teeth, of the oral cavity or of dentures; Dentifrices, e.g. toothpastes; Mouth rinses
Definitions
- the present invention relates to an oral composition.
- a non-aqueous oral composition that does not contain substantially water is advantageous in that the stability of the active ingredient, which is unstable in the aqueous system, can be ensured.
- a non-aqueous oral composition used for an oral application such as a dentifrice, an oral moisturizing gel, or an oral cream, which does not substantially contain water, is particularly resistant to water. It is advantageous in that it can be effectively blended while ensuring the stability of the unstable component.
- Patent Document 1 describes a composition used for whitening teeth, which adheres to the tooth surface at the time of application, remains on the tooth surface after removal of the application tool, and is an oral cavity at the time of application.
- A glycerin and 1,3-butylene glycol as tooth whitening components
- B zeolite having a predetermined structure
- C zeolite having a predetermined structure
- Non-aqueous compositions containing alkyl sulfates are disclosed.
- Patent Document 2 provides a non-aqueous oral composition containing no water or almost no water, which has excellent shape retention and is stable over time without separation of components.
- a base for an oral composition which comprises at least one selected from the group consisting of polyethylene powder and polyethylene wax, and at least one selected from the group consisting of liquid paraffin, squalane and squalane. Is disclosed.
- non-aqueous oral composition disclosed in the above patent document, it may be difficult to obtain a moisturizing feeling in the oral cavity after use, and a surfactant, particularly an anionic surfactant, is used in particular. If this is the case, the user may experience a strong feeling of degreasing after use, and as a result, the feeling of moisturizing in the oral cavity may be significantly reduced, resulting in a feeling of dryness.
- a surfactant particularly an anionic surfactant
- non-aqueous oral compositions including the oral compositions according to the above patent documents, are inorganic powders for the purpose of imparting polishing ability, caking ability, and suppressing spinnability.
- the body is compounded.
- a non-aqueous oral composition containing an inorganic powder if the amount of the above-mentioned surfactant is reduced in order to enhance the moisturizing feeling, it is used due to the inorganic powder, especially in the initial stage of use. A person may feel a strong squeaky feeling.
- an object of the present invention is to provide a non-aqueous oral composition capable of obtaining a good moisturizing sensation, suppressing a powdery squeaky sensation, and having good properties such as shape retention and spinnability. To do.
- the present invention provides the following [1] to [7].
- [1] Contains (A) inorganic powder and (B) cooling sensitizer.
- the content of the surfactant is 0.5% by mass or less, An oral composition having a water content of 2% by mass or less.
- (B) The cooling sensitizer is N-ethyl-p-menthane-3-carboxamide, mentyllactate, mentylmonosuccinate, isopregol, mentonglycerol ketal, N- (4-cyanomethylphenyl) -p-menthane.
- [4] The oral composition according to any one of [1] to [3], wherein the content of the cooling sensation agent is 0.0001 to 0.3% by mass.
- [5] The oral composition according to any one of [1] to [4], further comprising (C) glycyrrhizic acid, and one or more selected from the group consisting of glycyrrhizic acid and salts thereof.
- [6] The oral composition according to any one of [1] to [5], further comprising (D) a solvent, wherein the solvent is a polyhydric alcohol having a melting point of 25 ° C. or lower.
- [7] The oral composition according to any one of [1] to [6], which is a dentifrice or a coating agent.
- a non-aqueous oral composition capable of obtaining a good moisturizing sensation, suppressing a powdery squeaky sensation, and having good properties such as shape retention and spinnability. Can be done.
- the oral composition of the present invention contains (A) an inorganic powder and (B) a cooling sensation agent, and has a surfactant content of 0.5% by mass or less and a water content of 2% by mass or less.
- a certain oral composition which may further contain (C) glycyrrhetinic acid, and one or more selected from the group consisting of glycyrrhetinic acid and salts thereof, and / or (D) a solvent.
- the "moisturizing sensation” means a sensation that the user (tester) feels that the tongue and the oral mucosa are moisturized at the time of use.
- the "powder squeaky feeling” means a feeling of discomfort or a foreign body sensation that is felt especially when the upper and lower teeth come into contact with each other at the initial stage of use (beginning of polishing) due to the local presence of the inorganic powder.
- the term “threading property” refers to a property in which the oral composition stretches like a string when it is taken out from a container such as a laminated tube.
- the “component (A)” according to the embodiment of the present invention is an inorganic powder.
- the component (A) is a component generally used as an abrasive, an inorganic thickener, an inorganic pigment, or the like in an oral composition.
- examples of the inorganic powder include silica compounds such as silicic anhydride, precipitated silica, titanium-binding silica, silica gel, aluminosilicate, and zirconosilicate; calcium carbonate (light and heavy), calcium phosphate, calcium hydrogen phosphate, and the like.
- silica compounds such as silicic anhydride, precipitated silica, titanium-binding silica, silica gel, aluminosilicate, and zirconosilicate
- calcium phosphate calcium hydrogen phosphate
- Calcium salts such as calcium pyrophosphate, calcium metaphosphate, calcium hydroxide, calcium sulfate; aluminum salts such as aluminum oxide, aluminum hydroxide, and alumina; magnesium salts such as magnesium carbonate and tertiary magnesium phosphate; hydroxyapatite, fluoroapatite, calcium Examples thereof include apatites such as defective apatites; clay minerals such as kaolinite and bentonite; titanium compounds such as titanium dioxide, mica titanium and titanium oxide; and powders of inorganic substances such as titanium oxide. Of these, anhydrous silicic acid, calcium carbonate, aluminum oxide, aluminum hydroxide, and zeolite are more preferable.
- the average particle size (volume standard D50) of the inorganic powder is usually in the range of 1 to 30 ⁇ m, preferably in the range of 5 to 25 ⁇ m.
- the "average particle size” means the average particle size (volume standard D50) which is a measured value by the laser diffraction / scattering method as described above.
- a conventionally known arbitrary suitable particle size distribution measuring device for example, Microtrack particle size distribution measuring device (Made 117995-10, Type SRA) manufactured by Nikkiso Co., Ltd.) is used, and the turbidity (dV value) of the sample is used. Can be adjusted to 0.5 for measurement. The same measurement was performed in the examples described later.
- one selected from the above-exemplified inorganic powders may be used alone, or two or more thereof may be used in combination.
- a combination of two or more for example, an inorganic powder that can be used in an abrasive application (for example, RDA 50 to 120, preferably 70 to 150, more preferably 90 to 120) and an inorganic thickener are used.
- examples thereof include a combination with the obtained inorganic powder (for example, liquid absorption amount of 2 to 5 mL / g, preferably 2.5 to 5 mL / g).
- the liquid absorption amount can be calculated as, for example, the following measurement method as the liquid absorption amount (mL) per 1 g of thickened silica.
- the content of the component (A) is usually 2% by mass or more, preferably 5% by mass or more, and more preferably 8% by mass or more with respect to the total amount of the oral composition.
- the upper limit is usually 50% by mass or less, preferably 40% by mass or less, more preferably 30% by mass or less, still more preferably 20% by mass or less.
- the content of the component (A) is usually 2 to 50% by mass, preferably 5 to 50% by mass, and more preferably 8 to 40% by mass.
- the viscosity of the oral composition of this embodiment is preferably about 20 to 100 Pa ⁇ s at 25 ° C.
- the viscosity of the oral composition is, for example, Toki Sangyo Co., Ltd. (type: VISCOMETER TVB-10), rotor No. 6 or 7 can be used, the rotation speed is 20 rpm, the measurement time is 3 minutes, and the measurement can be performed under the condition of 25 ° C.
- the content of each component is based on the amount of each component charged at the time of manufacturing an oral composition.
- the component (B) according to the embodiment of the present invention is a cooling sensation agent.
- the oral composition of the present invention can improve the powdery squeaky feeling at the initial stage of use (beginning of polishing) caused by the component (A) and realize a good feeling of use. ..
- the cooling sensitizer as a component (B) is, for example, N-ethyl-p-menthan-3-carboxamide, mentyllactate, mentylmonosuccinate, isopulegol, mentonglycerol ketal, N- (4-cyanomethylphenyl) -p.
- -Mentancarboxamide 3-l-mentoxypropane-1,2-diol, 5-methyl-2-propane-2-yl-N- (2-pyridine-2-ylethyl) cyclohexane-1-carboxamide, 3-( p-mentan-3-carboxamide) It is preferably at least one selected from the group consisting of ethyl acetate, 2-isopropyl-N, and 2,3-trimethylbutylamide.
- N-ethyl-p-menthane-3-carboxamide, N- (4-cyanomethylphenyl) -p-menthan carboxamide, 3-l-mentoxypropane-1,2-diol, 5-methyl-2 -Propane-2-yl-N- (2-pyridine-2-ylethyl) cyclohexane-1-carboxamide and 3- (p-menthan-3-carboxamide) ethyl acetate are more preferred.
- the content of the component (B) is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, still more preferably 0, with respect to the total amount of the oral composition, from the viewpoint of improving the powdery squeaky feeling. It is 0.01% by mass or more. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use.
- the upper limit of the content of the component (B) is preferably 0.3% by mass or less, more preferably 0.2% by mass or less, still more preferably 0.1 from the viewpoint of optimally adjusting the viscosity of the oral composition. It is less than mass%.
- the content of the component (B) is preferably 0.0001 to 0.3% by mass, more preferably 0.001 to 0.2% by mass, and further preferably 0.01 to 0.1% by mass. It is mass%.
- the component (C) is one or more selected from the group consisting of glycyrrhetinic acid, glycyrrhizic acid and salts thereof.
- the glycyrrhetinic acid may be a derivative thereof, and for example, ⁇ -glycyrrhetinic acid, stearyl glycyrrhetinate and the like can be used.
- glycyrrhizate for example, dipotassium glycyrrhizinate, disodium glycyrrhizinate, trisodium glycyrrhizinate, monoammonium glycyrrhizinate and the like can be used. Above all, it is preferable to use dipotassium glycyrrhizinate and / or ⁇ -glycyrrhetinic acid from the viewpoint of reducing the feeling of powder squeaking at the initial stage of use.
- the content of the component (C) is usually 0.01% by mass or more, preferably 0.03% by mass or more, based on the total amount of the oral composition. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use.
- the upper limit is usually 0.1% by mass or less, preferably 0.05% by mass or less. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. Therefore, the content of the component (C) is usually 0.01 to 0.1% by mass, preferably 0.03 to 0.05% by mass.
- the component (D) is a solvent.
- a polyhydric alcohol can be used as the component (D) which is a solvent.
- the polyhydric alcohol it is preferable to use a polyhydric alcohol having a melting point of 25 ° C. or lower.
- polyhydric alcohol examples include glycerin (melting point: 17.8 ° C.) and polyethylene glycol (PEG200) having an average molecular weight of 190 to 630 (the average molecular weight described in the Quasi-drug Raw Material Standard 2006, the same applies hereinafter).
- glycerin polyethylene glycol having an average molecular weight of 190 to 630, and butylene glycol are preferable from the viewpoint of improving the moisturizing feeling in the oral cavity. These may be used alone or in combination of two or more.
- the average molecular weight of polyethylene glycol is usually 650 or less, preferably 630 or less, and more preferably 600 or less.
- the lower limit is usually 150 or more, preferably 250 or more. Therefore, the average molecular weight of polyethylene glycol is usually 150 to 650, preferably 150 to 630, and more preferably 250 to 600.
- the polyethylene glycol for example, polyethylene glycol 200 (average molecular weight 190 to 210), polyethylene glycol 400 (average molecular weight 380 to 420), and polyethylene glycol 600 (average molecular weight 570 to 630) can be used.
- the average molecular weight of polyethylene glycol is the average molecular weight described in the Quasi-drug Raw Material Standard 2006.
- Polyhydric alcohol has its own bitterness, but glycerin is a polyhydric alcohol with relatively little bitterness. Therefore, from the viewpoint of reducing the bitterness derived from the solvent, the solvent contains at least glycerin, and the content of glycerin is 20 to 100% by mass, particularly 50 to 85% by mass, and further 50 to 80% by mass of the total polyhydric alcohol. Is more preferable. Further, among the polyhydric alcohols, polyethylene glycol having the above average molecular weight is a preferable solvent because a good feeling of warmth can be obtained.
- the component (D) preferably contains at least polyethylene glycol, and the content of polyethylene glycol is 10% by mass or more, particularly 15 to 30% by mass of the entire oral composition. Is more preferable. If the content of polyethylene glycol exceeds 30% by mass, the bitterness derived from polyethylene glycol may affect the usability, but if it is 30% by mass or less, a good usability can be maintained.
- the polyhydric alcohol is a combination system of glycerin and polyethylene glycol having an average molecular weight of 190 to 630 and / or butylene glycol, particularly glycerin and polyethylene glycol having an average molecular weight of 190 to 630.
- the glycerin content is 50% by mass or more, particularly more preferably 50 to 85% by mass, based on the total amount of the polyhydric alcohol. That is, it is particularly preferable that the mass ratio of glycerin / (polyethylene glycol and / or butylene glycol having an average molecular weight of 190 to 630) is 50/50 to 85/15.
- the content ratio ((A) / (B)), which is the ratio of the content of the component (A) to the content of the component (B), is preferably 67 or more, more preferably 100 or more.
- (A) / (B) is preferably 200,000 or less, more preferably 2000 or less. By doing so, the viscosity and shape retention of the oral composition can be improved, and the powdery squeaky feeling at the initial stage of use can be reduced. Therefore, (A) / (B) is preferably 67 to 200,000, more preferably 100 to 2000.
- the oral composition of the present embodiment is a non-aqueous oral composition that does not substantially contain water.
- substantially water-free means that water is not intentionally added in the manufacturing process of the oral composition.
- non-aqueous is not limited to the absence of water in the oral composition as a result in any case.
- the oral composition of the present embodiment may contain water in an amount of 2% by mass or less due to, for example, water that can be inevitably mixed in the raw material.
- water that can be inevitably mixed in the raw material.
- concentrated glycerin which is a component (B) having a low water content, can inevitably contain about 0.5% by mass of water.
- the water content of the oral composition of the present embodiment is usually 2% by mass or less, preferably 1% by mass or less, and more preferably 0.5% by mass or less.
- the water content of the oral composition is the ratio (% by mass) of the total water content of the raw materials before compounding to the total raw materials, or the difference between the weight after drying and the weight before drying of the oral composition is dried. It can be calculated as a ratio (mass%) to the previous weight.
- the oral composition of the present embodiment may contain arbitrary components other than the components (A) to (D) already described, as long as the effects of the present invention are not impaired.
- Optional components include, for example, surfactants, sweeteners, fragrances, medicinal components, oily components, abrasives (organic abrasives), preservatives, wetting agents, binders, pH adjusters, colorants (pigments) and the like. Ingredients are mentioned.
- the optional components are not limited to these.
- the oral composition of the present embodiment has a surfactant content of 0.5% by mass or less. That is, in the oral composition of the present embodiment, the content of the surfactant is reduced to 0.5% by mass or less, or the content of the surfactant is reduced to 0.5% by mass or less from the viewpoint of suppressing the degreasing feeling at the time of use and realizing the moisturizing feeling. It is preferable that the surfactant is not contained.
- surfactant examples include an anionic surfactant, a nonionic surfactant, and an amphoteric surfactant.
- anionic surfactant examples include alkyl sulfates, acyl amino acid salts, acyl taurine salts, ⁇ -olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfates, and lauryl sulfoacetates.
- the alkyl group and the acyl group may be either a linear group or a branched chain, and may be saturated or unsaturated, and the number of carbon atoms thereof is usually 10 to 20, preferably 12 to 18, and more preferably 12 to 18. It is 14.
- the salt can be selected from pharmacologically acceptable salts.
- Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts.
- inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt
- organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt
- arginine salt and the like Basic amino acid salts of.
- an inorganic base salt is preferable, an alkali metal salt (for example, a sodium salt or a potassium salt) or an ammonium salt is more preferable, and a sodium salt is further preferable.
- alkyl sulfate examples include lauryl sulfate and myristoyl sulfate.
- acyl amino acid salt include acyl sarcosine salts such as lauroyl sarcosin salt and myristoyl sarcosin salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycine salt and cocoyl glycine.
- Acylglycine salts such as salts; N-lauroyl- ⁇ -alanine salt, N-myristyl- ⁇ -alanine salt, N-cocoyl- ⁇ -alanine salt, N-lauroyl-N-methyl- ⁇ -alanine salt, N-myristoyl Acylalanine salts such as -N-methyl- ⁇ -alanine salt, N-methyl-N-acylalanine salt; acylasparaginate such as lauroyl asparagate can be mentioned.
- the acyl taurine salt include lauroylmethyl taurine salt, N-methyl-N-acyl taurine salt, and N-cocoyl methyl taurine salt.
- ⁇ -olefin sulfonate examples include ⁇ -olefin sulfonate having 12 to 18 carbon atoms such as tetradecene sulfonate.
- anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
- the anionic surfactant preferably contains a sulfonic acid group in terms of foaming and good foam quality, and more preferably an alkyl sulfate or an ⁇ -olefin sulfonate.
- the content of the anionic surfactant is preferably 0.1 to 2.5% by mass, more preferably 0.6 to 2.5% by mass, still more preferably 1 to 2.5% by mass of the entire composition. ..
- nonionic surfactant examples include polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester (eg, polyoxyethylene sorbitan monostearate), alkylolamide, and polyoxy.
- Ethylene fatty acid ester polyoxyethylene alkenyl ether, glycerin fatty acid ester, sucrose fatty acid ester (eg, maltose fatty acid ester), sugar alcohol fatty acid ester (eg, multitoll fatty acid ester, lactitol fatty acid ester), fatty acid diethanolamide (eg, lauryl) Acid mono or diethanolamide), polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, and the like.
- the number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is usually 14 to 18, and the average number of moles of ethylene oxide added is usually 15 to 30 mol.
- the average number of moles of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is usually 20 to 100 mol, preferably 20 to 60 mol.
- the number of carbon atoms of the fatty acid of the sorbitan fatty acid ester is usually 12 to 18.
- the fatty acid of the polyoxyethylene sorbitan fatty acid ester usually has 16 to 18 carbon atoms, and the average number of moles of ethylene oxide added is usually 10 to 40 mol.
- the number of carbon atoms in the alkyl chain of the alkylolamide is usually 12 to 14.
- the nonionic surfactant polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene alkyl ether are preferable.
- amphoteric surfactant examples include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine) and fatty acid amide propyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); N-.
- alkyldimethylaminoacetic acid betaine eg, lauryldimethylaminoacetic acid betaine
- fatty acid amide propyldimethylaminoacetic acid betaine eg, cocamidopropyl betaine
- Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salt eg, N-palm oil fatty acid acyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine), coconut oil fatty acid imidazolinium betaine, 2-alkyl
- imidazoline-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine
- alkyl betaines such as lauryldimethylaminoacetic acid betaine.
- the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
- the content is 0.5% by mass or less of the total composition. It is preferably 0.2% by mass or less, more preferably 0.1% by mass or less, and particularly preferably 0.05% by mass or less.
- an anionic surfactant when used, the content thereof is preferably 0.1% by mass or less, preferably 0.05% by mass, from the viewpoint of reducing the feeling of degreasing during use and enhancing the feeling of moisturizing. The following is more preferable, and it is further preferable to make it non-containing (0% by mass).
- the oral composition of the present embodiment may contain any suitable sweetener previously known as an arbitrary suitable content.
- the oral composition contains a sweetening agent, the feeling of use can be further improved.
- sweetener examples include xylitol, erythritol, maltitol, saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, thaumatin, aspartylphenylalanine methyl ester and the like.
- the above-exemplified sweetener may be used alone or in combination of two or more.
- the oral composition of the present embodiment may contain any suitable fragrance previously known as an arbitrary suitable content.
- the oral composition contains a fragrance, the feeling of use can be further improved.
- fragrances include peppermint oil, sparemint oil, eucalyptus oil, winter green oil, clove oil, thyme oil, sage oil, cardamon oil, rosemary oil, majorum oil, lemon oil, orange oil, nutmeg oil, and lavender oil.
- Natural essential oils such as parlacles oil, laurel oil, piment oil, laurel oil, perilla oil, winter green oil; menthol, carboxylic, synamic aldehyde, anetol, 1,8-cineole, methyl salicylate, eugenol, timole, linalol, limonen, Perfume components contained in the above natural essential oils such as menthon, mentholacetate, citral, camphor, borneol, pinen, spirantol, n-decyl alcohol, citronellol, ⁇ -terpineol, citronellyl acetate, cineol, ethyllinalol, varnish and the like; ethyl acetate , Ethylbutyrate, isoamylacetate, hexanal, hexenal, methylanthranilate, ethylmethylphenylglycidate, benzaldehyde, vanill
- the medicinal ingredient examples include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timole, hinokithiol, and lysodium chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ⁇ -aminocaproic acid, allantin, tranexamic acid, allantinchlorhydroxyaluminum, azulene, dihydrocholesterol, etc.
- bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timole, hin
- Anti-inflammatory agents Metal salts such as zinc, copper salt, tin salt; Toothstone preventive agents such as condensed phosphate and ethanehydroxydiphosphonate; , Aluminum lactate, strontium chloride and other hypersensitivity inhibitors; coating agents such as hydroxyethyl cellulose dimethyldiallyl ammonium chloride; astringents such as vitamin C (eg, ascorbic acid or salts thereof), lysozyme chloride, sodium chloride and the like; copper chlorophyll, glucon Water-soluble copper compounds such as copper acid acid; amino acids such as dentin preventive agent, alanine, glycine and proline, plant extracts such as thyme, ginger, chow and hamamelis; caropeptide and polyvinylpyrrolidone can be mentioned.
- the medicinal ingredient may be used alone or in combination of two or more. The content of the medicinal ingredient can be appropriately set as an effective amount according to a conventional method.
- oily component examples include fatty acids such as squalane, liquid paraffin, vaseline, microcrystallin wax, carnauba wax, rice wax, and rosin; higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, iso). Alcohols with 8 to 22 carbon atoms such as stearyl alcohol); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), olive oil, castor oil, coconut oil and the like. Vegetable oils; fatty acid esters such as isopropyl myristate.
- fatty acids such as squalane, liquid paraffin, vaseline, microcrystallin wax, carnauba wax, rice wax, and rosin
- higher alcohols eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, iso
- the oral composition of the present embodiment may contain a conventionally known arbitrary suitable abrasive (excluding the raw material used as the component (A) already described) as an optional suitable content.
- any abrasive that can be contained in the oral composition examples include organic abrasives such as polymethylmethacrylate and synthetic resin-based abrasives.
- the content of the organic abrasive is preferably 10% by mass or less (0 to 10% by mass).
- the total amount of the organic abrasive and the component (A) is preferably 50% by mass or less, more preferably 8 to 50% by mass, based on the whole composition.
- the oral composition of the present embodiment may contain any suitable preservative previously known as an arbitrary suitable content.
- the oral composition contains an antiseptic, the antiseptic power of the oral composition can be ensured.
- preservative examples include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like.
- the preservative may be used alone or in combination of two or more.
- the oral composition of the present embodiment may contain any suitable wettable agent conventionally known (excluding those used as the component (D) already described) as an optional suitable content.
- any suitable wettable agent conventionally known (excluding those used as the component (D) already described) as an optional suitable content.
- the feeling of use can be further improved.
- polyhydric alcohols other than the polyhydric alcohol exemplified as the component (D) are preferable, and examples thereof include sugar alcohols such as sorbitol, erythritol, maltitol, lactitol, and xylitol; and reduced starch saccharified products.
- the content of the wetting agent is usually 0 to 20% by mass, preferably 1 to 10% by mass.
- the oral composition of the present embodiment may contain any suitable binder conventionally known as an arbitrary suitable content.
- an arbitrary binder in the oral composition, the viscosity can be optimized, and the shape retention and usability can be further improved.
- any binder that can be contained in the oral composition any suitable organic binder conventionally known, for example, a polysaccharide, a cellulosic binder (for example, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, etc.) Hydroxypropyl methylcellulose, methylcellulose, cationized cellulose, etc.), other polysaccharide thickeners (eg, xanthan gum, gua gum, gellan gum, tragant gum, karaya gum, arabiya gum, locust bean gum, carrageenan, sodium alginate, propylene glycol alginate), synthetic water Examples thereof include sex polymers (eg, sodium polyacrylate, carboxyvinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol).
- the content of any binder is preferably 0 to 1% by mass, more preferably 0.1 to 0.8% by mass.
- the oral composition of the present embodiment may contain a conventionally known arbitrary suitable pH adjuster as an arbitrary suitable content.
- a pH adjuster When the oral composition contains a pH adjuster, the pH stability of the oral composition can be ensured.
- Examples of the pH adjuster include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid and lactic acid or salts thereof, and inorganic acids such as phosphoric acid (orthoric acid) or salts thereof.
- organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid and lactic acid or salts thereof
- inorganic acids such as phosphoric acid (orthoric acid) or salts thereof.
- potassium salt, sodium salt and ammonium salt hydroxides such as sodium hydroxide and potassium hydroxide can be mentioned.
- Examples of the inorganic acid salt include disodium hydrogen phosphate and sodium dihydrogen phosphate.
- the content of the pH adjuster can usually be such that the pH of the oral composition after addition is 5 to 9, preferably 6 to 8.5.
- the pH value usually means a value at 25 ° C. after 3 minutes have passed from the start of measurement.
- the pH value can be measured using, for example, a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
- the oral composition of the present embodiment may contain a conventionally known arbitrary suitable colorant as an arbitrary suitable content.
- Colorants that can be contained in the oral composition include, for example, Benibana red pigment, gardenia yellow, gardenia blue pigment, perilla pigment, red koji pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, and the like.
- Natural pigments such as tamarind pigments and legal regulations such as red 2, red 3, red 104, red 105, red 106, red 227, yellow 4, yellow 5, green 3, and blue 1. Examples include dyes, riboflavin, sodium copper chlorofin, titanium dioxide and the like.
- the oral composition contains a colorant, the content thereof is preferably 0.00001 to 3% by mass with respect to the entire oral composition.
- the oral composition of the present embodiment may contain an arbitrary component other than the above as an arbitrary suitable content.
- the oral composition of the present invention can be in any suitable dosage form by any suitable method according to a conventional method.
- Dosage forms include, for example, liquids (solutions, emulsions, suspensions, syrups, etc.), semi-solids (gels, creams, pastes, etc.), solids (tablets, particulate agents, capsules, film agents, kneaded products, melts, etc.). Solids, waxy solids, elastic solids, soft capsules, etc.).
- the dosage form of the oral composition is preferably liquid or semi-solid.
- the oral composition of the present invention can be widely used in oral applications.
- Applications in solid dosage forms include, for example, troches, gummies, gums, powders or tablets of dentifrices.
- Examples of applications in the semi-solid dosage form include dentifrices and gel-like dentifrices.
- Examples of applications in the form of liquids include mouthwashes, liquid dentifrices, and mouthwashes (sprays and the like).
- the oral composition of the present invention realizes a good moisturizing sensation, suppresses a squeaky feeling, and can improve physical properties such as shape retention and spinnability. Therefore, a dentifrice (dentifrice, gel) can be obtained. It is preferably a dentifrice) or a coating agent (oral moisturizing gel, oral moisturizing claim).
- the method for producing the oral composition of the present invention is not particularly limited.
- Oral compositions can be prepared by their respective conventional methods, depending on the dosage form selected. For example, when the oral composition is used as a dentifrice, a component that dissolves in a solvent is first prepared, and then other insoluble components are mixed, and if necessary, the pressure is reduced, for example, to further remove the composition. A manufacturing method for foaming can be mentioned.
- the dentifrice thus obtained can be made into a product by accommodating it in a tube container such as a laminated tube or a pump-type container.
- the shape and material of the container in which the oral composition of the present invention can be contained are not particularly limited. Any suitable conventionally known container used for the oral composition can be used. Examples of the container include a container made of a plastic material such as polyethylene, polypropylene, polyethylene terephthalate, and nylon.
- Examples and Comparative Examples [Ingredients used in Examples and Comparative Examples] First, the components used in Examples and Comparative Examples will be described.
- test oral composition having the composition shown in Tables 1 to 3 below was prepared according to the following preparation method.
- the viscosities of the obtained test oral compositions were all in the range of 20 to 100 Pa ⁇ s at 25 ° C.
- the water content of the test oral composition was calculated as a ratio (mass%) of the total water content contained in the raw materials before compounding to all the raw materials, and is shown in Tables 1 to 3 below.
- the obtained test oral composition was evaluated by the following procedure. The evaluation results are shown in Tables 1 to 3 below.
- the test oral composition is filled in a laminated tube having an inner diameter of 8 mm, and then the test oral composition is extruded from the laminated tube onto a toothbrush brush, and about 1 g is placed on the laminated tube, and then the laminated tube and the toothbrush are upwardly loaded. Test when the toothbrush was pulled apart The breakage (spinning property) of the oral composition was tested.
- the spinnability was evaluated on a 4-point scale as excellent, good, acceptable, and unacceptable according to the following evaluation criteria, which can be evaluated by measuring the length of the filamentous portion drawn by the test oral composition.
- the results are shown in Tables 1 to 3 below.
- test oral composition is filled in a laminated tube having an inner diameter of 8 mm, the test oral composition is extruded from the laminated tube onto a toothbrush, and the state (shape retention) immediately after about 1.0 g is applied is as follows. According to the evaluation criteria, it was evaluated as evaluation A, evaluation BH, evaluation BS, evaluation CH, and evaluation CS. The results are shown in Tables 1 to 3 below.
- evaluation criteria A: The extruded test oral composition retains its shape and does not drip from the toothbrush (good usability).
- BH The extruded test oral composition is in the form of a hard paste, but does not roll off the toothbrush (no problem with usability).
- BS The extruded test oral composition slightly loses its shape but does not fall off the toothbrush (no problem with usability).
- CH The extruded test oral composition is in the form of a hard paste and rolls off the toothbrush (problems with usability).
- CS Extruded test oral composition loses its shape and drips from the toothbrush (problems with usability)
Abstract
Provided is a nonaqueous composition for the oral cavity that makes it possible to obtain a favorable moisturized feeling and suppresses a feeling of powder abrasion, and that has properties such as good shape retention and spinnability. This composition for the oral cavity: contains (A) an inorganic powder body and (B) a cooling agent; has a surfactant content of 0.5 mass% or less; and has a water content of 2 mass% or less.
Description
本発明は、口腔用組成物に関する。
The present invention relates to an oral composition.
実質的に水分を含まない非水系の口腔用組成物は、水系では不安定である有効成分の安定性を確保できる点で有利である。例えば、歯磨剤、又は口腔用保湿ジェル、口腔用クリーム等の口腔用塗布剤に用いられる口腔用組成物であって、水を実質的に含まない非水系口腔用組成物は、特に水に対して不安定である成分の安定性を確保しつつ効果的に配合できる点で有利である。
A non-aqueous oral composition that does not contain substantially water is advantageous in that the stability of the active ingredient, which is unstable in the aqueous system, can be ensured. For example, a non-aqueous oral composition used for an oral application such as a dentifrice, an oral moisturizing gel, or an oral cream, which does not substantially contain water, is particularly resistant to water. It is advantageous in that it can be effectively blended while ensuring the stability of the unstable component.
例えば、下記特許文献1には、歯牙美白用として用いられる組成物であって、貼付時の歯面への組成物の密着性と適用用具除去後の歯面への残存性、貼付時の口腔全体への組成物の漏出抑制とブラッシング時の分散性を両立させることを目的として、(A)歯牙白色化成分としてグリセリン及び1,3-ブチレングリコール、(B)所定構造のゼオライト、(C)キサンタンガム、カルボキメチルセルロース及びその塩、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、カルボキシビニルポリマー、カラギーナン、架橋剤により架橋されたメチルビニルエーテル/無水マレイン酸共重体の中から選ばれる少なくとも1種のゲル化剤、並びに(D)アルキル硫酸塩を含有する非水系組成物が開示されている。
For example, Patent Document 1 below describes a composition used for whitening teeth, which adheres to the tooth surface at the time of application, remains on the tooth surface after removal of the application tool, and is an oral cavity at the time of application. For the purpose of achieving both suppression of leakage of the composition to the whole and dispersibility during brushing, (A) glycerin and 1,3-butylene glycol as tooth whitening components, (B) zeolite having a predetermined structure, (C). Xanthan gum, carboxymethyl cellulose and salts thereof, hydroxyethyl cellulose, hydroxypropyl cellulose, carboxyvinyl polymer, carrageenan, at least one gelling agent selected from methyl vinyl ether / maleic anhydride copolymer crosslinked by a cross-linking agent, and ( D) Non-aqueous compositions containing alkyl sulfates are disclosed.
また、下記特許文献2には、保型性に優れ、成分の分離などが起こらない経時的に安定な、水を含まないか又は水を殆ど含まない非水系の口腔用組成物を提供することを目的として、ポリエチレン末及びポリエチレンワックスからなる群から選ばれる少なくとも1種、並びに流動パラフィン、スクワラン及びスクワレンからなる群から選ばれる少なくとも1種を配合したことを特徴とする口腔用組成物用基剤が開示されている。
Further, Patent Document 2 below provides a non-aqueous oral composition containing no water or almost no water, which has excellent shape retention and is stable over time without separation of components. A base for an oral composition, which comprises at least one selected from the group consisting of polyethylene powder and polyethylene wax, and at least one selected from the group consisting of liquid paraffin, squalane and squalane. Is disclosed.
しかしながら、上記特許文献が開示している非水系の口腔用組成物によれば、使用後の口腔内の保湿実感を得ることが難しい場合があり、特に界面活性剤、とりわけアニオン界面活性剤が用いられている場合には、使用後に使用者において脱脂感が強く発現し、口腔内の保湿実感が顕著に低下する結果として、乾燥感を感じてしまう場合がある。
However, according to the non-aqueous oral composition disclosed in the above patent document, it may be difficult to obtain a moisturizing feeling in the oral cavity after use, and a surfactant, particularly an anionic surfactant, is used in particular. If this is the case, the user may experience a strong feeling of degreasing after use, and as a result, the feeling of moisturizing in the oral cavity may be significantly reduced, resulting in a feeling of dryness.
また、上記特許文献にかかる口腔用組成物も含め、非水系の口腔用組成物には、多くの場合、研磨能、粘結能の付与、さらには曳糸性の抑制等を目的として無機粉体が配合されている。
In addition, in many cases, non-aqueous oral compositions, including the oral compositions according to the above patent documents, are inorganic powders for the purpose of imparting polishing ability, caking ability, and suppressing spinnability. The body is compounded.
しかしながら、無機粉体が配合された非水系の口腔用組成物においては、保湿実感を高めるために上記界面活性剤の配合量を低減すると、特に使用の初期において、無機粉体に起因して使用者が粉きしみ感を強く感じてしまう場合がある。
However, in a non-aqueous oral composition containing an inorganic powder, if the amount of the above-mentioned surfactant is reduced in order to enhance the moisturizing feeling, it is used due to the inorganic powder, especially in the initial stage of use. A person may feel a strong squeaky feeling.
よって、本発明の目的は、良好な保湿実感を得ることができ、粉きしみ感が抑制され、さらには保形性、曳糸性等の特性が良好である非水系の口腔用組成物を提供することにある。
Therefore, an object of the present invention is to provide a non-aqueous oral composition capable of obtaining a good moisturizing sensation, suppressing a powdery squeaky sensation, and having good properties such as shape retention and spinnability. To do.
すなわち、本発明は、以下の[1]~[7]を提供する。
[1] (A)無機粉体、及び
(B)冷感剤
を含み、
界面活性剤の含有量が0.5質量%以下であり、
水分量が2質量%以下である、口腔用組成物。
[2] (B)冷感剤が、N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、メントングリセロールケタール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3-カルボキサミド)酢酸エチル、2-イソプロピル-N,2,3-トリメチルブチルアミドからなる群から選ばれる少なくとも1種である、[1]に記載の口腔用組成物。
[3] (A)無機粉体の含有量が2~50質量%である、[1]又は[2]に記載の口腔用組成物。
[4] (B)冷感剤の含有量が0.0001~0.3質量%である、[1]~[3]のいずれか1つに記載の口腔用組成物。
[5] (C)グリチルレチン酸、並びにグリチルリチン酸及びその塩からなる群から選ばれる1種以上をさらに含む、[1]~[4]のいずれか1つに記載の口腔用組成物。
[6] (D)溶媒をさらに含み、(D)溶媒が、融点が25℃以下の多価アルコールである、[1]~[5]のいずれか1つに記載の口腔用組成物。
[7] 歯磨剤又は塗布剤である、[1]~[6]のいずれか1つに記載の口腔用組成物。 That is, the present invention provides the following [1] to [7].
[1] Contains (A) inorganic powder and (B) cooling sensitizer.
The content of the surfactant is 0.5% by mass or less,
An oral composition having a water content of 2% by mass or less.
[2] (B) The cooling sensitizer is N-ethyl-p-menthane-3-carboxamide, mentyllactate, mentylmonosuccinate, isopregol, mentonglycerol ketal, N- (4-cyanomethylphenyl) -p-menthane. Carboxamide, 3-l-mentoxypropane-1,2-diol, 5-methyl-2-propane-2-yl-N- (2-pyridine-2-ylethyl) cyclohexane-1-carboxamide, 3- (p-) Mentan-3-Carboxamide) The oral composition according to [1], which is at least one selected from the group consisting of ethyl acetate, 2-isopropyl-N, and 2,3-trimethylbutylamide.
[3] The oral composition according to [1] or [2], wherein the content of the inorganic powder (A) is 2 to 50% by mass.
[4] The oral composition according to any one of [1] to [3], wherein the content of the cooling sensation agent is 0.0001 to 0.3% by mass.
[5] The oral composition according to any one of [1] to [4], further comprising (C) glycyrrhizic acid, and one or more selected from the group consisting of glycyrrhizic acid and salts thereof.
[6] The oral composition according to any one of [1] to [5], further comprising (D) a solvent, wherein the solvent is a polyhydric alcohol having a melting point of 25 ° C. or lower.
[7] The oral composition according to any one of [1] to [6], which is a dentifrice or a coating agent.
[1] (A)無機粉体、及び
(B)冷感剤
を含み、
界面活性剤の含有量が0.5質量%以下であり、
水分量が2質量%以下である、口腔用組成物。
[2] (B)冷感剤が、N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、メントングリセロールケタール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3-カルボキサミド)酢酸エチル、2-イソプロピル-N,2,3-トリメチルブチルアミドからなる群から選ばれる少なくとも1種である、[1]に記載の口腔用組成物。
[3] (A)無機粉体の含有量が2~50質量%である、[1]又は[2]に記載の口腔用組成物。
[4] (B)冷感剤の含有量が0.0001~0.3質量%である、[1]~[3]のいずれか1つに記載の口腔用組成物。
[5] (C)グリチルレチン酸、並びにグリチルリチン酸及びその塩からなる群から選ばれる1種以上をさらに含む、[1]~[4]のいずれか1つに記載の口腔用組成物。
[6] (D)溶媒をさらに含み、(D)溶媒が、融点が25℃以下の多価アルコールである、[1]~[5]のいずれか1つに記載の口腔用組成物。
[7] 歯磨剤又は塗布剤である、[1]~[6]のいずれか1つに記載の口腔用組成物。 That is, the present invention provides the following [1] to [7].
[1] Contains (A) inorganic powder and (B) cooling sensitizer.
The content of the surfactant is 0.5% by mass or less,
An oral composition having a water content of 2% by mass or less.
[2] (B) The cooling sensitizer is N-ethyl-p-menthane-3-carboxamide, mentyllactate, mentylmonosuccinate, isopregol, mentonglycerol ketal, N- (4-cyanomethylphenyl) -p-menthane. Carboxamide, 3-l-mentoxypropane-1,2-diol, 5-methyl-2-propane-2-yl-N- (2-pyridine-2-ylethyl) cyclohexane-1-carboxamide, 3- (p-) Mentan-3-Carboxamide) The oral composition according to [1], which is at least one selected from the group consisting of ethyl acetate, 2-isopropyl-N, and 2,3-trimethylbutylamide.
[3] The oral composition according to [1] or [2], wherein the content of the inorganic powder (A) is 2 to 50% by mass.
[4] The oral composition according to any one of [1] to [3], wherein the content of the cooling sensation agent is 0.0001 to 0.3% by mass.
[5] The oral composition according to any one of [1] to [4], further comprising (C) glycyrrhizic acid, and one or more selected from the group consisting of glycyrrhizic acid and salts thereof.
[6] The oral composition according to any one of [1] to [5], further comprising (D) a solvent, wherein the solvent is a polyhydric alcohol having a melting point of 25 ° C. or lower.
[7] The oral composition according to any one of [1] to [6], which is a dentifrice or a coating agent.
本発明によれば、良好な保湿実感を得ることができ、粉きしみ感が抑制され、さらには保形性、曳糸性等の特性が良好である非水系の口腔用組成物を提供することができる。
According to the present invention, there is provided a non-aqueous oral composition capable of obtaining a good moisturizing sensation, suppressing a powdery squeaky sensation, and having good properties such as shape retention and spinnability. Can be done.
以下、本発明について詳細に説明する。
本発明の口腔用組成物は、(A)無機粉体、及び(B)冷感剤を含み、界面活性剤の含有量が0.5質量%以下であり、水分量が2質量%以下である口腔用組成物であって、(C)グリチルレチン酸、並びにグリチルリチン酸及びその塩からなる群から選択される1種以上及び/又は(D)溶媒をさらに含み得る口腔用組成物である。 Hereinafter, the present invention will be described in detail.
The oral composition of the present invention contains (A) an inorganic powder and (B) a cooling sensation agent, and has a surfactant content of 0.5% by mass or less and a water content of 2% by mass or less. A certain oral composition, which may further contain (C) glycyrrhetinic acid, and one or more selected from the group consisting of glycyrrhetinic acid and salts thereof, and / or (D) a solvent.
本発明の口腔用組成物は、(A)無機粉体、及び(B)冷感剤を含み、界面活性剤の含有量が0.5質量%以下であり、水分量が2質量%以下である口腔用組成物であって、(C)グリチルレチン酸、並びにグリチルリチン酸及びその塩からなる群から選択される1種以上及び/又は(D)溶媒をさらに含み得る口腔用組成物である。 Hereinafter, the present invention will be described in detail.
The oral composition of the present invention contains (A) an inorganic powder and (B) a cooling sensation agent, and has a surfactant content of 0.5% by mass or less and a water content of 2% by mass or less. A certain oral composition, which may further contain (C) glycyrrhetinic acid, and one or more selected from the group consisting of glycyrrhetinic acid and salts thereof, and / or (D) a solvent.
ここで、本明細書において、「保湿実感」とは、使用者(試験者)が使用時において舌や口腔粘膜が潤うと感じる感覚をいう。
また、本明細書において、「粉きしみ感」とは、無機粉体が局所的に存在することにより、使用初期(磨き始め)において、特に上下歯が接触した際などに感じる不快感、異物感をいう。
さらに、本明細書において、「曳糸性」とは、ラミネートチューブ等の容器から取り出した際に、口腔用組成物が糸を引くように伸びる性状をいう。 Here, in the present specification, the "moisturizing sensation" means a sensation that the user (tester) feels that the tongue and the oral mucosa are moisturized at the time of use.
Further, in the present specification, the "powder squeaky feeling" means a feeling of discomfort or a foreign body sensation that is felt especially when the upper and lower teeth come into contact with each other at the initial stage of use (beginning of polishing) due to the local presence of the inorganic powder. To say.
Further, as used herein, the term "threading property" refers to a property in which the oral composition stretches like a string when it is taken out from a container such as a laminated tube.
また、本明細書において、「粉きしみ感」とは、無機粉体が局所的に存在することにより、使用初期(磨き始め)において、特に上下歯が接触した際などに感じる不快感、異物感をいう。
さらに、本明細書において、「曳糸性」とは、ラミネートチューブ等の容器から取り出した際に、口腔用組成物が糸を引くように伸びる性状をいう。 Here, in the present specification, the "moisturizing sensation" means a sensation that the user (tester) feels that the tongue and the oral mucosa are moisturized at the time of use.
Further, in the present specification, the "powder squeaky feeling" means a feeling of discomfort or a foreign body sensation that is felt especially when the upper and lower teeth come into contact with each other at the initial stage of use (beginning of polishing) due to the local presence of the inorganic powder. To say.
Further, as used herein, the term "threading property" refers to a property in which the oral composition stretches like a string when it is taken out from a container such as a laminated tube.
以下、口腔用組成物に含まれ得る(A)成分~(D)成分について説明する。
Hereinafter, the components (A) to (D) that can be contained in the oral composition will be described.
[(A)無機粉体]
本発明の実施形態にかかる「(A)成分」は、無機粉体である。(A)成分は、口腔用組成物において、一般に、研磨剤、無機増粘剤、無機顔料等として使用されている成分である。 [(A) Inorganic powder]
The "component (A)" according to the embodiment of the present invention is an inorganic powder. The component (A) is a component generally used as an abrasive, an inorganic thickener, an inorganic pigment, or the like in an oral composition.
本発明の実施形態にかかる「(A)成分」は、無機粉体である。(A)成分は、口腔用組成物において、一般に、研磨剤、無機増粘剤、無機顔料等として使用されている成分である。 [(A) Inorganic powder]
The "component (A)" according to the embodiment of the present invention is an inorganic powder. The component (A) is a component generally used as an abrasive, an inorganic thickener, an inorganic pigment, or the like in an oral composition.
無機粉体としては、例えば、無水ケイ酸、沈降性シリカ、チタン結合性シリカ、シリカゲル、アルミノシリケート、ジルコノシリケート等のシリカ化合物;炭酸カルシウム(軽質、重質)、リン酸カルシウム、リン酸水素カルシウム、ピロリン酸カルシウム、メタリン酸カルシウム、水酸化カルシウム、硫酸カルシウム等のカルシウム塩;酸化アルミニウム、水酸化アルミニウム、アルミナ等のアルミニウム塩;炭酸マグネシウム、第3リン酸マグネシウム等のマグネシウム塩;ハイドロキシアパタイト、フルオロアパタイト、カルシウム欠損アパタイト等のアパタイト;カオリナイト、ベントナイト等の粘土鉱物;二酸化チタン、雲母チタン、酸化チタン等のチタン化合物;等の無機物の粉体が挙げられる。これらのうち、無水ケイ酸、炭酸カルシウム、酸化アルミニウム、水酸化アルミニウム、及びゼオライトがより好ましい。
Examples of the inorganic powder include silica compounds such as silicic anhydride, precipitated silica, titanium-binding silica, silica gel, aluminosilicate, and zirconosilicate; calcium carbonate (light and heavy), calcium phosphate, calcium hydrogen phosphate, and the like. Calcium salts such as calcium pyrophosphate, calcium metaphosphate, calcium hydroxide, calcium sulfate; aluminum salts such as aluminum oxide, aluminum hydroxide, and alumina; magnesium salts such as magnesium carbonate and tertiary magnesium phosphate; hydroxyapatite, fluoroapatite, calcium Examples thereof include apatites such as defective apatites; clay minerals such as kaolinite and bentonite; titanium compounds such as titanium dioxide, mica titanium and titanium oxide; and powders of inorganic substances such as titanium oxide. Of these, anhydrous silicic acid, calcium carbonate, aluminum oxide, aluminum hydroxide, and zeolite are more preferable.
無機粉体の平均粒子径(体積基準D50)は、通常、1~30μmの範囲であり、好ましくは5~25μmの範囲である。
The average particle size (volume standard D50) of the inorganic powder is usually in the range of 1 to 30 μm, preferably in the range of 5 to 25 μm.
本明細書において、「平均粒子径」とは、上記のとおり、レーザー回折・散乱法による測定値である平均粒子径(体積基準D50)をいう。
In the present specification, the "average particle size" means the average particle size (volume standard D50) which is a measured value by the laser diffraction / scattering method as described above.
平均粒子径は、例えば、従来公知の任意好適な粒度分布測定装置(例えば、マイクロトラック粒度分布測定装置(日機装社製、Mode117995-10,Type SRA))を用い、検体の濁度(dV値)を0.5に調整して測定することができる。なお、後述する実施例においても同様に測定した。
For the average particle size, for example, a conventionally known arbitrary suitable particle size distribution measuring device (for example, Microtrack particle size distribution measuring device (Made 117995-10, Type SRA) manufactured by Nikkiso Co., Ltd.) is used, and the turbidity (dV value) of the sample is used. Can be adjusted to 0.5 for measurement. The same measurement was performed in the examples described later.
(A)成分は、上記例示の無機粉体から選ばれる1種を単独で用いてもよいし、2種以上を組み合わせて用いてもよい。2種以上の組み合わせとしては、例えば、研磨剤用途で用いられ得る(例えば、RDA50~120、好ましくは70~150、より好ましくは90~120)無機粉体と、無機増粘剤用途で用いられ得る無機粉体(例えば、吸液量2~5mL/g、好ましくは2.5~5mL/g)との組み合わせ等が挙げられる。前記吸液量は、増粘性シリカ1g当たりの吸液量(mL)として、例えば下記の測定法により算出することができる。
As the component (A), one selected from the above-exemplified inorganic powders may be used alone, or two or more thereof may be used in combination. As a combination of two or more, for example, an inorganic powder that can be used in an abrasive application (for example, RDA 50 to 120, preferably 70 to 150, more preferably 90 to 120) and an inorganic thickener are used. Examples thereof include a combination with the obtained inorganic powder (for example, liquid absorption amount of 2 to 5 mL / g, preferably 2.5 to 5 mL / g). The liquid absorption amount can be calculated as, for example, the following measurement method as the liquid absorption amount (mL) per 1 g of thickened silica.
試料1.0gを清浄なガラス板上に量りとり、ミクロビュレットを用いて、42.5%グリセリンを少量ずつ滴下しながらステンレス製のへらで均一になるように試料を混合する。試料が一つの塊となり、へらでガラス板よりきれいに剥がれるようになるまでに要した液量(mL)を吸液量とする。
Weigh 1.0 g of the sample on a clean glass plate, and mix the sample with a stainless steel spatula while dropping 42.5% glycerin little by little using a micro burette. The amount of liquid (mL) required until the sample becomes one lump and can be peeled off cleanly from the glass plate with a spatula is defined as the liquid absorption amount.
-(A)成分の含有量-
(A)成分の含有量は、口腔用組成物の全量に対し、通常、2質量%以上、好ましくは5質量%以上、より好ましくは8質量%以上である。これにより、適度な粘度が付与でき、良好な保形性を確保することができ、良好な使用実感を実現することができる。上限は、通常、50質量%以下、好ましくは40質量%以下、より好ましくは30質量%以下、さらに好ましくは20質量%以下である。これにより、口腔用組成物の粘度の過度な上昇を抑制でき、良好な保形性を維持することができ、良好な使用実感(清掃実感)を実現することができる。従って、(A)成分の含有量は、通常、2~50質量%、好ましくは5~50質量%、より好ましくは8~40質量%である。 -Contents of (A) component-
The content of the component (A) is usually 2% by mass or more, preferably 5% by mass or more, and more preferably 8% by mass or more with respect to the total amount of the oral composition. As a result, an appropriate viscosity can be imparted, good shape retention can be ensured, and a good feeling of use can be realized. The upper limit is usually 50% by mass or less, preferably 40% by mass or less, more preferably 30% by mass or less, still more preferably 20% by mass or less. As a result, it is possible to suppress an excessive increase in the viscosity of the oral composition, maintain good shape retention, and realize a good feeling of use (feeling of cleaning). Therefore, the content of the component (A) is usually 2 to 50% by mass, preferably 5 to 50% by mass, and more preferably 8 to 40% by mass.
(A)成分の含有量は、口腔用組成物の全量に対し、通常、2質量%以上、好ましくは5質量%以上、より好ましくは8質量%以上である。これにより、適度な粘度が付与でき、良好な保形性を確保することができ、良好な使用実感を実現することができる。上限は、通常、50質量%以下、好ましくは40質量%以下、より好ましくは30質量%以下、さらに好ましくは20質量%以下である。これにより、口腔用組成物の粘度の過度な上昇を抑制でき、良好な保形性を維持することができ、良好な使用実感(清掃実感)を実現することができる。従って、(A)成分の含有量は、通常、2~50質量%、好ましくは5~50質量%、より好ましくは8~40質量%である。 -Contents of (A) component-
The content of the component (A) is usually 2% by mass or more, preferably 5% by mass or more, and more preferably 8% by mass or more with respect to the total amount of the oral composition. As a result, an appropriate viscosity can be imparted, good shape retention can be ensured, and a good feeling of use can be realized. The upper limit is usually 50% by mass or less, preferably 40% by mass or less, more preferably 30% by mass or less, still more preferably 20% by mass or less. As a result, it is possible to suppress an excessive increase in the viscosity of the oral composition, maintain good shape retention, and realize a good feeling of use (feeling of cleaning). Therefore, the content of the component (A) is usually 2 to 50% by mass, preferably 5 to 50% by mass, and more preferably 8 to 40% by mass.
本実施形態の口腔用組成物の粘度は、25℃で20~100Pa・s程度であることが好ましい。口腔用組成物の粘度は、例えば、東機産業(株)(形式:VISCOMETER TVB-10)、ローターNo.6または7を使用して、回転数を20rpmとし、測定時間を3分間として25℃の条件で測定することができる。
The viscosity of the oral composition of this embodiment is preferably about 20 to 100 Pa · s at 25 ° C. The viscosity of the oral composition is, for example, Toki Sangyo Co., Ltd. (type: VISCOMETER TVB-10), rotor No. 6 or 7 can be used, the rotation speed is 20 rpm, the measurement time is 3 minutes, and the measurement can be performed under the condition of 25 ° C.
なお、本明細書において、各成分の含有量は、口腔用組成物を製造する際の各成分の仕込み量を基準としている。
In addition, in this specification, the content of each component is based on the amount of each component charged at the time of manufacturing an oral composition.
[(B)冷感剤]
本発明の実施形態にかかる(B)成分は、冷感剤である。本発明の口腔用組成物は、(B)成分を含有することにより、(A)成分に起因する使用初期(磨き始め)の粉きしみ感を改善し、良好な使用実感を実現することができる。 [(B) Cooling sensitizer]
The component (B) according to the embodiment of the present invention is a cooling sensation agent. By containing the component (B), the oral composition of the present invention can improve the powdery squeaky feeling at the initial stage of use (beginning of polishing) caused by the component (A) and realize a good feeling of use. ..
本発明の実施形態にかかる(B)成分は、冷感剤である。本発明の口腔用組成物は、(B)成分を含有することにより、(A)成分に起因する使用初期(磨き始め)の粉きしみ感を改善し、良好な使用実感を実現することができる。 [(B) Cooling sensitizer]
The component (B) according to the embodiment of the present invention is a cooling sensation agent. By containing the component (B), the oral composition of the present invention can improve the powdery squeaky feeling at the initial stage of use (beginning of polishing) caused by the component (A) and realize a good feeling of use. ..
(B)成分である冷感剤は、例えば、N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、メントングリセロールケタール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3-カルボキサミド)酢酸エチル、2-イソプロピル-N,2,3-トリメチルブチルアミドからなる群から選ばれる少なくとも1種であることが好ましい。これらのうち、N-エチル-p-メンタン-3-カルボキサミド、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、及び3-(p-メンタン-3-カルボキサミド)酢酸エチルがより好ましい。
The cooling sensitizer as a component (B) is, for example, N-ethyl-p-menthan-3-carboxamide, mentyllactate, mentylmonosuccinate, isopulegol, mentonglycerol ketal, N- (4-cyanomethylphenyl) -p. -Mentancarboxamide, 3-l-mentoxypropane-1,2-diol, 5-methyl-2-propane-2-yl-N- (2-pyridine-2-ylethyl) cyclohexane-1-carboxamide, 3-( p-mentan-3-carboxamide) It is preferably at least one selected from the group consisting of ethyl acetate, 2-isopropyl-N, and 2,3-trimethylbutylamide. Of these, N-ethyl-p-menthane-3-carboxamide, N- (4-cyanomethylphenyl) -p-menthan carboxamide, 3-l-mentoxypropane-1,2-diol, 5-methyl-2 -Propane-2-yl-N- (2-pyridine-2-ylethyl) cyclohexane-1-carboxamide and 3- (p-menthan-3-carboxamide) ethyl acetate are more preferred.
-(B)成分の含有量-
(B)成分の含有量は、口腔用組成物の全量に対し、粉きしみ感を改善する観点から、好ましくは0.0001質量%以上、より好ましくは0.001質量%以上、さらに好ましくは0.01質量%以上である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。(B)成分の含有量の上限は、口腔用組成物の粘度を最適に調整する観点から、好ましくは0.3質量%以下、より好ましくは0.2質量%以下、さらに好ましくは0.1質量%以下である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。従って、(B)成分の含有量は、好ましくは0.0001~0.3質量%であり、より好ましくは0.001~0.2質量%であり、さらに好ましくは0.01~0.1質量%である。 -Contents of (B) component-
The content of the component (B) is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, still more preferably 0, with respect to the total amount of the oral composition, from the viewpoint of improving the powdery squeaky feeling. It is 0.01% by mass or more. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. The upper limit of the content of the component (B) is preferably 0.3% by mass or less, more preferably 0.2% by mass or less, still more preferably 0.1 from the viewpoint of optimally adjusting the viscosity of the oral composition. It is less than mass%. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. Therefore, the content of the component (B) is preferably 0.0001 to 0.3% by mass, more preferably 0.001 to 0.2% by mass, and further preferably 0.01 to 0.1% by mass. It is mass%.
(B)成分の含有量は、口腔用組成物の全量に対し、粉きしみ感を改善する観点から、好ましくは0.0001質量%以上、より好ましくは0.001質量%以上、さらに好ましくは0.01質量%以上である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。(B)成分の含有量の上限は、口腔用組成物の粘度を最適に調整する観点から、好ましくは0.3質量%以下、より好ましくは0.2質量%以下、さらに好ましくは0.1質量%以下である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。従って、(B)成分の含有量は、好ましくは0.0001~0.3質量%であり、より好ましくは0.001~0.2質量%であり、さらに好ましくは0.01~0.1質量%である。 -Contents of (B) component-
The content of the component (B) is preferably 0.0001% by mass or more, more preferably 0.001% by mass or more, still more preferably 0, with respect to the total amount of the oral composition, from the viewpoint of improving the powdery squeaky feeling. It is 0.01% by mass or more. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. The upper limit of the content of the component (B) is preferably 0.3% by mass or less, more preferably 0.2% by mass or less, still more preferably 0.1 from the viewpoint of optimally adjusting the viscosity of the oral composition. It is less than mass%. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. Therefore, the content of the component (B) is preferably 0.0001 to 0.3% by mass, more preferably 0.001 to 0.2% by mass, and further preferably 0.01 to 0.1% by mass. It is mass%.
[(C)グリチルレチン酸、並びにグリチルリチン酸及びその塩]
(C)成分は、グリチルレチン酸、グリチルリチン酸及びこれらの塩からなる群から選ばれる1種以上である。口腔用組成物が(C)成分をさらに含有することにより、特に使用初期の粉きしみ感をより低減して、良好な使用実感を実現することができる。 [(C) Glycyrrhizic acid, and glycyrrhizic acid and its salts]
The component (C) is one or more selected from the group consisting of glycyrrhetinic acid, glycyrrhizic acid and salts thereof. By further containing the component (C) in the oral composition, it is possible to further reduce the powdery squeaky feeling at the initial stage of use and realize a good feeling of use.
(C)成分は、グリチルレチン酸、グリチルリチン酸及びこれらの塩からなる群から選ばれる1種以上である。口腔用組成物が(C)成分をさらに含有することにより、特に使用初期の粉きしみ感をより低減して、良好な使用実感を実現することができる。 [(C) Glycyrrhizic acid, and glycyrrhizic acid and its salts]
The component (C) is one or more selected from the group consisting of glycyrrhetinic acid, glycyrrhizic acid and salts thereof. By further containing the component (C) in the oral composition, it is possible to further reduce the powdery squeaky feeling at the initial stage of use and realize a good feeling of use.
グリチルレチン酸は、その誘導体であってもよく、例えば、β-グリチルレチン酸、グリチルレチン酸ステアリルなどを用いることができる。
The glycyrrhetinic acid may be a derivative thereof, and for example, β-glycyrrhetinic acid, stearyl glycyrrhetinate and the like can be used.
グリチルリチン酸塩としては、例えば、グリチルリチン酸ジカリウム、グリチルリチン酸二ナトリウム、グリチルリチン酸三ナトリウム、グリチルリチン酸モノアンモニウムなどを用いることができる。中でも、使用初期の粉きしみ感を低減する観点から、グリチルリチン酸ジカリウム及び/又はβ-グリチルレチン酸を用いることが好ましい。
As the glycyrrhizate, for example, dipotassium glycyrrhizinate, disodium glycyrrhizinate, trisodium glycyrrhizinate, monoammonium glycyrrhizinate and the like can be used. Above all, it is preferable to use dipotassium glycyrrhizinate and / or β-glycyrrhetinic acid from the viewpoint of reducing the feeling of powder squeaking at the initial stage of use.
-(C)成分の含有量-
(C)成分の含有量は、口腔用組成物の全量に対し、通常、0.01質量%以上、好ましくは0.03質量%以上である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。上限は、通常、0.1質量%以下、好ましくは0.05質量%以下である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。従って、(C)成分の含有量は、通常、0.01~0.1質量%、好ましくは0.03~0.05質量%である。 -Contents of (C) component-
The content of the component (C) is usually 0.01% by mass or more, preferably 0.03% by mass or more, based on the total amount of the oral composition. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. The upper limit is usually 0.1% by mass or less, preferably 0.05% by mass or less. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. Therefore, the content of the component (C) is usually 0.01 to 0.1% by mass, preferably 0.03 to 0.05% by mass.
(C)成分の含有量は、口腔用組成物の全量に対し、通常、0.01質量%以上、好ましくは0.03質量%以上である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。上限は、通常、0.1質量%以下、好ましくは0.05質量%以下である。これにより、口腔用組成物の使用初期の粉きしみ感を改善し、良好な使用実感を実現することができる。従って、(C)成分の含有量は、通常、0.01~0.1質量%、好ましくは0.03~0.05質量%である。 -Contents of (C) component-
The content of the component (C) is usually 0.01% by mass or more, preferably 0.03% by mass or more, based on the total amount of the oral composition. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. The upper limit is usually 0.1% by mass or less, preferably 0.05% by mass or less. As a result, it is possible to improve the powdery squeaky feeling at the initial stage of using the oral composition and realize a good feeling of use. Therefore, the content of the component (C) is usually 0.01 to 0.1% by mass, preferably 0.03 to 0.05% by mass.
[(D)溶媒]
(D)成分は、溶媒である。溶媒である(D)成分としては、多価アルコールを使用することができる。多価アルコールとしては、融点が25℃以下の多価アルコールを用いることが好ましい。 [(D) Solvent]
The component (D) is a solvent. A polyhydric alcohol can be used as the component (D) which is a solvent. As the polyhydric alcohol, it is preferable to use a polyhydric alcohol having a melting point of 25 ° C. or lower.
(D)成分は、溶媒である。溶媒である(D)成分としては、多価アルコールを使用することができる。多価アルコールとしては、融点が25℃以下の多価アルコールを用いることが好ましい。 [(D) Solvent]
The component (D) is a solvent. A polyhydric alcohol can be used as the component (D) which is a solvent. As the polyhydric alcohol, it is preferable to use a polyhydric alcohol having a melting point of 25 ° C. or lower.
多価アルコールとしては、具体的には、グリセリン(融点:17.8℃)、平均分子量190~630(医薬部外品原料規格2006記載の平均分子量、以下同様である。)のポリエチレングリコール(PEG200(融点:-35℃)、300(融点:-10℃)、400(融点:6℃)、600(融点:20℃))、プロピレングリコール(融点:-20℃)、ジプロピレングリコール(融点:-20℃)、ブチレングリコール(融点:-54℃)、エチレングリコール(融点:-13℃)ポリプロピレングリコール(融点:-31℃)等が挙げられる。これらの中でも、口腔内の保湿実感を良好にする観点から、グリセリン、平均分子量190~630のポリエチレングリコール、ブチレングリコールが好ましい。これらは1種を単独で用いても2種以上を組み合わせて用いてもよい。
Specific examples of the polyhydric alcohol include glycerin (melting point: 17.8 ° C.) and polyethylene glycol (PEG200) having an average molecular weight of 190 to 630 (the average molecular weight described in the Quasi-drug Raw Material Standard 2006, the same applies hereinafter). (Melting point: -35 ° C), 300 (melting point: -10 ° C), 400 (melting point: 6 ° C), 600 (melting point: 20 ° C)), propylene glycol (melting point: -20 ° C), dipropylene glycol (melting point: -20 ° C) −20 ° C.), butylene glycol (melting point: −54 ° C.), ethylene glycol (melting point: −13 ° C.), polypropylene glycol (melting point: −31 ° C.) and the like. Among these, glycerin, polyethylene glycol having an average molecular weight of 190 to 630, and butylene glycol are preferable from the viewpoint of improving the moisturizing feeling in the oral cavity. These may be used alone or in combination of two or more.
なお、ポリエチレングリコールの平均分子量は、通常650以下、好ましくは630以下、より好ましくは600以下である。下限は、通常150以上、好ましくは250以上である。従って、ポリエチレングリコールの平均分子量は、通常150~650、好ましくは150~630、より好ましくは250~600である。ポリエチレングリコールとしては、例えばポリエチレングリコール200(平均分子量190~210)、ポリエチレングリコール400(平均分子量380~420)、ポリエチレングリコール600(平均分子量570~630)を使用することができる。本明細書において、ポリエチレングリコールの平均分子量は、医薬部外品原料規格2006に記載の平均分子量である。
The average molecular weight of polyethylene glycol is usually 650 or less, preferably 630 or less, and more preferably 600 or less. The lower limit is usually 150 or more, preferably 250 or more. Therefore, the average molecular weight of polyethylene glycol is usually 150 to 650, preferably 150 to 630, and more preferably 250 to 600. As the polyethylene glycol, for example, polyethylene glycol 200 (average molecular weight 190 to 210), polyethylene glycol 400 (average molecular weight 380 to 420), and polyethylene glycol 600 (average molecular weight 570 to 630) can be used. In the present specification, the average molecular weight of polyethylene glycol is the average molecular weight described in the Quasi-drug Raw Material Standard 2006.
多価アルコールは、それ自体の苦味があるが、中でもグリセリンは苦味が比較的少ない多価アルコールである。そのため、溶媒由来の苦味を低減する点から、溶媒は、少なくともグリセリンを含み、グリセリンの含有量が多価アルコール全体の20~100質量%、特に50~85質量%、さらには50~80質量%であることがより好ましい。また、多価アルコールの中でも、上記平均分子量のポリエチレングリコールは、良好な温感実感が得られることから、好ましい溶媒である。温感実感を良好にする観点から、(D)成分は、少なくともポリエチレングリコールを含むことが好ましく、ポリエチレングリコールの含有量が口腔用組成物全体の10質量%以上、特に15~30質量%であることがより好ましい。ポリエチレングリコールの含有量が30質量%を超えると、ポリエチレングリコール由来の苦味が使用感に影響するおそれがあるが、30質量%以下とすれば、味のよい使用感を維持できる。
Polyhydric alcohol has its own bitterness, but glycerin is a polyhydric alcohol with relatively little bitterness. Therefore, from the viewpoint of reducing the bitterness derived from the solvent, the solvent contains at least glycerin, and the content of glycerin is 20 to 100% by mass, particularly 50 to 85% by mass, and further 50 to 80% by mass of the total polyhydric alcohol. Is more preferable. Further, among the polyhydric alcohols, polyethylene glycol having the above average molecular weight is a preferable solvent because a good feeling of warmth can be obtained. From the viewpoint of improving the feeling of warmth, the component (D) preferably contains at least polyethylene glycol, and the content of polyethylene glycol is 10% by mass or more, particularly 15 to 30% by mass of the entire oral composition. Is more preferable. If the content of polyethylene glycol exceeds 30% by mass, the bitterness derived from polyethylene glycol may affect the usability, but if it is 30% by mass or less, a good usability can be maintained.
口腔用組成物に温感を付与する観点では、多価アルコールが、グリセリンと平均分子量190~630のポリエチレングリコール及び/又はブチレングリコールとの併用系、特にグリセリンと平均分子量190~630のポリエチレングリコールとの併用系であることが好ましく、グリセリンの含有量が多価アルコール全体の50質量%以上、特に50~85質量%であることがより好ましい。すなわち、グリセリン/(平均分子量190~630のポリエチレングリコール及び/又はブチレングリコール)の質量比が50/50~85/15であることが特に好ましい。
From the viewpoint of imparting a warm feeling to the oral composition, the polyhydric alcohol is a combination system of glycerin and polyethylene glycol having an average molecular weight of 190 to 630 and / or butylene glycol, particularly glycerin and polyethylene glycol having an average molecular weight of 190 to 630. It is preferable that the glycerin content is 50% by mass or more, particularly more preferably 50 to 85% by mass, based on the total amount of the polyhydric alcohol. That is, it is particularly preferable that the mass ratio of glycerin / (polyethylene glycol and / or butylene glycol having an average molecular weight of 190 to 630) is 50/50 to 85/15.
[含有比率]
-(A)/(B)-
(A)成分の含有量の(B)成分の含有量に対する比である含有比率((A)/(B))は、好ましくは67以上、より好ましくは100以上である。(A)/(B)は、好ましくは200000以下、より好ましくは2000以下である。このようにすることにより、口腔用組成物の粘度、保形性を良好にすることができ、さらには使用初期の粉きしみ感を低減することができる。従って、(A)/(B)は、好ましくは67~200000であり、より好ましくは100~2000である。 [Content ratio]
-(A) / (B)-
The content ratio ((A) / (B)), which is the ratio of the content of the component (A) to the content of the component (B), is preferably 67 or more, more preferably 100 or more. (A) / (B) is preferably 200,000 or less, more preferably 2000 or less. By doing so, the viscosity and shape retention of the oral composition can be improved, and the powdery squeaky feeling at the initial stage of use can be reduced. Therefore, (A) / (B) is preferably 67 to 200,000, more preferably 100 to 2000.
-(A)/(B)-
(A)成分の含有量の(B)成分の含有量に対する比である含有比率((A)/(B))は、好ましくは67以上、より好ましくは100以上である。(A)/(B)は、好ましくは200000以下、より好ましくは2000以下である。このようにすることにより、口腔用組成物の粘度、保形性を良好にすることができ、さらには使用初期の粉きしみ感を低減することができる。従って、(A)/(B)は、好ましくは67~200000であり、より好ましくは100~2000である。 [Content ratio]
-(A) / (B)-
The content ratio ((A) / (B)), which is the ratio of the content of the component (A) to the content of the component (B), is preferably 67 or more, more preferably 100 or more. (A) / (B) is preferably 200,000 or less, more preferably 2000 or less. By doing so, the viscosity and shape retention of the oral composition can be improved, and the powdery squeaky feeling at the initial stage of use can be reduced. Therefore, (A) / (B) is preferably 67 to 200,000, more preferably 100 to 2000.
[水分量]
本実施形態の口腔用組成物は、実質的に水分を含まない非水系の口腔用組成物である。
ここで、「実質的に水分を含まない」とは、口腔用組成物の製造工程において、水が意図的に加えられていないことを意味している。 [amount of water]
The oral composition of the present embodiment is a non-aqueous oral composition that does not substantially contain water.
Here, "substantially water-free" means that water is not intentionally added in the manufacturing process of the oral composition.
本実施形態の口腔用組成物は、実質的に水分を含まない非水系の口腔用組成物である。
ここで、「実質的に水分を含まない」とは、口腔用組成物の製造工程において、水が意図的に加えられていないことを意味している。 [amount of water]
The oral composition of the present embodiment is a non-aqueous oral composition that does not substantially contain water.
Here, "substantially water-free" means that water is not intentionally added in the manufacturing process of the oral composition.
また、「非水系」とは、いかなる場合にも、結果として口腔用組成物中に水が全く存在しないということに限定されない。
Further, "non-aqueous" is not limited to the absence of water in the oral composition as a result in any case.
本実施形態の口腔用組成物は、例えば、原料中に不可避的に混在し得る水などに起因して、2質量%以下の量で水を含有し得る。例えば、水の含有量が少ないとされる(B)成分である濃グリセリンであっても0.5質量%程度の水を不可避的に含み得る。
The oral composition of the present embodiment may contain water in an amount of 2% by mass or less due to, for example, water that can be inevitably mixed in the raw material. For example, even concentrated glycerin, which is a component (B) having a low water content, can inevitably contain about 0.5% by mass of water.
本実施形態の口腔用組成物の水分量は、通常、2質量%以下、好ましくは1質量%以下、より好ましくは0.5質量%以下である。
The water content of the oral composition of the present embodiment is usually 2% by mass or less, preferably 1% by mass or less, and more preferably 0.5% by mass or less.
口腔用組成物の水分量は、配合前の原料に含まれる水分量の合計の全原料に対する割合(質量%)として、または、口腔用組成物の乾燥後重量と乾燥前重量との差分の乾燥前重量に対する割合(質量%)として、算出できる。
The water content of the oral composition is the ratio (% by mass) of the total water content of the raw materials before compounding to the total raw materials, or the difference between the weight after drying and the weight before drying of the oral composition is dried. It can be calculated as a ratio (mass%) to the previous weight.
[任意成分]
本実施形態の口腔用組成物は、本発明の効果を損なわない範囲で、既に説明した(A)成分~(D)成分以外の任意成分を含有していてもよい。任意成分としては、例えば、界面活性剤、甘味剤、香料、薬効成分、油性成分、研磨剤(有機研磨剤)、防腐剤、湿潤剤、粘結剤、pH調整剤、着色剤(色素)等の成分が挙げられる。本実施形態の口腔用組成物において、任意成分はこれらに限定されない。 [Arbitrary ingredient]
The oral composition of the present embodiment may contain arbitrary components other than the components (A) to (D) already described, as long as the effects of the present invention are not impaired. Optional components include, for example, surfactants, sweeteners, fragrances, medicinal components, oily components, abrasives (organic abrasives), preservatives, wetting agents, binders, pH adjusters, colorants (pigments) and the like. Ingredients are mentioned. In the oral composition of the present embodiment, the optional components are not limited to these.
本実施形態の口腔用組成物は、本発明の効果を損なわない範囲で、既に説明した(A)成分~(D)成分以外の任意成分を含有していてもよい。任意成分としては、例えば、界面活性剤、甘味剤、香料、薬効成分、油性成分、研磨剤(有機研磨剤)、防腐剤、湿潤剤、粘結剤、pH調整剤、着色剤(色素)等の成分が挙げられる。本実施形態の口腔用組成物において、任意成分はこれらに限定されない。 [Arbitrary ingredient]
The oral composition of the present embodiment may contain arbitrary components other than the components (A) to (D) already described, as long as the effects of the present invention are not impaired. Optional components include, for example, surfactants, sweeteners, fragrances, medicinal components, oily components, abrasives (organic abrasives), preservatives, wetting agents, binders, pH adjusters, colorants (pigments) and the like. Ingredients are mentioned. In the oral composition of the present embodiment, the optional components are not limited to these.
-界面活性剤-
本実施形態の口腔用組成物は、界面活性剤の含有量が0.5質量%以下とされる。すなわち、本実施形態の口腔用組成物においては、使用時の脱脂感を抑制し、保湿実感を実現する観点から、界面活性剤の含有量が0.5質量%以下に低減されているか、又は界面活性剤が不含とされることが好ましい。 -Surfactant-
The oral composition of the present embodiment has a surfactant content of 0.5% by mass or less. That is, in the oral composition of the present embodiment, the content of the surfactant is reduced to 0.5% by mass or less, or the content of the surfactant is reduced to 0.5% by mass or less from the viewpoint of suppressing the degreasing feeling at the time of use and realizing the moisturizing feeling. It is preferable that the surfactant is not contained.
本実施形態の口腔用組成物は、界面活性剤の含有量が0.5質量%以下とされる。すなわち、本実施形態の口腔用組成物においては、使用時の脱脂感を抑制し、保湿実感を実現する観点から、界面活性剤の含有量が0.5質量%以下に低減されているか、又は界面活性剤が不含とされることが好ましい。 -Surfactant-
The oral composition of the present embodiment has a surfactant content of 0.5% by mass or less. That is, in the oral composition of the present embodiment, the content of the surfactant is reduced to 0.5% by mass or less, or the content of the surfactant is reduced to 0.5% by mass or less from the viewpoint of suppressing the degreasing feeling at the time of use and realizing the moisturizing feeling. It is preferable that the surfactant is not contained.
口腔用組成物に用いられ得る界面活性剤としては、例えば、アニオン界面活性剤、ノニオン界面活性剤、両性界面活性剤が挙げられる。
Examples of the surfactant that can be used in the oral composition include an anionic surfactant, a nonionic surfactant, and an amphoteric surfactant.
アニオン界面活性剤としては、例えば、アルキル硫酸塩、アシルアミノ酸塩、アシルタウリン塩、α-オレフィンスルホン酸塩、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸塩、ラウリルスルホ酢酸塩が挙げられる。アルキル基、アシル基は直鎖及び分岐鎖のいずれでもよく、飽和及び不飽和のいずれでもよく、その炭素原子数は通常10~20であり、好ましくは12~18であり、より好ましくは12~14である。塩は、薬理学的に許容される塩から選択され得る。薬理学的に許容される塩としては、例えば、塩基付加塩及びアミノ酸塩が挙げられる。その具体例としては、ナトリウム塩、カリウム塩、カルシウム塩、マグネシウム塩、アンモニウム塩等の無機塩基塩;トリエチルアンモニウム塩、トリエタノールアンモニウム塩、ピリジニウム塩、ジイソプロピルアンモニウム塩等の有機塩基塩;アルギニン塩等の塩基性アミノ酸塩が挙げられる。中でも、薬理学的に許容される塩としては、無機塩基塩が好ましく、アルカリ金属塩(例えば、ナトリウム塩、カリウム塩)又はアンモニウム塩がより好ましく、ナトリウム塩が更に好ましい。
Examples of the anionic surfactant include alkyl sulfates, acyl amino acid salts, acyl taurine salts, α-olefin sulfonates, hydrogenated coconut fatty acid monoglyceride monosulfates, and lauryl sulfoacetates. The alkyl group and the acyl group may be either a linear group or a branched chain, and may be saturated or unsaturated, and the number of carbon atoms thereof is usually 10 to 20, preferably 12 to 18, and more preferably 12 to 18. It is 14. The salt can be selected from pharmacologically acceptable salts. Pharmacologically acceptable salts include, for example, base addition salts and amino acid salts. Specific examples thereof include inorganic base salts such as sodium salt, potassium salt, calcium salt, magnesium salt and ammonium salt; organic base salts such as triethylammonium salt, triethanolammonium salt, pyridinium salt and diisopropylammonium salt; arginine salt and the like. Basic amino acid salts of. Among them, as the pharmacologically acceptable salt, an inorganic base salt is preferable, an alkali metal salt (for example, a sodium salt or a potassium salt) or an ammonium salt is more preferable, and a sodium salt is further preferable.
アルキル硫酸塩としては、例えば、ラウリル硫酸塩、ミリストイル硫酸塩が挙げられる。アシルアミノ酸塩としては、例えば、ラウロイルサルコシン塩、ミリストイルサルコシン塩等のアシルサルコシン塩;ラウロイルグルタミン酸塩、ミリストイルグルタミン酸塩、パルミトイルグルタミン酸塩等のアシルグルタミン酸塩;N-ラウロイル-N-メチルグリシン塩、ココイルグリシン塩等のアシルグリシン塩;N-ラウロイル-β-アラニン塩、N-ミリスチル-β-アラニン塩、N-ココイル-β-アラニン塩、N-ラウロイル-N-メチル-β-アラニン塩、N-ミリストイル-N-メチル-β-アラニン塩、N-メチル-N-アシルアラニン塩等のアシルアラニン塩;ラウロイルアスパラギン酸塩等のアシルアスパラギン酸塩が挙げられる。アシルタウリン塩としては、例えば、ラウロイルメチルタウリン塩、N-メチル-N-アシルタウリン塩、N-ココイルメチルタウリン塩が挙げられる。α-オレフィンスルホン酸塩としては、例えば、テトラデセンスルホン酸塩等の炭素原子数12~18のα-オレフィンスルホン酸塩が挙げられる。アニオン界面活性剤の他の例としては、水素添加ココナッツ脂肪酸モノグリセリドモノ硫酸ナトリウム、ラウリルスルホ酢酸ナトリウムが挙げられる。
Examples of the alkyl sulfate include lauryl sulfate and myristoyl sulfate. Examples of the acyl amino acid salt include acyl sarcosine salts such as lauroyl sarcosin salt and myristoyl sarcosin salt; acyl glutamates such as lauroyl glutamate, myristoyl glutamate and palmitoyl glutamate; N-lauroyl-N-methylglycine salt and cocoyl glycine. Acylglycine salts such as salts; N-lauroyl-β-alanine salt, N-myristyl-β-alanine salt, N-cocoyl-β-alanine salt, N-lauroyl-N-methyl-β-alanine salt, N-myristoyl Acylalanine salts such as -N-methyl-β-alanine salt, N-methyl-N-acylalanine salt; acylasparaginate such as lauroyl asparagate can be mentioned. Examples of the acyl taurine salt include lauroylmethyl taurine salt, N-methyl-N-acyl taurine salt, and N-cocoyl methyl taurine salt. Examples of the α-olefin sulfonate include α-olefin sulfonate having 12 to 18 carbon atoms such as tetradecene sulfonate. Other examples of anionic surfactants include hydrogenated coconut fatty acid monoglyceride sodium monosulfate, sodium lauryl sulfoacetate.
アニオン界面活性剤は、泡立ち、泡質の良さの点で、スルホン酸基を含有することが好ましく、アルキル硫酸塩、α-オレフィンスルホン酸塩がより好ましい。アニオン界面活性剤の含有量は、好ましくは組成物全体の0.1~2.5質量%、より好ましくは0.6~2.5質量%、さらに好ましくは1~2.5質量%である。
The anionic surfactant preferably contains a sulfonic acid group in terms of foaming and good foam quality, and more preferably an alkyl sulfate or an α-olefin sulfonate. The content of the anionic surfactant is preferably 0.1 to 2.5% by mass, more preferably 0.6 to 2.5% by mass, still more preferably 1 to 2.5% by mass of the entire composition. ..
ノニオン界面活性剤としては、例えば、ポリオキシエチレンアルキルエーテル、ポリオキシエチレン硬化ヒマシ油、ソルビタン脂肪酸エステル、ポリオキシエチレンソルビタン脂肪酸エステル(例、ポリオキシエチレンソルビタンモノステアレート)、アルキロールアミド、ポリオキシエチレン脂肪酸エステル、ポリオキシエチレンアルケニルエーテル、グリセリン脂肪酸エステル、ショ糖脂肪酸エステル(例、マルトース脂肪酸エステル)、糖アルコール脂肪酸エステル(例、マルチトール脂肪酸エステル、ラクチトール脂肪酸エステル)、脂肪酸ジエタノールアミド(例、ラウリル酸モノ又はジエタノールアミド)、ポリオキシエチレンポリオキシプロピレン共重合体、ポリオキシエチレンポリオキシプロピレン脂肪酸エステルが挙げられる。ポリオキシエチレンアルキルエーテルのアルキル鎖の炭素原子数は、通常、14~18であり、エチレンオキサイド平均付加モル数は、通常、15~30モルである。ポリオキシエチレン硬化ヒマシ油のエチレンオキサイド平均付加モル数は、通常20~100モル、好ましくは20~60モルである。ソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常12~18である。ポリオキシエチレンソルビタン脂肪酸エステルの脂肪酸の炭素原子数は、通常16~18であり、エチレンオキサイド平均付加モル数は、通常10~40モルである。アルキロールアミドのアルキル鎖の炭素原子数は、通常12~14である。ノニオン界面活性剤としては、ポリオキシエチレン硬化ヒマシ油、ポリオキシエチレンソルビタン脂肪酸エステル、ポリオキシエチレンアルキルエーテルが好ましい。
Examples of the nonionic surfactant include polyoxyethylene alkyl ether, polyoxyethylene hydrogenated castor oil, sorbitan fatty acid ester, polyoxyethylene sorbitan fatty acid ester (eg, polyoxyethylene sorbitan monostearate), alkylolamide, and polyoxy. Ethylene fatty acid ester, polyoxyethylene alkenyl ether, glycerin fatty acid ester, sucrose fatty acid ester (eg, maltose fatty acid ester), sugar alcohol fatty acid ester (eg, multitoll fatty acid ester, lactitol fatty acid ester), fatty acid diethanolamide (eg, lauryl) Acid mono or diethanolamide), polyoxyethylene polyoxypropylene copolymer, polyoxyethylene polyoxypropylene fatty acid ester, and the like. The number of carbon atoms in the alkyl chain of the polyoxyethylene alkyl ether is usually 14 to 18, and the average number of moles of ethylene oxide added is usually 15 to 30 mol. The average number of moles of ethylene oxide added to the polyoxyethylene hydrogenated castor oil is usually 20 to 100 mol, preferably 20 to 60 mol. The number of carbon atoms of the fatty acid of the sorbitan fatty acid ester is usually 12 to 18. The fatty acid of the polyoxyethylene sorbitan fatty acid ester usually has 16 to 18 carbon atoms, and the average number of moles of ethylene oxide added is usually 10 to 40 mol. The number of carbon atoms in the alkyl chain of the alkylolamide is usually 12 to 14. As the nonionic surfactant, polyoxyethylene hydrogenated castor oil, polyoxyethylene sorbitan fatty acid ester, and polyoxyethylene alkyl ether are preferable.
両性界面活性剤としては、例えば、アルキルジメチルアミノ酢酸ベタイン(例えば、ラウリルジメチルアミノ酢酸ベタイン)、脂肪酸アミドプロピルジメチルアミノ酢酸ベタイン(例えば、コカミドプロピルベタイン)等のベタイン型両性界面活性剤;N-脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルエチレンジアミン塩(例えば、N-ヤシ油脂肪酸アシル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン)、ヤシ油脂肪酸イミダゾリニウムベタイン、2-アルキル-N-カルボキシメチル-N-ヒドロキシエチルイミダゾリニウムベタイン等のイミダゾリン型両性界面活性剤;ラウリルジメチルアミノ酢酸ベタイン等のアルキルベタインが挙げられる。カチオン界面活性剤としては、例えば、アルキルアンモニウム塩、アルキルベンジルアンモニウム塩が挙げられる。
Examples of the amphoteric surfactant include betaine-type amphoteric surfactants such as alkyldimethylaminoacetic acid betaine (eg, lauryldimethylaminoacetic acid betaine) and fatty acid amide propyldimethylaminoacetic acid betaine (eg, cocamidopropyl betaine); N-. Fatty acid acyl-N-carboxymethyl-N-hydroxyethylethylenediamine salt (eg, N-palm oil fatty acid acyl-N-carboxymethyl-N-hydroxyethyl imidazolinium betaine), coconut oil fatty acid imidazolinium betaine, 2-alkyl Examples include imidazoline-type amphoteric surfactants such as -N-carboxymethyl-N-hydroxyethyl imidazolinium betaine; alkyl betaines such as lauryldimethylaminoacetic acid betaine. Examples of the cationic surfactant include an alkylammonium salt and an alkylbenzylammonium salt.
口腔用組成物が、アニオン界面活性剤、ノニオン界面活性剤、両性界面活性剤それぞれ、又はこれらの2種以上の組合せとして含む場合、含有量は、組成物全体の0.5質量%以下であり、好ましくは0.2質量%以下であり、より好ましくは0.1%質量以下であり、特に好ましくは0.05質量%以下である。中でも、アニオン界面活性剤が用いられる場合には、使用時の脱脂感を低減し、保湿実感を高める観点から、その含有量を0.1質量%以下とすることが好ましく、0.05質量%以下とすることがより好ましく、不含(0質量%)とすることがさらに好ましい。
When the oral composition contains an anionic surfactant, a nonionic surfactant, an amphoteric surfactant, or a combination of two or more thereof, the content is 0.5% by mass or less of the total composition. It is preferably 0.2% by mass or less, more preferably 0.1% by mass or less, and particularly preferably 0.05% by mass or less. Above all, when an anionic surfactant is used, the content thereof is preferably 0.1% by mass or less, preferably 0.05% by mass, from the viewpoint of reducing the feeling of degreasing during use and enhancing the feeling of moisturizing. The following is more preferable, and it is further preferable to make it non-containing (0% by mass).
-甘味剤-
本実施形態の口腔用組成物は、従来公知の任意好適な甘味剤を任意好適な含有量として含有していてもよい。口腔用組成物が甘味剤を含むことにより、使用感をより向上させることができる。 -Sweetener-
The oral composition of the present embodiment may contain any suitable sweetener previously known as an arbitrary suitable content. When the oral composition contains a sweetening agent, the feeling of use can be further improved.
本実施形態の口腔用組成物は、従来公知の任意好適な甘味剤を任意好適な含有量として含有していてもよい。口腔用組成物が甘味剤を含むことにより、使用感をより向上させることができる。 -Sweetener-
The oral composition of the present embodiment may contain any suitable sweetener previously known as an arbitrary suitable content. When the oral composition contains a sweetening agent, the feeling of use can be further improved.
甘味剤としては、例えば、キシリトール、エリスリトール、マルチトール、サッカリン、サッカリンナトリウム、アスパルテーム、ステビオサイド、ステビアエキス、パラメトキシシンナミックアルデヒド、ネオヘスペリジンジヒドロカルコン、ペリラルチン、ソーマチン、アスパラチルフェニルアラニンメチルエステル等が挙げられる。甘味剤としては、上記例示の甘味剤を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
Examples of the sweetener include xylitol, erythritol, maltitol, saccharin, saccharin sodium, aspartame, stebioside, stevia extract, paramethoxycinnamic aldehyde, neohesperidin dihydrochalcone, perillartine, thaumatin, aspartylphenylalanine methyl ester and the like. As the sweetener, the above-exemplified sweetener may be used alone or in combination of two or more.
-香料-
本実施形態の口腔用組成物は、従来公知の任意好適な香料を任意好適な含有量として含有していてもよい。口腔用組成物が香料を含むことにより、使用感をより向上させることができる。 -Fragrance-
The oral composition of the present embodiment may contain any suitable fragrance previously known as an arbitrary suitable content. When the oral composition contains a fragrance, the feeling of use can be further improved.
本実施形態の口腔用組成物は、従来公知の任意好適な香料を任意好適な含有量として含有していてもよい。口腔用組成物が香料を含むことにより、使用感をより向上させることができる。 -Fragrance-
The oral composition of the present embodiment may contain any suitable fragrance previously known as an arbitrary suitable content. When the oral composition contains a fragrance, the feeling of use can be further improved.
香料としては、例えば、ペパーミント油、スペアミント油、ユーカリ油、ウィンターグリーン油、クローブ油、タイム油、セージ油、カルダモン油、ローズマリー油、マジョラム油、レモン油、オレンジ油、ナツメグ油、ラベンダー油、パラクレス油、桂皮油、ピメント油、桂葉油、シソ油、冬緑油等の天然精油;メントール、カルボン、シンナミックアルデヒド、アネトール、1,8-シネオール、メチルサリシレート、オイゲノール、チモール、リナロール、リモネン、メントン、メンチルアセテート、シトラール、カンファー、ボルネオール、ピネン、スピラントール、n-デシルアルコール、シトロネロール、α-テルピネオール、シトロネリルアセテート、シネオール、エチルリナロール、ワニリン等の上記天然精油中に含まれる香料成分;エチルアセテート、エチルブチレート、イソアミルアセテート、ヘキサナール、ヘキセナール、メチルアンスラニレート、エチルメチルフェニルグリシデート、ベンズアルデヒド、バニリン、エチルバニリン、フラネオール、等の香料成分;及びいくつかの香料成分や天然精油を組み合わせてなるミント系、フルーツ系、ハーブ系等の各種調合フレーバーが挙げられる。香料としては、上記例示の香料を1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
Examples of fragrances include peppermint oil, sparemint oil, eucalyptus oil, winter green oil, clove oil, thyme oil, sage oil, cardamon oil, rosemary oil, majorum oil, lemon oil, orange oil, nutmeg oil, and lavender oil. Natural essential oils such as parlacles oil, laurel oil, piment oil, laurel oil, perilla oil, winter green oil; menthol, carboxylic, synamic aldehyde, anetol, 1,8-cineole, methyl salicylate, eugenol, timole, linalol, limonen, Perfume components contained in the above natural essential oils such as menthon, mentholacetate, citral, camphor, borneol, pinen, spirantol, n-decyl alcohol, citronellol, α-terpineol, citronellyl acetate, cineol, ethyllinalol, varnish and the like; ethyl acetate , Ethylbutyrate, isoamylacetate, hexanal, hexenal, methylanthranilate, ethylmethylphenylglycidate, benzaldehyde, vanillin, ethylvaniline, flaneol, etc.; and a combination of several perfume ingredients and natural essential oils. Examples include various blended flavors such as mint-based, fruit-based, and herbal-based. As the fragrance, the above-exemplified fragrance may be used alone or in combination of two or more.
-薬効成分-
薬効成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、グルコン酸亜鉛、クエン酸亜鉛、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、アラントインクロルヒドロキシアルミニウム、アズレン、ジヒドロコレステロール等の抗炎症剤;亜鉛、銅塩、スズ塩等の金属塩;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;硝酸カリウム、乳酸アルミニウム、塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸またはその塩)、塩化リゾチーム、塩化ナトリウム等の収斂剤;銅クロロフィル、グルコン酸銅等の水溶性銅化合物;歯石予防剤、アラニン、グリシン、プロリン等のアミノ酸類、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。薬効成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬効成分の含有量は、常法に従って有効量を適宜設定できる。 -Medicinal ingredient-
Examples of the medicinal ingredient include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timole, hinokithiol, and lysodium chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ε-aminocaproic acid, allantin, tranexamic acid, allantinchlorhydroxyaluminum, azulene, dihydrocholesterol, etc. Anti-inflammatory agents; Metal salts such as zinc, copper salt, tin salt; Toothstone preventive agents such as condensed phosphate and ethanehydroxydiphosphonate; , Aluminum lactate, strontium chloride and other hypersensitivity inhibitors; coating agents such as hydroxyethyl cellulose dimethyldiallyl ammonium chloride; astringents such as vitamin C (eg, ascorbic acid or salts thereof), lysozyme chloride, sodium chloride and the like; copper chlorophyll, glucon Water-soluble copper compounds such as copper acid acid; amino acids such as dentin preventive agent, alanine, glycine and proline, plant extracts such as thyme, ginger, chow and hamamelis; caropeptide and polyvinylpyrrolidone can be mentioned. The medicinal ingredient may be used alone or in combination of two or more. The content of the medicinal ingredient can be appropriately set as an effective amount according to a conventional method.
薬効成分としては、例えば、塩化セチルピリジニウム、塩化ベンザルコニウム、塩化ベンゼトニウム、イソプロピルメチルフェノール、グルコン酸亜鉛、クエン酸亜鉛、トリクロサン、チモール、ヒノキチオール、塩化リゾチーム等の殺菌又は抗菌剤;デキストラナーゼ、ムタナーゼ、アミラーゼ、プロテアーゼ、リテックエンザイム等の酵素;フッ化ナトリウム、モノフルオロリン酸ナトリウム、フッ化スズ等のフッ化物;ε-アミノカプロン酸、アラントイン、トラネキサム酸、アラントインクロルヒドロキシアルミニウム、アズレン、ジヒドロコレステロール等の抗炎症剤;亜鉛、銅塩、スズ塩等の金属塩;縮合リン酸塩、エタンヒドロキシジホスフォネート等の歯石予防剤;ビタミンE(例えば、酢酸トコフェロール)等の血流促進剤;硝酸カリウム、乳酸アルミニウム、塩化ストロンチウム等の知覚過敏抑制剤;ヒドロキシエチルセルロースジメチルジアリルアンモニウムクロリド等のコーティング剤;ビタミンC(例えば、アスコルビン酸またはその塩)、塩化リゾチーム、塩化ナトリウム等の収斂剤;銅クロロフィル、グルコン酸銅等の水溶性銅化合物;歯石予防剤、アラニン、グリシン、プロリン等のアミノ酸類、タイム、オウゴン、チョウジ、ハマメリス等の植物エキス;カロペプタイド、ポリビニルピロリドンを挙げることができる。薬効成分は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。上記薬効成分の含有量は、常法に従って有効量を適宜設定できる。 -Medicinal ingredient-
Examples of the medicinal ingredient include bactericidal or antibacterial agents such as cetylpyridinium chloride, benzalkonium chloride, benzethonium chloride, isopropylmethylphenol, zinc gluconate, zinc citrate, triclosan, timole, hinokithiol, and lysodium chloride; Enzymes such as mutanase, amylase, protease, lytecenzyme; fluorides such as sodium fluoride, sodium monofluorophosphate, tin fluoride; ε-aminocaproic acid, allantin, tranexamic acid, allantinchlorhydroxyaluminum, azulene, dihydrocholesterol, etc. Anti-inflammatory agents; Metal salts such as zinc, copper salt, tin salt; Toothstone preventive agents such as condensed phosphate and ethanehydroxydiphosphonate; , Aluminum lactate, strontium chloride and other hypersensitivity inhibitors; coating agents such as hydroxyethyl cellulose dimethyldiallyl ammonium chloride; astringents such as vitamin C (eg, ascorbic acid or salts thereof), lysozyme chloride, sodium chloride and the like; copper chlorophyll, glucon Water-soluble copper compounds such as copper acid acid; amino acids such as dentin preventive agent, alanine, glycine and proline, plant extracts such as thyme, ginger, chow and hamamelis; caropeptide and polyvinylpyrrolidone can be mentioned. The medicinal ingredient may be used alone or in combination of two or more. The content of the medicinal ingredient can be appropriately set as an effective amount according to a conventional method.
-油性成分-
油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス、カルナバワックス、ライスワックス、ロジン等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ヒマシ油、ヤシ油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。 -Oil component-
Examples of the oily component include fatty acids such as squalane, liquid paraffin, vaseline, microcrystallin wax, carnauba wax, rice wax, and rosin; higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, iso). Alcohols with 8 to 22 carbon atoms such as stearyl alcohol); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), olive oil, castor oil, coconut oil and the like. Vegetable oils; fatty acid esters such as isopropyl myristate.
油性成分としては、例えば、スクワラン、流動パラフィン、ワセリン、マイクロクリスタリンワックス、カルナバワックス、ライスワックス、ロジン等の炭化水素類;高級アルコール(例えば、ラウリルアルコール、セチルアルコール、セトステアリルアルコール、オレイルアルコール、イソステアリルアルコール等の炭素原子数8~22のアルコール);高級脂肪酸(例えば、ラウリン酸、ミリスチン酸、オレイン酸、イソステアリン酸等の炭素原子数8~22の脂肪酸)、オリーブ油、ヒマシ油、ヤシ油等の植物油;ミリスチン酸イソプロピル等の脂肪酸エステルが挙げられる。 -Oil component-
Examples of the oily component include fatty acids such as squalane, liquid paraffin, vaseline, microcrystallin wax, carnauba wax, rice wax, and rosin; higher alcohols (eg, lauryl alcohol, cetyl alcohol, cetostearyl alcohol, oleyl alcohol, iso). Alcohols with 8 to 22 carbon atoms such as stearyl alcohol); higher fatty acids (eg, fatty acids with 8 to 22 carbon atoms such as lauric acid, myristic acid, oleic acid, isostearic acid), olive oil, castor oil, coconut oil and the like. Vegetable oils; fatty acid esters such as isopropyl myristate.
-研磨剤-
本実施形態の口腔用組成物は、従来公知の任意好適な研磨剤(既に説明した(A)成分として用いられる原料を除く。)を任意好適な含有量として含有していてもよい。 -Abrasive-
The oral composition of the present embodiment may contain a conventionally known arbitrary suitable abrasive (excluding the raw material used as the component (A) already described) as an optional suitable content.
本実施形態の口腔用組成物は、従来公知の任意好適な研磨剤(既に説明した(A)成分として用いられる原料を除く。)を任意好適な含有量として含有していてもよい。 -Abrasive-
The oral composition of the present embodiment may contain a conventionally known arbitrary suitable abrasive (excluding the raw material used as the component (A) already described) as an optional suitable content.
口腔用組成物が含み得る任意の研磨剤としては、例えば、ポリメチルメタアクリレート、合成樹脂系研磨剤等の有機研磨剤が挙げられる。有機研磨剤の含有量は、10質量%以下(0~10質量%)であることが好ましい。また、有機研磨剤と(A)成分との合計量は、組成物全体の50質量%以下とすることが好ましく、8~50質量%とすることがより好ましい。
Examples of any abrasive that can be contained in the oral composition include organic abrasives such as polymethylmethacrylate and synthetic resin-based abrasives. The content of the organic abrasive is preferably 10% by mass or less (0 to 10% by mass). The total amount of the organic abrasive and the component (A) is preferably 50% by mass or less, more preferably 8 to 50% by mass, based on the whole composition.
-防腐剤-
本実施形態の口腔用組成物は、従来公知の任意好適な防腐剤を任意好適な含有量として含有していてもよい。口腔用組成物が防腐剤を含むことにより、口腔用組成物の防腐力を確保できる。 -Preservative-
The oral composition of the present embodiment may contain any suitable preservative previously known as an arbitrary suitable content. When the oral composition contains an antiseptic, the antiseptic power of the oral composition can be ensured.
本実施形態の口腔用組成物は、従来公知の任意好適な防腐剤を任意好適な含有量として含有していてもよい。口腔用組成物が防腐剤を含むことにより、口腔用組成物の防腐力を確保できる。 -Preservative-
The oral composition of the present embodiment may contain any suitable preservative previously known as an arbitrary suitable content. When the oral composition contains an antiseptic, the antiseptic power of the oral composition can be ensured.
口腔用組成物が含み得る防腐剤としては、例えば、パラオキシ安息香酸エステル(例えば、パラオキシ安息香酸メチル、パラオキシ安息香酸エチル、パラオキシ安息香酸ブチル)、安息香酸ナトリウム等が挙げられる。防腐剤は、1種単独で用いてもよく、2種以上を組み合わせて用いてもよい。
Examples of the preservative that can be contained in the oral composition include paraoxybenzoic acid esters (for example, methyl paraoxybenzoate, ethyl paraoxybenzoate, butyl paraoxybenzoate), sodium benzoate and the like. The preservative may be used alone or in combination of two or more.
-湿潤剤-
本実施形態の口腔用組成物は、従来公知の任意好適な湿潤剤(既に説明した(D)成分として用いられるものを除く。)を任意好適な含有量として含有していてもよい。口腔用組成物が任意の湿潤剤を含むことにより、使用感をより向上させることができる。 -Wetting agent-
The oral composition of the present embodiment may contain any suitable wettable agent conventionally known (excluding those used as the component (D) already described) as an optional suitable content. When the oral composition contains an arbitrary wetting agent, the feeling of use can be further improved.
本実施形態の口腔用組成物は、従来公知の任意好適な湿潤剤(既に説明した(D)成分として用いられるものを除く。)を任意好適な含有量として含有していてもよい。口腔用組成物が任意の湿潤剤を含むことにより、使用感をより向上させることができる。 -Wetting agent-
The oral composition of the present embodiment may contain any suitable wettable agent conventionally known (excluding those used as the component (D) already described) as an optional suitable content. When the oral composition contains an arbitrary wetting agent, the feeling of use can be further improved.
湿潤剤としては、(D)成分として例示された多価アルコール以外の多価アルコールが好ましく、例えば、ソルビトール、エリスリトール、マルチトール、ラクチトール、キシリトール等の糖アルコール;還元でんぷん糖化物が挙げられる。湿潤剤の含有量は、通常、0~20質量%であり、好ましくは1~10質量%である。
As the wetting agent, polyhydric alcohols other than the polyhydric alcohol exemplified as the component (D) are preferable, and examples thereof include sugar alcohols such as sorbitol, erythritol, maltitol, lactitol, and xylitol; and reduced starch saccharified products. The content of the wetting agent is usually 0 to 20% by mass, preferably 1 to 10% by mass.
-粘結剤-
本実施形態の口腔用組成物は、従来公知の任意好適な粘結剤を任意好適な含有量として含有していてもよい。口腔用組成物が任意の粘結剤を含むことにより、粘度を最適化することができ、保形性、使用感をより向上させることができる。 -Blotting agent-
The oral composition of the present embodiment may contain any suitable binder conventionally known as an arbitrary suitable content. By including an arbitrary binder in the oral composition, the viscosity can be optimized, and the shape retention and usability can be further improved.
本実施形態の口腔用組成物は、従来公知の任意好適な粘結剤を任意好適な含有量として含有していてもよい。口腔用組成物が任意の粘結剤を含むことにより、粘度を最適化することができ、保形性、使用感をより向上させることができる。 -Blotting agent-
The oral composition of the present embodiment may contain any suitable binder conventionally known as an arbitrary suitable content. By including an arbitrary binder in the oral composition, the viscosity can be optimized, and the shape retention and usability can be further improved.
口腔用組成物が含み得る任意の粘結剤としては、従来公知の任意好適な有機粘結剤、例えば、多糖類、セルロース系粘結剤(例えば、カルボキシメチルセルロースナトリウム、ヒドロキシエチルセルロース、ヒドロキシプロピルセルロース、ヒドロキシプロピルメチルセルロース、メチルセルロース、カチオン化セルロース等)、その他の多糖系増粘剤(例、キサンタンガム、グアガム、ジェランガム、トラガントガム、カラヤガム、アラビヤガム、ローカストビーンガム、カラギーナン、アルギン酸ナトリウム、アルギン酸プロピレングリコール)、合成水溶性高分子(例、ポリアクリル酸ナトリウム、カルボキシビニルポリマー、ポリビニルピロリドン、ポリビニルアルコール)が挙げられる。任意の粘結剤の含有量は、0~1質量%であることが好ましく、0.1~0.8質量%であることがより好ましい。
As any binder that can be contained in the oral composition, any suitable organic binder conventionally known, for example, a polysaccharide, a cellulosic binder (for example, sodium carboxymethyl cellulose, hydroxyethyl cellulose, hydroxypropyl cellulose, etc.) Hydroxypropyl methylcellulose, methylcellulose, cationized cellulose, etc.), other polysaccharide thickeners (eg, xanthan gum, gua gum, gellan gum, tragant gum, karaya gum, arabiya gum, locust bean gum, carrageenan, sodium alginate, propylene glycol alginate), synthetic water Examples thereof include sex polymers (eg, sodium polyacrylate, carboxyvinyl polymer, polyvinylpyrrolidone, polyvinyl alcohol). The content of any binder is preferably 0 to 1% by mass, more preferably 0.1 to 0.8% by mass.
-pH調整剤-
本実施形態の口腔用組成物は、従来公知の任意好適なpH調整剤を任意好適な含有量として含有していてもよい。口腔用組成物がpH調整剤を含むことにより、口腔用組成物のpH安定性を確保することができる。 -PH regulator-
The oral composition of the present embodiment may contain a conventionally known arbitrary suitable pH adjuster as an arbitrary suitable content. When the oral composition contains a pH adjuster, the pH stability of the oral composition can be ensured.
本実施形態の口腔用組成物は、従来公知の任意好適なpH調整剤を任意好適な含有量として含有していてもよい。口腔用組成物がpH調整剤を含むことにより、口腔用組成物のpH安定性を確保することができる。 -PH regulator-
The oral composition of the present embodiment may contain a conventionally known arbitrary suitable pH adjuster as an arbitrary suitable content. When the oral composition contains a pH adjuster, the pH stability of the oral composition can be ensured.
pH調整剤としては、例えば、フタル酸、クエン酸、コハク酸、酢酸、フマル酸、リンゴ酸、及び乳酸等の有機酸又はそれらの塩、リン酸(オルトリン酸)等の無機酸又はそれらの塩(例えば、カリウム塩、ナトリウム塩及びアンモニウム塩)、水酸化ナトリウム、水酸化カリウム等の水酸化物が挙げられる。無機酸塩としては、例えば、リン酸水素二ナトリウム、リン酸二水素ナトリウムが挙げられる。
Examples of the pH adjuster include organic acids such as phthalic acid, citric acid, succinic acid, acetic acid, fumaric acid, malic acid and lactic acid or salts thereof, and inorganic acids such as phosphoric acid (orthoric acid) or salts thereof. (For example, potassium salt, sodium salt and ammonium salt), hydroxides such as sodium hydroxide and potassium hydroxide can be mentioned. Examples of the inorganic acid salt include disodium hydrogen phosphate and sodium dihydrogen phosphate.
pH調整剤の含有量は、通常、添加後の口腔用組成物のpHが5~9、好ましくは6~8.5となる量とすることができる。
The content of the pH adjuster can usually be such that the pH of the oral composition after addition is 5 to 9, preferably 6 to 8.5.
本明細書において、pH値は、通常、25℃、測定開始から3分間経過後の値をいう。pH値は、例えば、東亜電波工業社製のpHメーター(型番Hm-30S)を用いて測定することができる。
In the present specification, the pH value usually means a value at 25 ° C. after 3 minutes have passed from the start of measurement. The pH value can be measured using, for example, a pH meter (model number Hm-30S) manufactured by Toa Denpa Kogyo Co., Ltd.
-着色剤-
本実施形態の口腔用組成物は、従来公知の任意好適な着色剤を任意好適な含有量として含有していてもよい。 -Colorant-
The oral composition of the present embodiment may contain a conventionally known arbitrary suitable colorant as an arbitrary suitable content.
本実施形態の口腔用組成物は、従来公知の任意好適な着色剤を任意好適な含有量として含有していてもよい。 -Colorant-
The oral composition of the present embodiment may contain a conventionally known arbitrary suitable colorant as an arbitrary suitable content.
口腔用組成物が含み得る着色剤としては、例えば、ベニバナ赤色素、クチナシ黄色素、クチナシ青色素、シソ色素、紅麹色素、赤キャベツ色素、ニンジン色素、ハイビスカス色素、カカオ色素、スピルリナ青色素、タマリンド色素等の天然色素や、赤色2号、赤色3号、赤色104号、赤色105号、赤色106号、赤色227号、黄色4号、黄色5号、緑色3号、青色1号等の法定色素、リボフラビン、銅クロロフィンナトリウム、二酸化チタン等が挙げられる。口腔用組成物が着色剤を含む場合、その含有量は、口腔用組成物の全体に対し0.00001~3質量%とすることが好ましい。
Colorants that can be contained in the oral composition include, for example, Benibana red pigment, gardenia yellow, gardenia blue pigment, perilla pigment, red koji pigment, red cabbage pigment, carrot pigment, hibiscus pigment, cacao pigment, spirulina blue pigment, and the like. Natural pigments such as tamarind pigments and legal regulations such as red 2, red 3, red 104, red 105, red 106, red 227, yellow 4, yellow 5, green 3, and blue 1. Examples include dyes, riboflavin, sodium copper chlorofin, titanium dioxide and the like. When the oral composition contains a colorant, the content thereof is preferably 0.00001 to 3% by mass with respect to the entire oral composition.
-他の任意成分-
本実施形態の口腔用組成物は、上記以外の他の任意成分を任意好適な含有量として含有していてもよい。 -Other optional ingredients-
The oral composition of the present embodiment may contain an arbitrary component other than the above as an arbitrary suitable content.
本実施形態の口腔用組成物は、上記以外の他の任意成分を任意好適な含有量として含有していてもよい。 -Other optional ingredients-
The oral composition of the present embodiment may contain an arbitrary component other than the above as an arbitrary suitable content.
[口腔用組成物の剤形及び用途]
本発明の口腔用組成物は、常法に従う任意好適な方法により、任意好適な剤形とすることができる。剤形としては、例えば、液体(溶液、乳液、懸濁液、シロップ等)、半固体(ジェル、クリーム、ペースト等)、固体(錠剤、粒子状剤、カプセル剤、フィルム剤、混練物、溶融固体、ロウ状固体、弾性固体、ソフトカプセル剤等)が挙げられる。口腔用組成物の剤形は、好ましくは、液体、半固体である。 [Dosage form and use of oral composition]
The oral composition of the present invention can be in any suitable dosage form by any suitable method according to a conventional method. Dosage forms include, for example, liquids (solutions, emulsions, suspensions, syrups, etc.), semi-solids (gels, creams, pastes, etc.), solids (tablets, particulate agents, capsules, film agents, kneaded products, melts, etc.). Solids, waxy solids, elastic solids, soft capsules, etc.). The dosage form of the oral composition is preferably liquid or semi-solid.
本発明の口腔用組成物は、常法に従う任意好適な方法により、任意好適な剤形とすることができる。剤形としては、例えば、液体(溶液、乳液、懸濁液、シロップ等)、半固体(ジェル、クリーム、ペースト等)、固体(錠剤、粒子状剤、カプセル剤、フィルム剤、混練物、溶融固体、ロウ状固体、弾性固体、ソフトカプセル剤等)が挙げられる。口腔用組成物の剤形は、好ましくは、液体、半固体である。 [Dosage form and use of oral composition]
The oral composition of the present invention can be in any suitable dosage form by any suitable method according to a conventional method. Dosage forms include, for example, liquids (solutions, emulsions, suspensions, syrups, etc.), semi-solids (gels, creams, pastes, etc.), solids (tablets, particulate agents, capsules, film agents, kneaded products, melts, etc.). Solids, waxy solids, elastic solids, soft capsules, etc.). The dosage form of the oral composition is preferably liquid or semi-solid.
本発明の口腔用組成物は、口腔用途において広く利用することができる。固体である剤形での用途としては、例えば、トローチ、グミ、ガム、粉状又は錠剤の歯磨剤が挙げられる。半固体である剤形での用途としては、例えば、練歯磨剤、ジェル状歯磨剤が挙げられる。液体である剤形での用途としては、例えば、洗口剤、液体歯磨剤、口中清涼剤(スプレー等)が挙げられる。本発明の口腔用組成物は、良好な保湿実感を実現し、粉きしみ感が抑制され、さらには保形性、曳糸性等の物性を良好にできるので、歯磨剤(練歯磨剤、ジェル状歯磨剤)又は塗布剤(口腔用保湿ジェル、口腔用保湿クレーム)とすることが好ましい。
The oral composition of the present invention can be widely used in oral applications. Applications in solid dosage forms include, for example, troches, gummies, gums, powders or tablets of dentifrices. Examples of applications in the semi-solid dosage form include dentifrices and gel-like dentifrices. Examples of applications in the form of liquids include mouthwashes, liquid dentifrices, and mouthwashes (sprays and the like). The oral composition of the present invention realizes a good moisturizing sensation, suppresses a squeaky feeling, and can improve physical properties such as shape retention and spinnability. Therefore, a dentifrice (dentifrice, gel) can be obtained. It is preferably a dentifrice) or a coating agent (oral moisturizing gel, oral moisturizing claim).
[口腔用組成物の製造方法]
本発明の口腔用組成物の製造方法は特に限定されない。口腔用組成物は、選択された剤形に応じて、それぞれの通常の方法で製造され得る。例えば、口腔用組成物を練歯磨剤とする場合には、まず溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて、例えば減圧等することにより、さらに脱泡を行う製造方法が挙げられる。このようにして得られた練歯磨剤を、ラミネートチューブといったチューブ容器やポンプ型容器に収容することによって製品とすることができる。 [Manufacturing method of oral composition]
The method for producing the oral composition of the present invention is not particularly limited. Oral compositions can be prepared by their respective conventional methods, depending on the dosage form selected. For example, when the oral composition is used as a dentifrice, a component that dissolves in a solvent is first prepared, and then other insoluble components are mixed, and if necessary, the pressure is reduced, for example, to further remove the composition. A manufacturing method for foaming can be mentioned. The dentifrice thus obtained can be made into a product by accommodating it in a tube container such as a laminated tube or a pump-type container.
本発明の口腔用組成物の製造方法は特に限定されない。口腔用組成物は、選択された剤形に応じて、それぞれの通常の方法で製造され得る。例えば、口腔用組成物を練歯磨剤とする場合には、まず溶媒に溶解する成分を調製した後、それ以外の不溶性成分を混合し、必要に応じて、例えば減圧等することにより、さらに脱泡を行う製造方法が挙げられる。このようにして得られた練歯磨剤を、ラミネートチューブといったチューブ容器やポンプ型容器に収容することによって製品とすることができる。 [Manufacturing method of oral composition]
The method for producing the oral composition of the present invention is not particularly limited. Oral compositions can be prepared by their respective conventional methods, depending on the dosage form selected. For example, when the oral composition is used as a dentifrice, a component that dissolves in a solvent is first prepared, and then other insoluble components are mixed, and if necessary, the pressure is reduced, for example, to further remove the composition. A manufacturing method for foaming can be mentioned. The dentifrice thus obtained can be made into a product by accommodating it in a tube container such as a laminated tube or a pump-type container.
本発明の口腔用組成物が収容され得る容器の形状、材質は特に制限されない。口腔用組成物に使用される任意好適な従来公知の容器を使用することができる。容器としては、例えば、ポリエチレン、ポリプロピレン、ポリエチレンテレフタレート、ナイロンなどのプラスチック素材の容器等が挙げられる。
The shape and material of the container in which the oral composition of the present invention can be contained are not particularly limited. Any suitable conventionally known container used for the oral composition can be used. Examples of the container include a container made of a plastic material such as polyethylene, polypropylene, polyethylene terephthalate, and nylon.
以下、実施例及び比較例を示して本発明を具体的に説明する。本発明は下記実施例に制限されない。なお、表中の数値は特に断らない限り、各成分の純分量(AI量)、質量%を示す。
Hereinafter, the present invention will be specifically described with reference to Examples and Comparative Examples. The present invention is not limited to the following examples. Unless otherwise specified, the numerical values in the table indicate the pure content (AI amount) and mass% of each component.
[実施例及び比較例に使用された成分]
まず、実施例及び比較例において用いた成分について説明する。
(A)無機ケイ酸(シリカ):Solvay社製、Tixosil(登録商標)73(平均粒子径(体積基準D50):9μm)
(B)N-エチル-p-メンタン-3-カルボキサミド:シムライズ社製
N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド:ジボダン社製
3-l-メントキシプロパン-1,2-ジオール:高砂香料工業株式会社製
(C)グリチルリチン酸ジカリウム:丸善製薬社製
(D)濃グリセリン(99.5%):阪本薬品工業社製、化粧品用濃グリセリン
ポリエチレングリコール:三洋化成工業(株)製、ポリエチレングリコール400
((A)成分~(D)成分以外の成分)
カルボキシメチルセルロース(CMC):ダイセルファインケム(株)製、CMC1260
モノフルオロリン酸ナトリウム
サッカリンナトリウム
ポリオキシエチレン(20)硬化ヒマシ油
香料
上記成分については医薬部外品原料規格2006に適合した原料を用いた。 [Ingredients used in Examples and Comparative Examples]
First, the components used in Examples and Comparative Examples will be described.
(A) Inorganic silicic acid (silica): manufactured by Solvay, Tixosil (registered trademark) 73 (average particle size (volume standard D50): 9 μm)
(B) N-ethyl-p-menthan-3-carboxamide: N- (4-cyanomethylphenyl) -p-menthancarboxamide manufactured by Symrise: 3-l-mentoxypropane-1,2-diol manufactured by Dibodan: Takasago Perfume Industry Co., Ltd. (C) Dipotassium glycyrrhizinate: Maruzen Pharmaceuticals Co., Ltd. (D) Concentrated glycerin (99.5%): Sakamoto Pharmaceutical Co., Ltd., Concentrated glycerin polyethylene glycol for cosmetics: Sanyo Kasei Kogyo Co., Ltd. Polyethylene glycol 400
(Components other than component (A) to component (D))
Carboxymethyl cellulose (CMC): CMC1260 manufactured by Dycel Finechem Co., Ltd.
Sodium monofluorophosphate Sodium saccharinso Polyoxyethylene (20) Hardened castor oil Fragrance For the above ingredients, raw materials conforming to the quasi-drug raw material standard 2006 were used.
まず、実施例及び比較例において用いた成分について説明する。
(A)無機ケイ酸(シリカ):Solvay社製、Tixosil(登録商標)73(平均粒子径(体積基準D50):9μm)
(B)N-エチル-p-メンタン-3-カルボキサミド:シムライズ社製
N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド:ジボダン社製
3-l-メントキシプロパン-1,2-ジオール:高砂香料工業株式会社製
(C)グリチルリチン酸ジカリウム:丸善製薬社製
(D)濃グリセリン(99.5%):阪本薬品工業社製、化粧品用濃グリセリン
ポリエチレングリコール:三洋化成工業(株)製、ポリエチレングリコール400
((A)成分~(D)成分以外の成分)
カルボキシメチルセルロース(CMC):ダイセルファインケム(株)製、CMC1260
モノフルオロリン酸ナトリウム
サッカリンナトリウム
ポリオキシエチレン(20)硬化ヒマシ油
香料
上記成分については医薬部外品原料規格2006に適合した原料を用いた。 [Ingredients used in Examples and Comparative Examples]
First, the components used in Examples and Comparative Examples will be described.
(A) Inorganic silicic acid (silica): manufactured by Solvay, Tixosil (registered trademark) 73 (average particle size (volume standard D50): 9 μm)
(B) N-ethyl-p-menthan-3-carboxamide: N- (4-cyanomethylphenyl) -p-menthancarboxamide manufactured by Symrise: 3-l-mentoxypropane-1,2-diol manufactured by Dibodan: Takasago Perfume Industry Co., Ltd. (C) Dipotassium glycyrrhizinate: Maruzen Pharmaceuticals Co., Ltd. (D) Concentrated glycerin (99.5%): Sakamoto Pharmaceutical Co., Ltd., Concentrated glycerin polyethylene glycol for cosmetics: Sanyo Kasei Kogyo Co., Ltd. Polyethylene glycol 400
(Components other than component (A) to component (D))
Carboxymethyl cellulose (CMC): CMC1260 manufactured by Dycel Finechem Co., Ltd.
Sodium monofluorophosphate Sodium saccharinso Polyoxyethylene (20) Hardened castor oil Fragrance For the above ingredients, raw materials conforming to the quasi-drug raw material standard 2006 were used.
実施例1~16及び比較例1~6(試験口腔用組成物)
上述の成分を用いて、下記の調製方法に従って、下記表1~3に示す配合組成を有する試験口腔用組成物を調製した。 Examples 1 to 16 and Comparative Examples 1 to 6 (test oral composition)
Using the above-mentioned components, a test oral composition having the composition shown in Tables 1 to 3 below was prepared according to the following preparation method.
上述の成分を用いて、下記の調製方法に従って、下記表1~3に示す配合組成を有する試験口腔用組成物を調製した。 Examples 1 to 16 and Comparative Examples 1 to 6 (test oral composition)
Using the above-mentioned components, a test oral composition having the composition shown in Tables 1 to 3 below was prepared according to the following preparation method.
得られた試験口腔用組成物の粘度は、いずれも25℃で20~100Pa・sの範囲であった。
また、試験口腔用組成物の水分量は、配合前の原料に含まれる水分量の合計の全原料に対する割合(質量%)として算出し、下記表1~3に示した。 The viscosities of the obtained test oral compositions were all in the range of 20 to 100 Pa · s at 25 ° C.
The water content of the test oral composition was calculated as a ratio (mass%) of the total water content contained in the raw materials before compounding to all the raw materials, and is shown in Tables 1 to 3 below.
また、試験口腔用組成物の水分量は、配合前の原料に含まれる水分量の合計の全原料に対する割合(質量%)として算出し、下記表1~3に示した。 The viscosities of the obtained test oral compositions were all in the range of 20 to 100 Pa · s at 25 ° C.
The water content of the test oral composition was calculated as a ratio (mass%) of the total water content contained in the raw materials before compounding to all the raw materials, and is shown in Tables 1 to 3 below.
[試験口腔用組成物の調製方法]
下記表1~3に示す原料を常法により配合し、1.5Lニーダー(石山工作所社製)を用い常温で混合し、減圧(圧力4kPa)による脱泡を行い、歯磨剤(練歯磨剤)である試験口腔用組成物を得た。 [Preparation method of test oral composition]
The raw materials shown in Tables 1 to 3 below are blended by a conventional method, mixed at room temperature using a 1.5 L kneader (manufactured by Ishiyama Kosakusho Co., Ltd.), defoamed under reduced pressure (pressure 4 kPa), and dentifrice (dentifrice). ) Was obtained.
下記表1~3に示す原料を常法により配合し、1.5Lニーダー(石山工作所社製)を用い常温で混合し、減圧(圧力4kPa)による脱泡を行い、歯磨剤(練歯磨剤)である試験口腔用組成物を得た。 [Preparation method of test oral composition]
The raw materials shown in Tables 1 to 3 below are blended by a conventional method, mixed at room temperature using a 1.5 L kneader (manufactured by Ishiyama Kosakusho Co., Ltd.), defoamed under reduced pressure (pressure 4 kPa), and dentifrice (dentifrice). ) Was obtained.
得られた試験口腔用組成物を下記の手順で評価した。評価結果を下記表1~3に示した。
The obtained test oral composition was evaluated by the following procedure. The evaluation results are shown in Tables 1 to 3 below.
[評価方法]
-使用後の口腔内の保湿実感の評価-
試験口腔用組成物1gを歯ブラシ(クリニカアドバンテージ歯ブラシ、4列コンパクトふつう、ライオン社製:以下の評価方法において用いた歯ブラシも同様である。)のブラシ上に載せ、試験者が通常の方法でブラッシングしてすすいだ後(使用後)の、口腔内の保湿実感を、5段階で評価した。具体的には、下記の評点基準に従って採点した試験者10名の平均点を算出し、これに基づいて秀、優、良、可、不可と5段階で評価した。結果を下記表1~3に示した。 [Evaluation methods]
-Evaluation of moisturizing feeling in the oral cavity after use-
1 g of the test oral composition was placed on the brush of a toothbrush (Clinica Advantage toothbrush, 4-row compact, usually manufactured by Lion: the same applies to the toothbrush used in the following evaluation method), and the tester brushed it in the usual manner. The moisturizing sensation in the oral cavity after rinsing (after use) was evaluated on a 5-point scale. Specifically, the average score of 10 examiners who scored according to the following scoring criteria was calculated, and based on this, evaluation was made on a 5-point scale of excellent, excellent, good, acceptable, and unacceptable. The results are shown in Tables 1 to 3 below.
-使用後の口腔内の保湿実感の評価-
試験口腔用組成物1gを歯ブラシ(クリニカアドバンテージ歯ブラシ、4列コンパクトふつう、ライオン社製:以下の評価方法において用いた歯ブラシも同様である。)のブラシ上に載せ、試験者が通常の方法でブラッシングしてすすいだ後(使用後)の、口腔内の保湿実感を、5段階で評価した。具体的には、下記の評点基準に従って採点した試験者10名の平均点を算出し、これに基づいて秀、優、良、可、不可と5段階で評価した。結果を下記表1~3に示した。 [Evaluation methods]
-Evaluation of moisturizing feeling in the oral cavity after use-
1 g of the test oral composition was placed on the brush of a toothbrush (Clinica Advantage toothbrush, 4-row compact, usually manufactured by Lion: the same applies to the toothbrush used in the following evaluation method), and the tester brushed it in the usual manner. The moisturizing sensation in the oral cavity after rinsing (after use) was evaluated on a 5-point scale. Specifically, the average score of 10 examiners who scored according to the following scoring criteria was calculated, and based on this, evaluation was made on a 5-point scale of excellent, excellent, good, acceptable, and unacceptable. The results are shown in Tables 1 to 3 below.
(評点基準)
5点:口腔内の保湿実感を高く感じる
4点:口腔内の保湿実感を感じる
3点:口腔内の保湿実感をやや感じる
2点:口腔内の保湿実感をほとんど感じない
1点:口腔内の保湿実感を全く感じない
(評価基準)
秀:平均4.5点以上5.0点以下
優:平均4.0点以上4.5点未満
良:平均3.0点以上4.0点未満
可:平均2.0点以上3.0点未満
不可:平均1.0点以上2.0点未満 (Score criteria)
5 points: Feel the moisturizing feeling in the oral cavity 4 points: Feel the moisturizing feeling in the oral cavity 3 points: Feel the moisturizing feeling in the oral cavity a little 2 points: Feel the moisturizing feeling in the oral cavity almost 1 point: In the oral cavity I do not feel any moisturizing feeling (evaluation criteria)
Excellent: Average 4.5 points or more and 5.0 points or less Excellent: Average 4.0 points or more and less than 4.5 points Good: Average 3.0 points or more and less than 4.0 points Possible: Average 2.0 points or more and 3.0 No less than points: 1.0 points or more and less than 2.0 points on average
5点:口腔内の保湿実感を高く感じる
4点:口腔内の保湿実感を感じる
3点:口腔内の保湿実感をやや感じる
2点:口腔内の保湿実感をほとんど感じない
1点:口腔内の保湿実感を全く感じない
(評価基準)
秀:平均4.5点以上5.0点以下
優:平均4.0点以上4.5点未満
良:平均3.0点以上4.0点未満
可:平均2.0点以上3.0点未満
不可:平均1.0点以上2.0点未満 (Score criteria)
5 points: Feel the moisturizing feeling in the oral cavity 4 points: Feel the moisturizing feeling in the oral cavity 3 points: Feel the moisturizing feeling in the oral cavity a little 2 points: Feel the moisturizing feeling in the oral cavity almost 1 point: In the oral cavity I do not feel any moisturizing feeling (evaluation criteria)
Excellent: Average 4.5 points or more and 5.0 points or less Excellent: Average 4.0 points or more and less than 4.5 points Good: Average 3.0 points or more and less than 4.0 points Possible: Average 2.0 points or more and 3.0 No less than points: 1.0 points or more and less than 2.0 points on average
-磨き始めの粉きしみ感の評価-
試験口腔用組成物1gを歯ブラシのブラシ上に載せ、試験者が通常の方法でブラッシングを開始した時の、口腔内の粉きしみ感のなさを、下記に示す評点基準によって、5段階で評価した。試験者10名の平均点を算出し、下記の評価基準に従って、優、良、可、不可と4段階で評価した。結果を下記表1~3に示した。 -Evaluation of powder squeaky feeling at the beginning of polishing-
When 1 g of the test oral composition was placed on the brush of a toothbrush and the examiner started brushing by a usual method, the lack of powdery sensation in the oral cavity was evaluated on a 5-point scale according to the following scoring criteria. .. The average score of 10 testers was calculated and evaluated on a 4-point scale as excellent, good, acceptable, and unacceptable according to the following evaluation criteria. The results are shown in Tables 1 to 3 below.
試験口腔用組成物1gを歯ブラシのブラシ上に載せ、試験者が通常の方法でブラッシングを開始した時の、口腔内の粉きしみ感のなさを、下記に示す評点基準によって、5段階で評価した。試験者10名の平均点を算出し、下記の評価基準に従って、優、良、可、不可と4段階で評価した。結果を下記表1~3に示した。 -Evaluation of powder squeaky feeling at the beginning of polishing-
When 1 g of the test oral composition was placed on the brush of a toothbrush and the examiner started brushing by a usual method, the lack of powdery sensation in the oral cavity was evaluated on a 5-point scale according to the following scoring criteria. .. The average score of 10 testers was calculated and evaluated on a 4-point scale as excellent, good, acceptable, and unacceptable according to the following evaluation criteria. The results are shown in Tables 1 to 3 below.
(評点基準)
5点:磨き始めの粉きしみ感を全く感じない
4点:磨き始めの粉きしみ感をほとんど感じない
3点:磨き始めの粉きしみ感をわずかに感じるが許容範囲
2点:磨き始めの粉きしみ感を感じる
1点:磨き始めの粉きしみ感を強く感じる
(評価基準)
優:平均4.0点以上5.0点以下
良:平均3.0点以上4.0点未満
可:平均2.5点以上3.0点未満
不可:平均1.0点以上2.5点未満 (Score criteria)
5 points: No powder squeaky feeling at the beginning of polishing 4 points: Almost no powder squeaky feeling at the beginning of polishing 3 points: Slightly felt powder squeaky feeling at the beginning of polishing but allowable range 2 points: Powder squeaky feeling at the beginning of polishing 1 point to feel the feeling: I strongly feel the powdery squeaky feeling at the beginning of polishing (evaluation standard)
Excellent: Average 4.0 points or more and 5.0 points or less Good: Average 3.0 points or more and less than 4.0 points Possible: Average 2.5 points or more and less than 3.0 points Impossible: Average 1.0 points or more 2.5 Less than a point
5点:磨き始めの粉きしみ感を全く感じない
4点:磨き始めの粉きしみ感をほとんど感じない
3点:磨き始めの粉きしみ感をわずかに感じるが許容範囲
2点:磨き始めの粉きしみ感を感じる
1点:磨き始めの粉きしみ感を強く感じる
(評価基準)
優:平均4.0点以上5.0点以下
良:平均3.0点以上4.0点未満
可:平均2.5点以上3.0点未満
不可:平均1.0点以上2.5点未満 (Score criteria)
5 points: No powder squeaky feeling at the beginning of polishing 4 points: Almost no powder squeaky feeling at the beginning of polishing 3 points: Slightly felt powder squeaky feeling at the beginning of polishing but allowable range 2 points: Powder squeaky feeling at the beginning of polishing 1 point to feel the feeling: I strongly feel the powdery squeaky feeling at the beginning of polishing (evaluation standard)
Excellent: Average 4.0 points or more and 5.0 points or less Good: Average 3.0 points or more and less than 4.0 points Possible: Average 2.5 points or more and less than 3.0 points Impossible: Average 1.0 points or more 2.5 Less than a point
-曳糸性の評価-
まず、試験口腔用組成物を口内径8mmのラミネートチューブに充填し、次いで、試験口腔用組成物をラミネートチューブより歯ブラシのブラシ上に押し出して、約1g載せた後、上方向にラミネートチューブと歯ブラシを引き離した際の試験口腔用組成物剤の切れ(曳糸性)を試験した。 -Evaluation of spinnability-
First, the test oral composition is filled in a laminated tube having an inner diameter of 8 mm, and then the test oral composition is extruded from the laminated tube onto a toothbrush brush, and about 1 g is placed on the laminated tube, and then the laminated tube and the toothbrush are upwardly loaded. Test when the toothbrush was pulled apart The breakage (spinning property) of the oral composition was tested.
まず、試験口腔用組成物を口内径8mmのラミネートチューブに充填し、次いで、試験口腔用組成物をラミネートチューブより歯ブラシのブラシ上に押し出して、約1g載せた後、上方向にラミネートチューブと歯ブラシを引き離した際の試験口腔用組成物剤の切れ(曳糸性)を試験した。 -Evaluation of spinnability-
First, the test oral composition is filled in a laminated tube having an inner diameter of 8 mm, and then the test oral composition is extruded from the laminated tube onto a toothbrush brush, and about 1 g is placed on the laminated tube, and then the laminated tube and the toothbrush are upwardly loaded. Test when the toothbrush was pulled apart The breakage (spinning property) of the oral composition was tested.
曳糸性は、試験口腔用組成物が曳いた糸状部分の長さを測定することで評価することができる、下記の評価基準に従って、優、良、可、不可として4段階で評価した。結果を下記表1~3に示した。
The spinnability was evaluated on a 4-point scale as excellent, good, acceptable, and unacceptable according to the following evaluation criteria, which can be evaluated by measuring the length of the filamentous portion drawn by the test oral composition. The results are shown in Tables 1 to 3 below.
(評価基準)
優:曳糸性が0.5cm未満であり、切れが良い(使用性は良好)
良:0.5cm以上、0.7cm未満の曳糸性が認められる(使用性に問題なし)
可:0.7cm以上、1cm未満の曳糸性が認められる(使用性にやや問題はあるが許容できる)
不可:1cm以上の曳糸性が認められる(使用性に問題あり) (Evaluation criteria)
Excellent: Spinnability is less than 0.5 cm and sharpness is good (usability is good).
Good: Spinnability of 0.5 cm or more and less than 0.7 cm is observed (no problem with usability).
Possible: Spinning property of 0.7 cm or more and less than 1 cm is recognized (although there is a slight problem in usability, it is acceptable).
Impossible: Spinning property of 1 cm or more is recognized (problem with usability)
優:曳糸性が0.5cm未満であり、切れが良い(使用性は良好)
良:0.5cm以上、0.7cm未満の曳糸性が認められる(使用性に問題なし)
可:0.7cm以上、1cm未満の曳糸性が認められる(使用性にやや問題はあるが許容できる)
不可:1cm以上の曳糸性が認められる(使用性に問題あり) (Evaluation criteria)
Excellent: Spinnability is less than 0.5 cm and sharpness is good (usability is good).
Good: Spinnability of 0.5 cm or more and less than 0.7 cm is observed (no problem with usability).
Possible: Spinning property of 0.7 cm or more and less than 1 cm is recognized (although there is a slight problem in usability, it is acceptable).
Impossible: Spinning property of 1 cm or more is recognized (problem with usability)
-ラミネートチューブからの押し出し時における保形性の評価-
試験口腔用組成物を口内径8mmのラミネートチューブに充填し、ラミネートチューブより歯ブラシのブラシ上に試験口腔用組成物を押し出して、約1.0gのせた直後の状態(保形性)を下記の評価基準に従って、評価A、評価BH、評価BS、評価CH、評価CSとして評価した。結果を下記表1~3に示した。
(評価基準)
A :押し出された試験口腔用組成物は形状が保たれており、歯ブラシからたれ落ちることもない(使用性は良好)
BH:押し出された試験口腔用組成物は固いペースト状であるが、歯ブラシから転がり落ちない(使用性に問題なし)
BS:押し出された試験口腔用組成物は形状がやや崩れるが、歯ブラシからはたれ落ちない(使用性に問題なし)
CH:押し出された試験口腔用組成物は固いペースト状であり、歯ブラシから転がり落ちる(使用性に問題あり)
CS:押し出された試験口腔用組成物は形状が崩れ、歯ブラシからたれ落ちる(使用性に問題あり) -Evaluation of shape retention when extruded from laminated tube-
The test oral composition is filled in a laminated tube having an inner diameter of 8 mm, the test oral composition is extruded from the laminated tube onto a toothbrush, and the state (shape retention) immediately after about 1.0 g is applied is as follows. According to the evaluation criteria, it was evaluated as evaluation A, evaluation BH, evaluation BS, evaluation CH, and evaluation CS. The results are shown in Tables 1 to 3 below.
(Evaluation criteria)
A: The extruded test oral composition retains its shape and does not drip from the toothbrush (good usability).
BH: The extruded test oral composition is in the form of a hard paste, but does not roll off the toothbrush (no problem with usability).
BS: The extruded test oral composition slightly loses its shape but does not fall off the toothbrush (no problem with usability).
CH: The extruded test oral composition is in the form of a hard paste and rolls off the toothbrush (problems with usability).
CS: Extruded test oral composition loses its shape and drips from the toothbrush (problems with usability)
試験口腔用組成物を口内径8mmのラミネートチューブに充填し、ラミネートチューブより歯ブラシのブラシ上に試験口腔用組成物を押し出して、約1.0gのせた直後の状態(保形性)を下記の評価基準に従って、評価A、評価BH、評価BS、評価CH、評価CSとして評価した。結果を下記表1~3に示した。
(評価基準)
A :押し出された試験口腔用組成物は形状が保たれており、歯ブラシからたれ落ちることもない(使用性は良好)
BH:押し出された試験口腔用組成物は固いペースト状であるが、歯ブラシから転がり落ちない(使用性に問題なし)
BS:押し出された試験口腔用組成物は形状がやや崩れるが、歯ブラシからはたれ落ちない(使用性に問題なし)
CH:押し出された試験口腔用組成物は固いペースト状であり、歯ブラシから転がり落ちる(使用性に問題あり)
CS:押し出された試験口腔用組成物は形状が崩れ、歯ブラシからたれ落ちる(使用性に問題あり) -Evaluation of shape retention when extruded from laminated tube-
The test oral composition is filled in a laminated tube having an inner diameter of 8 mm, the test oral composition is extruded from the laminated tube onto a toothbrush, and the state (shape retention) immediately after about 1.0 g is applied is as follows. According to the evaluation criteria, it was evaluated as evaluation A, evaluation BH, evaluation BS, evaluation CH, and evaluation CS. The results are shown in Tables 1 to 3 below.
(Evaluation criteria)
A: The extruded test oral composition retains its shape and does not drip from the toothbrush (good usability).
BH: The extruded test oral composition is in the form of a hard paste, but does not roll off the toothbrush (no problem with usability).
BS: The extruded test oral composition slightly loses its shape but does not fall off the toothbrush (no problem with usability).
CH: The extruded test oral composition is in the form of a hard paste and rolls off the toothbrush (problems with usability).
CS: Extruded test oral composition loses its shape and drips from the toothbrush (problems with usability)
本発明の上記要件を満たしていない比較例1~6では、口腔内の保湿実感、特に使用初期(磨き始め)の粉きしみ感、曳糸性、保形性のいずれかの評価が低かったのに対し、本発明の上記要件を満たす実施例1~16においては、口腔内の保湿実感、使用初期の粉きしみ感、曳糸性、保形性の評価がいずれも良好であった。
また、グリセリンとポリエチレングリコールとを併用した実施例1~15及び比較例1~6にかかる口腔用組成物と歯ブラシとを用いて歯磨きを行った場合には、試験者は、ブラッシング中、刺激がない良好な温感を感じることができた。 In Comparative Examples 1 to 6 which did not satisfy the above requirements of the present invention, the evaluation of the moisturizing feeling in the oral cavity, particularly the powdery squeaky feeling at the initial stage of use (beginning of polishing), the spinnability, and the shape retention was low. On the other hand, in Examples 1 to 16 satisfying the above requirements of the present invention, the evaluation of the moisturizing feeling in the oral cavity, the powdery squeaking feeling at the initial stage of use, the spinnability, and the shape-retaining property were all good.
In addition, when toothbrushing was performed using the oral composition and the toothbrush according to Examples 1 to 15 and Comparative Examples 1 to 6 in which glycerin and polyethylene glycol were used in combination, the examiner was irritated during brushing. I could feel no good warmth.
また、グリセリンとポリエチレングリコールとを併用した実施例1~15及び比較例1~6にかかる口腔用組成物と歯ブラシとを用いて歯磨きを行った場合には、試験者は、ブラッシング中、刺激がない良好な温感を感じることができた。 In Comparative Examples 1 to 6 which did not satisfy the above requirements of the present invention, the evaluation of the moisturizing feeling in the oral cavity, particularly the powdery squeaky feeling at the initial stage of use (beginning of polishing), the spinnability, and the shape retention was low. On the other hand, in Examples 1 to 16 satisfying the above requirements of the present invention, the evaluation of the moisturizing feeling in the oral cavity, the powdery squeaking feeling at the initial stage of use, the spinnability, and the shape-retaining property were all good.
In addition, when toothbrushing was performed using the oral composition and the toothbrush according to Examples 1 to 15 and Comparative Examples 1 to 6 in which glycerin and polyethylene glycol were used in combination, the examiner was irritated during brushing. I could feel no good warmth.
Claims (7)
- (A)無機粉体、及び
(B)冷感剤
を含み、
界面活性剤の含有量が0.5質量%以下であり、
水分量が2質量%以下である、口腔用組成物。 Contains (A) inorganic powder and (B) cooling sensitizer
The content of the surfactant is 0.5% by mass or less,
An oral composition having a water content of 2% by mass or less. - (B)冷感剤が、N-エチル-p-メンタン-3-カルボキサミド、メンチルラクテート、メンチルモノサクシネート、イソプレゴール、メントングリセロールケタール、N-(4-シアノメチルフェニル)-p-メンタンカルボキサミド、3-l-メントキシプロパン-1,2-ジオール、5-メチル-2-プロパン-2-イル-N-(2-ピリジン-2-イルエチル)シクロヘキサン-1-カルボキサミド、3-(p-メンタン-3-カルボキサミド)酢酸エチル、2-イソプロピル-N,2,3-トリメチルブチルアミドからなる群から選ばれる少なくとも1種である、請求項1に記載の口腔用組成物。 (B) The cooling agent is N-ethyl-p-menthane-3-carboxamide, menthyllactate, menthylmonosuccinate, isopregol, mentonglycerol ketal, N- (4-cyanomethylphenyl) -p-menthancarboxamide, 3 -L-mentoxypropane-1,2-diol, 5-methyl-2-propane-2-yl-N- (2-pyridine-2-ylethyl) cyclohexane-1-carboxamide, 3- (p-menthane-3) -Carboxamide) The oral composition according to claim 1, which is at least one selected from the group consisting of ethyl acetate, 2-isopropyl-N, and 2,3-trimethylbutylamide.
- (A)無機粉体の含有量が2~50質量%である、請求項1又は2に記載の口腔用組成物。 (A) The oral composition according to claim 1 or 2, wherein the content of the inorganic powder is 2 to 50% by mass.
- (B)冷感剤の含有量が0.0001~0.3質量%である、請求項1~3のいずれか1項に記載の口腔用組成物。 (B) The oral composition according to any one of claims 1 to 3, wherein the content of the cooling sensation agent is 0.0001 to 0.3% by mass.
- (C)グリチルレチン酸、並びにグリチルリチン酸及びその塩からなる群から選ばれる1種以上をさらに含む、請求項1~4のいずれか1項に記載の口腔用組成物。 (C) The oral composition according to any one of claims 1 to 4, further comprising one or more selected from the group consisting of glycyrrhetinic acid and glycyrrhizic acid and a salt thereof.
- (D)溶媒をさらに含み、(D)溶媒が、融点が25℃以下の多価アルコールである、請求項1~5のいずれか1項に記載の口腔用組成物。 The oral composition according to any one of claims 1 to 5, further comprising (D) a solvent, and (D) a polyhydric alcohol having a melting point of 25 ° C. or lower.
- 歯磨剤又は塗布剤である、請求項1~6のいずれか1項に記載の口腔用組成物。 The oral composition according to any one of claims 1 to 6, which is a dentifrice or a coating agent.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN202180075386.0A CN116744890A (en) | 2020-11-10 | 2021-11-09 | Oral composition |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2020-187405 | 2020-11-10 | ||
JP2020187405A JP2022076813A (en) | 2020-11-10 | 2020-11-10 | Composition for oral cavity |
Publications (1)
Publication Number | Publication Date |
---|---|
WO2022102628A1 true WO2022102628A1 (en) | 2022-05-19 |
Family
ID=81602318
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
PCT/JP2021/041226 WO2022102628A1 (en) | 2020-11-10 | 2021-11-09 | Composition for oral cavity |
Country Status (3)
Country | Link |
---|---|
JP (1) | JP2022076813A (en) |
CN (1) | CN116744890A (en) |
WO (1) | WO2022102628A1 (en) |
Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005015432A (en) * | 2003-06-27 | 2005-01-20 | Lion Corp | Tablet dentifrice |
JP2011046654A (en) * | 2009-08-27 | 2011-03-10 | Lion Corp | Dentifrice composition |
JP2011522871A (en) * | 2008-06-17 | 2011-08-04 | ザ プロクター アンド ギャンブル カンパニー | Compositions and methods for improving general dental health and appearance |
-
2020
- 2020-11-10 JP JP2020187405A patent/JP2022076813A/en active Pending
-
2021
- 2021-11-09 CN CN202180075386.0A patent/CN116744890A/en active Pending
- 2021-11-09 WO PCT/JP2021/041226 patent/WO2022102628A1/en active Application Filing
Patent Citations (3)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2005015432A (en) * | 2003-06-27 | 2005-01-20 | Lion Corp | Tablet dentifrice |
JP2011522871A (en) * | 2008-06-17 | 2011-08-04 | ザ プロクター アンド ギャンブル カンパニー | Compositions and methods for improving general dental health and appearance |
JP2011046654A (en) * | 2009-08-27 | 2011-03-10 | Lion Corp | Dentifrice composition |
Also Published As
Publication number | Publication date |
---|---|
JP2022076813A (en) | 2022-05-20 |
CN116744890A (en) | 2023-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
WO2008059881A1 (en) | Oral composition containing crystalline cellulose surface-treated with water-soluble substance | |
JP5233399B2 (en) | Oral spray composition and oral preparation | |
JP2022000420A (en) | Oral cavity composition | |
JP2003104858A (en) | Composition for oral cavity | |
TWI806916B (en) | Pump type toothpaste composition and pump type toothpaste | |
WO2022102628A1 (en) | Composition for oral cavity | |
JP3189549B2 (en) | Oral composition | |
JP2007070256A (en) | Dentifrice composition | |
JP7347916B2 (en) | dentifrice composition | |
WO2022075422A1 (en) | Dentifrice composition | |
JP4126140B2 (en) | Oral composition | |
WO2022145160A1 (en) | Composition for oral cavity | |
WO2022138487A1 (en) | Oral composition | |
JP7034612B2 (en) | Oral composition | |
JP7000823B2 (en) | Toothpaste composition | |
WO2022145167A1 (en) | Oral composition | |
WO2023277084A1 (en) | Composition for oral cavity | |
WO2022145162A1 (en) | Composition for oral cavity | |
WO2022145166A1 (en) | Composition for oral use | |
WO2022071593A1 (en) | Dentifrice composition | |
JP2024000720A (en) | Composition for oral cavity | |
JP2022046221A (en) | Dentifrice composition | |
WO2022054959A1 (en) | Composition for oral cavity | |
JP5720416B2 (en) | Gel oral composition and method for producing the same | |
JP5489479B2 (en) | Oral microgel |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
121 | Ep: the epo has been informed by wipo that ep was designated in this application |
Ref document number: 21891874 Country of ref document: EP Kind code of ref document: A1 |
|
WWE | Wipo information: entry into national phase |
Ref document number: 202180075386.0 Country of ref document: CN |
|
NENP | Non-entry into the national phase |
Ref country code: DE |
|
122 | Ep: pct application non-entry in european phase |
Ref document number: 21891874 Country of ref document: EP Kind code of ref document: A1 |